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Zusammenfassung 
 
Struktur-Funktions-Analyse des Hsp70-Kochaperons Bag-1 
Molekulare Chaperone der Hitzeschockprotein 70 (Hsp70)-Familie sind 
konserviert von E. coli bis zu Säugetieren. Sie assistieren sowohl der Faltung 
naszierender Proteine als auch der Rückfaltung von Proteinen, die durch Streß denaturiert 
wurden. In Eukaryoten existieren Paraloge im endoplasmatischen Reticulum und in 
Mitochondrien. Strukturell sind Hsp70-Proteine aus einer amino-terminalen ATPase-
Domäne und einer carboxy-terminalen Peptidbindungsdomäne aufgebaut. Im 
eukaryotischen Zytosol agiert Hsp70 zusammen mit verschiedenen Kochaperonen, die 
entweder die ATP-Hydrolyse oder die Peptidbindung beeinflussen oder eine Verbindung 
zum Hsp90-Chaperon-System vermitteln. Das Kochaperon Bag-1 stimuliert die ATPase-
Rate von Hsp70 in Abhängigkeit von Hsp40, einem weiteren Kochaperon von Hsp70, 
und ist involviert in verschiedene zelluläre Prozesse wie zum Beispiel Transkription und 
Apoptose. 
 Eine stabile Domäne von humanem Bag-1M (Bag-Domäne) wurde durch 
limitierte Proteolyse bestimmt. Die isolierte Bag-Domäne weist die gleiche Affinität zu 
Hsp70 und dessen ATPase-Domäne auf wie das Bag-1-Vollängenprotein. Weiterhin 
steigert die Bag-Domäne die Hsp40-stimulierte ATP-Hydrolyse von Hsp70 und die 
Nukleotid-abhängige Substrat-Freisetzung vom Chaperon in gleichem Maße wie das Bag-
1-Vollängenprotein. Kristallisation und Strukturlösung eines Komplexes bestehend aus 
der ATPase-Domäne von Hsc70, dem konstitutiv-exprimierten, zytosolischen Hsp70 und 
der Bag-Domäne führte zu einem 1.9 Å-Modell des Nukleotid-freien Komplexes. Dabei 
induziert die Bag-Domäne eine Konformation in Hsp70, die identisch ist mit der des 
bakteriellen Hsp70-Homologs, DnaK, wenn dieses den Nukleotidaustauschfaktor GrpE 
gebunden hat. Dieses Ergebnis etabliert Bag-1 und andere Proteine, die eine Bag-Domäne 
enthalten, als GrpE-ähnliche Nukleotidaustauschfaktoren von Hsp70, obwohl Bag-1 und 
GrpE keine Sequenzhomologien aufweisen. Diese Frage wurde bisher in der Literatur 
kontrovers diskutiert. Die hohe Auflösung der Komplex-Struktur erlaubte eine detailierte 
Analyse der konformationellen Änderungen der Reste in der ATP-Bindetasche von 
Hsp70, die an der ATP-Bindung und -Hydrolyse beteiligt sind. Mutationsanalysen 
bestätigten die biochemischen Vorhersagen über die Relevanz der Bindung von Bag-1 an 
Hsp70. Außerdem wurden weitere Bag-Proteine in sämtlichen eukaryotischen 
Organismen durch strukturelle Sequenzvergleichsanalyse identifieziert. Das so 
identifizierte Bag-Protein von S. sereviciae, Snl1p, wurde biochemisch analysiert, um 
dessen Funktion als Bag-homologen Nukleotidaustauschfaktor für Hsp70-Chaperone zu 
verifizieren. 
 
 
Rezeptor-vermittelte Bindung und Aufnahme von Hsp70 durch Antigen-
präsentierende Zellen 
Neben der zentralen Rolle bei der Proteinfaltung wurde gezeigt, daß molekulare 
Chaperone spezifische Immunantworten gegen verschiedene Tumorarten als auch gegen 
Virus-infizierte Zellen auslösen können. Die Rezeptor-vermittelte Endozytose von 
Chaperon-Peptid-Komplexen wird dabei als ein entscheidender Schritt diskutiert. Der 
molekulare Mechanismus der Chaperon-vermitttelten Tumorregression ist jedoch bislang 
weitestgehend unverstanden. 
Im zweiten Teil der vorliegenden Arbeit wurde eine auf der Durchflusszytometrie 
basierende Methode entwickelt, um die spezifische Bindung des humanen, zytosolischen 
Hsp70-Proteins an professionelle Antigen-präsentierende Zellen zu zeigen. Die 
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Behandlung der Zelloberfläche mit Proteasen resultierte im Verlust der spezifischen 
Bindung von Hsp70 und demonstrierte damit die Existenz eines Proteinrezptors. Die 
Bindungsstellen für Hsp70 auf der Zelloberfläche konnten gesättigt werden. Die Affinität 
des Hsp70-Rezeptors liegt im submikromolaren Bereich. Die Bindung war insensitiv 
gegenüber der Anwesenheit von Nukleotid, Peptid und Kochaperonen, jedoch spezifisch 
für Hsp70 und Hsc70 von höheren Eukaryoten. Außerdem war die Hsp70-Bindung 
ausgesprochen Zelltyp-spezifisch und wurde nur an Makrophagen und Monocyten 
beobachtet. Die Bindung wurde nicht durch CD14 vermittelt, den Rezeptor für 
Lipopolysaccharide, der für Zellen dieser Abstammungslinie charakteristisch ist, und 
außerdem in der Chaperon-vermittelten Aktivierung von Monocyten beteiligt ist. 
Gebundenes Hsp70 wurde bei physiologischen Temperaturen von den Zellen endozytiert, 
welches zu einer vesikulären Färbung führte. Diese Ergebnisse liefern die Basis für 
weitere Untersuchungen der molekularen Mechanismen Chaperon-vermittelter 
Antigenpräsentierung, bzw. der Aktivierung von Monocyten und Makrophagen durch 
molekulare Chaperone. 
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A Summary 
Structure/function analysis of the Hsp70 cochaperone Bag-1 
 Molecular chaperones of the heat shock protein 70 (Hsp70) family are conserved 
from E. coli to mammals and assist the folding of nascent proteins as well as the refolding 
of proteins denatured under stress. In eukaryotes, Hsp70 paralogs exist in the endoplasmic 
reticulum and mitochondria. Structurally, all family members contain an N-terminal 
ATPase domain and a C-terminal peptide binding domain. In the eukaryotic cytosol, 
Hsc70 acts together with various cochaperones which either influence ATP hydrolysis or 
the peptide binding state of Hsp70, or functionally connect Hsp70 to the Hsp90 chaperone 
system. The cochaperone Bag-1 stimulates the ATPase rate of Hsp70 in a Hsp40 
dependent manner, and functions in cellular processes such as transcription and control of 
apoptosis. 
 A stable domain of human Bag-1 was defined by limited proteolysis. The domain 
had the same affinity for the ATPase domain of Hsp70 as the full length proteins, as 
measured by isothermal titration calorimetry. Furthermore, the domain is fully functional 
in stimulating the ATPase rate of Hsc70, and in nucleotide-dependent release of 
polypeptide substrate from the chaperone. Crystallization and structure solution of the 
complex of the fragment of Bag-1 and the ATPase domain of Hsc70 led to a 1.9 Å model 
of the nucleotide-free complex. Interestingly, Bag-1 induced a conformational change in 
Hsp70 identical to that induced in the bacterial Hsp70 chaperone DnaK by the 
cochaperone GrpE. This suggests that like GrpE, Bag-1 may act as a nucleotide exchange 
factor for Hsp70, although there is no sequence similarity between the two cochaperones. 
The high resolution of the structure allowed an analysis of the conformational changes of 
residues which would contact the nucleotide providing insight into the molecular 
mechanism by which nucleotide exchange is achieved. Mutational analysis confirmed the 
biochemical predictions. Various Bag homologs were predicted based on the presence of 
key residues involved in mediating the interaction of the Bag domain with Hsp70. The 
proposed S.cerevisiae Bag protein, Snl1p, was analyzed biochemically confirming its 
function as a Bag homolog. 
 
 
Receptor-mediated binding and uptake of Hsp70 by antigen presenting cells 
Besides their important role in protein folding, chaperones have been shown more 
recently to mediate specific immune responses against various tumors as well as virally 
infected cells, a process proposed to involve receptor-mediated endocytosis of chaperone-
peptide complexes. However, the molecular mechanism behind this chaperone-mediated 
anti-tumor response is only poorly understood. 
In the second part of this thesis, a flow cytometry-based assay was established to 
analyze the specific binding of mammalian cytosolic, stress-inducible Hsp70 and 
constitutively expressed Hsc70 to the cell surface of professional antigen presenting cells. 
Treatment of the cell surface with proteases resulted in loss of binding, demonstrating the 
existence of a proteinaceous receptor. Binding was saturable and occured with sub-
micromolar affinity. Hsp70 binding was highly cell-type specific and was restricted to 
cells from the monocyte/macrophage lineage. However, the binding was apparently not 
mediated by CD14, the LPS receptor, which was reported to be involved in Hsp70-
mediated activation of macrophages and monocytes. Bound Hsp70 was internalized into 
an intracellular, vesicular compartment. These results provide the basis for a molecular 
dissection of the pathway of Hsp70-mediated antigen presentation. 
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B Introduction 
 
 
B.1 Chaperone mediated protein folding 
 Proteins are central to all biological processes such as metabolism, motility, intra- 
as well as intercellular communication and transport, and maintenance of cellular 
structure. All these processes rely on highly specific molecular recognition mechanisms, 
which are manifested in the three-dimensional fold of proteins. Proteins are synthesized 
as linear polypeptide chains, which in theory could adopt an enormous number of 
different conformations, but in vivo their native, active structure is usually well defined 
and attained efficiently. The aim of protein folding research is to understand how this 
highly selective process is achieved and maintained. 
 
 
B.1.1 Protein folding in vitro 
 In the late 1960’s, Anfinsen performed key experiments on protein refolding in 
vitro, monitoring the gain of activity of purified, heat-denatured Ribonuclease A as a 
measure of productive folding (Taniuchi and Anfinsen, 1969). His experiments 
demonstrated that the information necessary for reaching the native, folded state lies in 
the amino acid sequence of the folding protein itself, as folding occured spontaneously 
without the aid by additional factors (Anfinsen, 1972; Anfinsen, 1973). The folding 
reaction was reversible and proceeded with biologically relevant kinetics (usually within 
seconds) (Schechter et al., 1970). 
 The Levinthal paradox illustrates in a striking manner the complexity of the 
folding problem. Given a protein consisting of 100 amino acids and assuming that each 
amino acid only adopts the two most stable conformations of its main chain (a and b) 
(Ramachandran and Sassiekharan, 1968; Branden and Tooze, 1991), there would be 1030 
different conformations the chain could adopt. An unbiased, random folding process 
leading to the native structure, i.e. to a defined structure among the 1030 possible ones, 
would take over a billion years, even if a single conformational change would take only 
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10-11 sec (Levinthal, 1968; Levinthal, 1969), a conundrum that became known as the 
Levinthal paradox. As a possible solution, it was suggested that folding occurs along a 
vectorial route via folding intermediates containing increasing amounts of native-like 
structural elements (Baldwin, 1996; Privalov, 1996; Ptitsyn, 1998). This idea of a defined 
folding pathway was suggested to minimize the number of conformations that must be 
reached during the folding process. In the following years, folding intermediates were 
detected for several proteins, including apomyoglobin, ribonuclease A, barstar and 
lysozyme (Scheraga et al., 1984; Udgaonkar and Baldwin, 1990; Radford et al., 1992; 
Barrick and Baldwin, 1993; Agashe et al., 1995; Jamin and Baldwin, 1996; Matagene et 
al., 1997; Wildegger and Kiefhaber, 1997). 
 More recently, experiments demonstrating the existence of multiple folding 
pathways for a given protein have led to a more complex view of protein folding 
reactions. Rather than following a defined pathway, the folding process is described by an 
energy landscape or folding funnel with a vast array of down-hill routes to the native state 
(Baldwin, 1995; Dobson et al., 1998). Typically, the native state of a protein can be 
described thermodynamically as the free energy minimum of all possible structures (the 
bottom of the folding funnel). Populated intermediates could be either transient states 
(local energy minima) or kinetically trapped states (misfolded states) (Radford, 2000; 
Schultz, 2000). Whether a denatured protein is prone to intramolecular aggregation or 
reaches the native state efficiently depends on the rate of the folding process, that is how 
fast a globular structure is reached in which hydrophobic surfaces are minimally exposed. 
How a given amino acid sequence encodes a defined three-dimensional structure is not 
yet understood precisely. 
 
 
B.1.2 Protein folding in the cell 
Protein folding in vitro differs substantially from protein folding in a living cell. 
The high complexity of the latter process is due to the very high concentration of 
macromolecules in the cell (about 300 g/l) providing a crowded environment. This results 
in different thermodynamic properties of partially folded proteins and in stronger 
competition of unproductive side reactions (aggregation) with the productive folding 
pathway compared to the situation in vitro (Hartl, 1996; Ellis, 1997). The in vivo situation 
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is complicated further by an intimate coupling of biosynthesis and folding since the rate 
of folding is much faster (t1/2 < 1 sec) than the translation rate (4-20 amino acids per sec). 
Emerging polypeptides at the ribosome either fold cotranslationally or have to be 
protected from aggregation and misfolding until translation is complete (Netzer and Hartl, 
1998). Other restrictions in parameters such as ionic strength, temperature and pH within 
the cell limit the possible folding pathways additionally. 
In the past decade, a cellular machinery of various proteins, called molecular 
chaperones, has been identified and studied. These proteins capture nonnative structures 
of other proteins, assist their proper folding but are themselves not components of the 
final biologically active structure (Hartl, 1996; Bukau and Horwich, 1998). To do this, 
chaperones recognize exposed hydrophobic surfaces of nascent or misfolded polypeptides 
which will be buried in the native state (Dobson et al. 1998). Binding and release of 
bound polypeptide substrates by chaperones is often achieved by ATP-driven 
conformational changes, permitting multiple rounds of interactions between substrates 
and the folding machinery. Nevertheless, chaperones do not provide an input of structural 
information in the folding process and hence chaperone action is in agreement with 
Anfinsen’s findings that the primary sequence determines the native fold (Anfinsen, 
1973). It was suggested that chaperones provide an environment in which the productive 
pathway leading to the native structure, the thermodynamic free energy minimum in the 
folding landscape, is favored and the accumulation of kinetically trapped intermediates is 
minimized. Chaperones are not folding catalysts in that they typically increase the yield 
but not the rate of a folding reaction, and can even slow down folding kinetics in some 
cases. This is in contrast to folding catalysts like peptidylprolyl isomerases or protein 
disulfide isomerases, which catalyze isomerization reactions required for folding. 
Besides their function in de novo protein folding, molecular chaperones can refold 
proteins that have become misfolded because of some denaturing stress on the cell. 
Consistent with this, chaperone expression is upregulated upon cellular stress (heat shock, 
oxidative stress, etc.), i.e. under conditions that increase the danger of misfolding or 
aggregation. In addition to protein folding, chaperones are involved in several other 
cellular processes, e.g. protein targeting, degradation, and signal transduction (Ellis, 
2000). 
Despite these sophisticated chaperone mechanisms, there are special cases where 
mutant proteins with aberrant stability or folding remain misfolded persistently. In recent 
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years, it has been realized that the basis for several diseases (e.g. Creutzfeld-Jakob, 
Alzheimers or Huntingtons disease) lies in a conformational change or aggregation of 
proteins (Cohen, 2000; Dobson, 1999; Wanker, 2000). 
 
 
B.1.3 Chaperone families and folding networks 
 During translation, the polypeptide chain of a nascent protein appears at the 
ribosome exposed to the cytosol. Folding into a stable tertiary structure is only possible 
once a domain has been translated. Hydrophobic surfaces will be exposed during protein 
synthesis until the full information for its tertiary structure has been translated. Especially 
on polysomes, the local accumulation of aggregation-prone surfaces would be 
problematic for the cell if efficient chaperone machines did not exist (Goodsell, 1991). 
 Prevention of aggregation of nascent chains is achieved by binding of chaperones 
and other factors to exposed hydrophobic surfaces. In bacteria, there are two ribosome-
bound factors that recognize newly synthezised polypeptide chains, namely the 
peptidylprolyl isomerase trigger factor and the 70 kDa heat shock protein (Hsp70) 
homolog DnaK (Deuerling et al, 1999; Teter et al., 1999). The situation in eukaryotes is 
less well established. In yeast, Ssb proteins, specialized Hsp70 proteins, bind to nascent 
chains on the ribosome (Pfund et al., 1998). With increasing polypeptide length, 
chaperones of the Hsp40/DnaJ and Hsp70/DnaK family bind to exposed hydrophobic 
stretches in bacteria and higher eukaryotes (Langer et al., 1992; Frydman et al., 1994). 
The Hsp70 family represents the most highly conserved of the heat shock proteins 
being at least 45% identical in sequence between the most distantly related species 
(Bukau and Horwich, 1998). It includes constitutively expressed and inducible members 
in several cellular compartments (e. g. Hsc70 and Hsp70 in the mammalian cytosol, Ssa 
in the yeast cytosol, BiP/Grp78 in the endoplasmic reticulum, and mitochondrial Hsp70). 
Hsp70 proteins are very abundant accounting for as much as 1-2% of total cellular protein 
(Herendeen et al., 1979). Most of the biochemical work has been carried out with the 
bacterial chaperone DnaK. Nevertheless, it is believed that the eukaryotic Hsp70s in 
principle function in a similar manner. Henceforth, the general term ‘Hsp70’ will be used 
for all members of this familiy; when appropriate, the distinction will be made between 
the different mammalian homologs, especially the constitutive (Hsc70) and inducible 
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(Hsp70) homologs. The mechanism and function of Hsp70 and Hsp40 will be described 
in more detail in the following chapters. 
 In addition to their association with nascent chain-binding chaperones, slow-
folding proteins with a tendency to aggregate (10-30% of all bacterial proteins; Horwich 
et al., 1993; Ewalt et al., 1997) can interact with another chaperone system which 
provides a sequestrated environment for folding, the barrel-shaped chaperonins. 
Representatives in eukaryotes are the cytosolic TRiC/CTT and the mitochondrial Hsp60, 
but the best-characterized chaperonin is the bacterial protein GroEL. GroEL is composed 
of 14 subunits with a molecular weight of 60 kDa each (Langer et al, 1992). The subunits 
assemble into two rings forming a cylinder-shaped structure with two central cavities 
(Braig et al., 1994). In contrast to Hsp70 proteins, which bind linear sequences, the 
chaperonins recognize collapsed folding intermediates (molten globules) (Hayer-Hartl et 
al., 1994). The cochaperone GroES (Hsp10 in mitochondria) closes the GroEL cavity and 
the substrate molecule is completely encapsulated by the chaperone complex. The cavity 
provides a hydrophilic environment in which the protein can fold into its native structure 
in one or more rounds of interaction with the chaperone system (Martin et al., 1993; 
Mayhew et al., 1996). Thereby, substrate binding and release is regulated by the ATPase 
activity of GroEL. 
 The eukaryotic chaperonin works independently of a GroES cofactor but it is 
likely that its general mechanism is comparable to GroEL/ES. Helical extensions at each 
subunit are suggested to fulfil the function of the cochaperone (Klumpp et al., 1997). 
Nevertheless, substrate-specificity seems to be more restricted for the eukaryotic 
chaperonins. So far, only actin and tubulin have been identified as substrates in vivo. 
There is also a recently identified factor, Prefoldin/Gim, probably working in concert with 
the chaperonin system (Vainberg et al. 1998; Leroux and Hartl, 2000). 
 A scheme of the protein folding pathways in the cytosol of prokaryotes and 
eukaryotes is presented in Figure 1 (modified from Bukau et al., 2000). As indicated, only 
two systems, the Hsp70/DnaK and chaperonin systems, are capable of promoting folding 
proteins as opposed to simply preventing aggregation. In some cases these also work 
cooperatively. All other chaperone families mentioned in the next paragraphs bind to 
(partially) unfolded proteins and prevent their aggregation but require specific 
interactions with Hsp70/DnaK or the chaperonins to promote refolding. Others work 
downstream of Hsp70, e.g. Hsp90, and possess a more specialized function. 
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Figure 1. Overview of protein folding pathway in the prokaryotic and eukaryotic cytosol. 
(modified from Bukau et al., 2000). Gim, genes involved in microtubule biogenesis; TF, 
trigger factor; TRiC/CCT, cytosolic chaperonin TCP-1. 
 
 
 The 90 kDa heat shock protein (Hsp90) family is a chaperone system acting 
downstream of Hsp70/Hsp40 with a more restricted role in protein folding. Although the 
function of the bacterial homolog, HtpG, has remained enigmatic, the function and 
mechanism of the mammalian Hsp90 is reasonably well established. Hsp90 consists of 
three domains: a N-terminal ATPase domain, a middle domain, and a C-terminal 
dimerization domain (Stebbins et al, 1997). As for Hsp70, the extreme C-terminus 
contains the EEVD peptide motif known to mediate binding to one of the TPR-domains 
of the Hsp70-Hsp90 organizing protein p60/Hop and other TPR-domain containing 
proteins (Scheufler et al, 2000). The N-terminal and C-terminal domain possess general 
chaperone activity in vitro (Young et al., 1997; Scheibel et al., 1998). However, Hsp90 
seems to bind a more restricted subset of client proteins in vivo (Nathan et al., 1997), 
being highly specific for signal transduction molecules, e.g. steroid hormone receptors 
and protein kinases. It is involved in the maturation of these signalling molecules rather 
than possessing the function of a general chaperone (Smith, 2000). 
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 The ATPase activity of Hsp90 is essential in vivo in regulating substrate binding 
and release by the chaperone (Obermann et al., 1998; Panaretou et al., 1998; Young and 
Hartl, 2000). Although crystal structures of the ATPase domain with bound ATP or ADP 
do not show any major differences, major conformational changes in the Hsp90 dimer 
have been observed by electron microscopy and biochemical assays depending on the 
bound nucleotide (Maruya et al., 1999; Prodromou et al., 2000). Hsp90 function 
furthermore relies on several cofactors depending on the client protein bound. Among 
these are the peptidylprolylisomerases (immunophilins and cyclophilins), p50/cdc37, p23 
and the serine/threonine phosphatase 5 (Pratt and Toft, 1997; Silverstein et al., 1997; Pratt 
et al., 1999; Weaver et al., 2000; Young and Hartl, 2000). 
 The Hsp90 paralog in the endoplasmic reticulum (ER), Grp94 (also known as 
Gp96 and endoplasmin), is less characterized with regard to function, mechanism, and 
regulation in protein folding/assembly (Nicchitta, 1998). However, like Hsp70, Grp94 has 
a function in immunology unrelated to protein folding, which will be introduced in the 
second part of this thesis. 
 Small heat shock proteins are a class of stress-inducible molecular chaperones 
which bind unfolded proteins preventing aggregation (van den IJssel et al., 1999). 
Subsequent refolding is achieved by the Hsp70 and/or chaperonin systems. Members in 
the eukaryotic cytosol are Hsp12, Hsp42 and the mammalian a-crystallin. The bacterial 
small heat shock proteins IbpA and IbpB also prevent aggregation and have been found 
associated with inclusion bodies. 
 Hsp100/Clp proteins are yet another class of chaperones. Their unique function is 
the disassembly of protein oligomers and aggregates which can subsequently refolded by 
the Hsp70/Hsp40 system or degraded by the proteasome (Glover and Lindquist, 1998; 
Schirmer et al., 1996). 
 Besides these cytosolic factors, there exist several other more specialized 
chaperones in various cellular compartments, whose more detailed discussion is beyond 
the scope of this introduction. Among these, Calreticulin and Calnexin, chaperones 
resident in the endoplasmic reticulum, function in the folding and assembly pathway of 
secreted proteins. As described in section 2, Calreticulin also has immune stimulatory 
properties. 
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C Structure/function analysis of the Hsp70 cochaperone Bag-1 
 
 
C.1 Introduction 
 The activity of molecular chaperones from several families, e.g. the Hsp60 system 
(including GroEL/ES and TRiC/CTT), Hsp70, and Hsp90, is dependent on ATP binding 
and hydrolysis. Further regulation is achieved by cofactors modulating various steps of 
the reaction cycle. In this chapter, the Hsp70 chaperone system will be described in detail 
with emphasis on its ATPase cycle and its cochaperones. This will be the basis for the 
structure/function analysis of Bag proteins, regulators of eukaryotic Hsp70. 
 
 
C.1.1 Cellular function of Hsp70 
 As a result of its function in de novo protein folding and prevention of aggregation 
(see general introduction), Hsp70 is involved in several cellular processes in addition to 
protein folding, including targeting and translocation, degradation, apoptosis and stress 
signalling (Jensen and Johnson, 1999; Pilon and Schekman, 1999; Saleh et al., 2000; 
Beere et al., 2000; McClellan and Frydman, 2001). These functions are briefly outlined 
here. 
 During biogenesis at the ribosome and translocation across intracellular 
membranes, nascent polypeptide chains targeted to the endoplasmic reticulum or 
mitochondria have to be kept in a translocation competent state and additionally 
aggregation of the partially unfolded protein must be prevented. For post-translationally 
targeted proteins, this is mainly achieved by cytosolic Hsp70 proteins (Chirico et al., 
1988; Deshaies et al., 1988; Murakami et al, 1988). Upon translocation across the 
mitochondrial and endoplasmic reticulum membrane, members of the Hsp70 family 
located inside the respective compartment bind to the emerging polypeptide chain and 
facilitate completion of translocation (Kang et al, 1990; Nguyen et al., 1991; reviewed in 
Pilon and Schekman, 1997). 
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 In the cytosol, a role of Hsp70 in proteasomal degradation has been suggested 
(Fisher et al., 1997). Recently, a direct link between the Hsp70 machinery and the 
degradation machinery has been demonstrated in vitro (Lüders et al., 2000), based on the 
finding that the Hsp70 cofactor Bag-1 binds directly to the proteasome, suggesting a 
function of Bag-1 in degradation. Another cofactor, the Hsp70/Hsp90-binding protein 
CHIP, stimulates ubiqutination in live cells promoting proteasomal degradation of 
chaperone substrates (Meacham et al., 2001; Connell et al., 2001). 
 Expression of the inducible form of Hsp70 (and development of cellular 
thermotolerance) has been shown to correlate with resistance to apoptosis. Indeed, an 
involvement of Hsp70 in various stages of the apoptotic cascade has been suggested. At a 
very early step, Hsp70 inhibits the stress-activated signalling by the c-Jun N-terminal 
kinase (JNK1) by direct interaction via the peptide binding domain of Hsp70. This might 
influence the activation of proteins of the Bcl-2 family upstream of cytochrome c release. 
Other apoptosis-inhibitory effects of Hsp70 were mapped downstream of cytochrome c 
release, but upstream of procaspase-3 activation (Mosser et al., 1997; Beere et al., 2000; 
Saleh et al., 2000; Li et al., 2000). The chaperone interacts with the cytosolic apoptosome, 
specifically with the apoptotic protease activating factor 1 (Apaf-1) preventing 
procaspase-9 recruitment to the complex and inhibiting caspase activation and substrate 
cleavage. Finally, a function in inhibition of apoptosis by Hsp70 has been located 
downstream of caspase-3 (Jaattela et al., 1998). 
Additionally, Hsp70 has been shown to modulate cellular stress signalling 
initiated by heat shock, ceramide, ethanol, irradiation, TNFa and ischemia (Jaattela, 
1993; Simon et al., 1995; Bellmann et al., 1996; Samali and Cotter, 1996; Gabai et al., 
1997; Liossis et al., 1997; Mosser et al., 1997; Meriin et al., 1998; Sharp et al., 1999). 
 In a mechanistic rather than regulatory role, Hsp70 has also been implicated in 
releasing clathrin and associated proteins from clathrin-coated vesicles during receptor 
mediated endocytosis (Schlossman et al., 1984; Hannan et al., 1998; Honing et al., 1994; 
Sherri et al., 2001). 
Recently, several classes of chaperones, namely Hsp70, Hsp90, their respective 
ER-paralogs, and the ER-resident chaperone calreticulin, have been shown to be 
associated extracellularly with tumor cells and their application as potent vaccines in 
tumor rejection experiments has been established. The latter will be the focus of the 
second part of this thesis. 
C.1 Introduction 19
C.1.2 Structure of Hsp70 
 Mechanistically, Hsp70 proteins are molecular chaperones with a weak intrinsic 
ATPase activity. They constist of two functional domains, a highly conserved N-terminal 
ATPase domain and a less conserved peptide binding domain close to the C-terminus. 
The extreme C-terminus of eukaryotic Hsp70 is unstructured but harbors the peptide 
motif EEVD, a binding site for cofactors of the TPR protein family (Scheufler et al., 
2000). The ATPase domain is highly conserved from bacteria to mammals. Regions with 
higher divergence are located at the C-terminus and the peptide binding domain. The 
structures of both domains of Hsp70 have been solved by X-ray crystallography but not 
that of the full length protein (Figure 2). 
The overall fold of the ATPase domain is similar to that of actin (Flaherty et al., 
1991). It can be subdivided into four subdomains, named IA (residues 1-39 and 116-188), 
IB (residues 40-115), IIA (residues 189-228 and 307-385), and IIB (residues 229-306) 
(Figure 2). The center of the heart-shaped molecule forms a nucleotide binding cleft with 
residues responsible for nucleotide binding and hydrolysis mainly located in subdomains 
IA and IIB. The N- and C-termini of the domain are located at the same site of the 
ATPase. The phosphate groups of the bound nucleotide are coordinated by a Mg2+ ion. 
Additionally, two monovalent potassium cations are important for optimal nucleotide 
hydrolysis and substrate release by coordinating Mg2+/ADP and Pi in the ATPase active 
site (Palleros et al., 1993; O’Brien and McKay, 1995; Wilbanks and McKay, 1995). 
The X-ray structure of the peptide binding domain of the E. coli homolog of 
Hsp70, DnaK, in complex with a heptapeptide (NRLLLTG) has also been determined 
(Zhu et al., 1996). The model is shown in the right panel of Figure 2. It consists of a b-
sandwich subdomain (residues 393-501) comprising the peptide binding cleft. The 
peptide is bound in an extended conformation. Two of the peptide’s leucines (Leu3 and 
Leu4) contribute most to the contact with the b-sheet region forming the peptide binding 
groove (mainly to the highly conserved residues Gln433, Phe426, Val436, Ile438, Ile401 
and Thr403 of the b-subdomain of DnaK in Figure 2). A hydrophobic arch over the top of 
the binding channel is generated by Met404 and Ala429 that encloses the peptide 
backbone (to the left of the peptide in Figure 2). The C-terminus of the domain forms an 
all a-helical subdomain (residues 509-607) composed of five helices. Connected via a 
short helix to the b-sheet subdomain, a long helix covers the peptide binding cleft serving 
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as a lid, followed by three shorter helices at the C-terminus. Based on alternate 
conformations in the crystal lattice, a hinge at residues 536-538 in the middle of the long 
helix of DnaK has been proposed around which the a-helical lid opens and closes 
depending on the bound nucleotide (ATP, open; ADP, closed) (Zhu et al., 1996). The 11-
degree rigid body rotation of this C-terimal lid region results in a loss of the latch-like 
contact of the helix with the outer loops. The helical subdomain does not contact the 
peptide directly. The hydrophobic arch and the lid together form a closing device for the 
substrate binding channel whereas the substrate binding free energy mostly relies on 
contributions of the central pocket (Mayer et al., 2000). 
 
 
Figure 2. Structures of the domains of Hsp70. The N-terminal ATPase of Hsc70 with 
bound ATP has been solved by X-ray diffraction (PDB code 3HSC). The X-ray structure 
of the peptide binding domain of the E. coli Hsp70, DnaK, has been solved in complex 
with a peptide substrate (PDB code 1DKZ). 
 
 
 Attempts to crystallize the full length Hsp70 molecule have failed so far. This 
structure would be particularly interesting since there is a high degree of regulation and 
coordination between ATP hydrolysis and peptide binding and release as will be 
summarized in the next paragraph. 
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C.1.3 The molecular mechanism of Hsp70 function 
 Chaperones of the Hsp70 family bind short stretches of unfolded proteins. In a 
folding reaction, substrate proteins undergo multiple rounds of Hsp70 interaction (Szabo 
et al., 1994; Buchberger et al., 1996). Modulation of this reaction is achieved by ATP 
binding and hydrolysis and several cochaperones working in concert with Hsp70. Most of 
the biochemical and biophysical characterization regarding Hsp70 function was carried 
out with the bacterial homolog, DnaK, and will be the focus of the next paragraphs. 
Nevertheless, the general principle of chaperone action applies also to the eukaryotic 
homologs (Theyssen et al., 1996; Ha and McKay, 1994; Ha and McKay, 1995; Takeda 
and McKay, 1996). 
In principle, Hsp70 alternates between two states, the ATP-bound form 
characterized by low affinity for substrate and high on- and off-rates, and the ADP-bound 
state, characterized by high substrate affinity and slow exchange. Binding of ATP to 
DnaK results in an increase in the off-rate for substrate by 2-3 orders of magnitude and 
concomitantly leads to a 50-fold increase in the on-rate for substrate. This is also reflected 
by a dissociation constant for substrate 5- to 85-fold higher than the one of the ADP-
bound form (Palleros et al., 1993; Schmid et al., 1994; McCarty et al., 1995; Theyssen et 
al., 1996). Upon hydrolysis of ATP, major conformational rearrangements within the C-
terminal peptide binding domain lead to a state characterized by a low on- and off-rate for 
substrate. Structurally, the peptide binding cleft is in a closed conformation in the ADP-
bound form, and is open when ATP is bound. Thus, ATP hydrolysis works as a pace 
setter for the interaction between unfolded polypeptides and the chaperone. 
Nucleotide hydrolysis after peptide binding, together with conversion from the 
low to the high affinity state for substrate binding, is the rate limiting step in the reaction 
(Gao et al., 1993; McCarty et al., 1995; Karzai and McMacken, 1996; Theyssen et al., 
1996). The steady-state ATPase rate (0.02-0.2 min-1) is too slow to enable efficient 
chaperone function and protein folding, although peptide binding already stimulates the 
turnover 2- to 10-fold (Flynn et al., 1989; Gao et al., 1994; Ha and McKay, 1994; Jordan 
and McMacken, 1995; McCarty et al., 1995; Theyssen et al., 1996). Therefore, several 
cofactors act in concert with Hsp70/DnaK accelerating the ATP hydrolysis cycle and 
thereby substrate binding and release. 
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C.1.4 Cochaperones of Hsp70 
Cochaperones of the Hsp40/DnaJ family (J-domain proteins) stimulate the ATP 
hydrolysis step of the ATPase cycle (Liberek et al., 1991). These cochaperones are a 
heterogeneous group of multidomain proteins which share a conserved J-domain. J-
domains are about 80 amino acids long and fold as a four helix bundle. The loop between 
helix 2 and 3 comprises a conserved sequence motif (HPD) suggested to be involved in 
the interaction of the J-domain with Hsp70 (Wall et al., 1994; Karzai and McMacken, 
1996; Pellecchia et al., 1996; Qian et al., 1996; Szabo et al., 1996; Szyperski et al., 1994). 
The J-domain is essential for the stimulatory effect on the intrinsically low ATPase rate of 
Hsp70 by directly interacting with the ATPase domain, resulting in the ADP-bound state 
which tightly binds substrate. Some J-domain cochaperones also contact regions in the C-
terminal domain of Hsp70, stabilizing the substrate-binding state. DnaJ is the main J-
domain protein in the bacterial cytosol. In addition to its effect on the ATPase rate of 
DnaK, DnaJ also possesses an intrinsic chaperone activity sufficient to prevent 
aggregation of unfolded polypeptides and might be involved in delivering these to DnaK 
(Langer et al., 1992; Schroder et al., 1993; Gamer et al., 1996). However, this function 
seems not to be a general feature of J-domain proteins since such an activity has not been 
observed with the mammalian J-proteins (Nagata et al., 1998). 
The main J-domain proteins in the mammalian cytosol are Hdj-1/Hsp40, Hdj-2, 
Hsj-1 and Hsj-2 (Ohtsuka, 1993; Yan et al., 1998; Cheetham et al., 1992; Oh et al., 1993). 
Others are found in all cellular compartments, including specialized J-domain proteins 
more divergent from Hsp40/DnaJ outside of the J-domain (zuotin, auxilin etc.). 
Differences in other parts of these proteins account for different cellular activities, but the 
overall stimulation of Hsp70’s ATP turnover by the J-domain is in common to all of these 
cofactors. 
In the presence of DnaJ, ATP hydrolysis by DnaK is fast enough that exchange of 
ADP for fresh ATP becomes the rate-limiting step in the ATPase cycle (Liberek et al., 
1991; McCarty et al., 1995). In the bacterial cytosol, mitochondria and chloroplast, GrpE-
like proteins facilitate nucleotide exchange enhancing the overall ATPase rate and 
thereby the protein folding efficiency of Hsp70 (Liberek et al., 1991; Dekker and Pfanner, 
1997; Miao et al., 1997). Association of GrpE with the DnaK/ADP complex reduces the 
affinity of DnaK for ADP about 200-fold and accelerates the nucleotide exchange rate 
about 5000-fold (Packschies et al., 1997). A model of the chaperone cycle of the 
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DnaK/DnaJ/GrpE system is presented in Figure 3. At saturating conditions, the ATP 
turnover rate is stimulated several hundred fold by the presence of both DnaJ and GrpE 
compared to the unstimulated reaction, probably more than is necessary to support proper 
protein folding. Therefore, the expression of their genes is coregulated in vivo to ensure 
the optimal balance between efficient ATP turnover and protein folding within this 
system. The structure of a stable DnaK/GrpE complex shows DnaK in a nucleotide-free 
state induced by rotation of subdomain IIB in the ATPase of DnaK relative to the 
nucleotide-bound structure resulting in an opening of the nucleotide binding pocket upon 
GrpE binding (Harrison et al., 1997). 
 
 
Figure 3. Model of the chaperone cycle of DnaK/DnaJ/GrpE. Substrate polypeptides (S) 
first interact with DnaJ (J), followed by transfer of the substrate to DnaK and subsequent 
ATP hydrolysis. DnaJ leaves the complex, and GrpE (E) associates with DnaK resulting 
in a release of ADP. This allows binding of ATP and release of GrpE and substrate from 
DnaK. 
 
However, a eukaryotic, cytosolic GrpE homolog has not been found so far. Such a 
function has been proposed for the Bcl2-associated athanogene 1 (Bag-1) protein but has 
not been definitively proven and is rather controversally discussed in the literature 
(Höhfeld and Jentsch, 1997; Bimston et al. 1998). The structure and function of Bag-1 
have been analyzed in the first part of this thesis. A detailed description of Bag-1 and the 
family of Bag proteins will be presented in the next chapters. 
C.1 Introduction 24
In the eukaryotic cytosol, further regulators and cofactors of Hsp70 proteins have 
been identified that are unique to this phylogenetic kingdom. A common structural motif 
of these are tetratrico-peptide domains (Honore et al., 1992; Smith et al., 1993), highly 
degenerate 34 amino acid repeats (Lamb et al., 1995). The cochaperone p48/Hip binds to 
the ATPase domain of Hsp70 with a preference for the nucleotide-bound state of the 
chaperone (Höhfeld et al., 1995). It is composed of a N-terminal dimerization domain and 
a TPR motif which is responsible for its interaction with Hsp70. It is thought to stabilize 
the ADP-bound complex, thereby antagonizing the putative nucleotide exchange activity 
of Bag-1 (Irmer and Höhfeld, 1997; Nollen et al., 2001). Its interaction with Hsp70 was 
suggested to involve subdomain IIB of the ATPase (Velten et al., 2000). 
The cochaperone p60/Hop binds to the EEVD motifs of Hsp70 and Hsp90 via its 
TPR domains (Scheufler et al., 2000), and thereby works as a adaptor for the two 
chaperone systems. The close proximity of the two chaperone systems might facilitate 
substrate transfer from Hsp70 to Hsp90 (Morishima et al., 2000; Frydman and Höhfeld, 
1997). 
 Recently, another cochaperone belonging to the TPR protein family, CHIP (for 
carboxy terminus of Hsp70-interacting protein), has been identified (Ballinger et al., 
1999). In addition to its TPR motif, it harbors a region similar to the proteasome-
associated RING-finger protein UFD2, the U-box, a domain characteristic for E4 ubiqutin 
conjugation factors. CHIP inhibits the ATPase and chaperone function of Hsp70 by an as 
yet unknown mechanism. In vivo, CHIP promotes the ubiquitination and proteasomal 
degradation of Hsp70- and Hsp90-bound substrates by serving as a direct link between 
folding and degradation (Ballinger et al., 1999; Meacham et al., 2001; Connell et al., 
2001). 
Another, yet less characterized cofactor of mammalian Hsp70 is HspBP1. It has 
been reported to inhibit ATP turnover by Hsp70 and renaturation of model substrates in 
vitro (Raynes and Guerriero, 1998). In Figure 4, the domain organization of Hsp70 is 
shown with the established binding regions for the various cofactors. 
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C.1.5 The Bag protein family of Hsp70 cochaperones 
 Since the identification of the first Bag protein in 1995, Bag-1, an increasing 
number of related proteins has been identified (Takayama et al., 1995; Takayama et al., 
1999). They all contain a conserved consensus sequence at their C-termini, the so called 
‘Bag domain’, but they differ substantially in their N-termini. 
 
Figure 4. Domain organization of Hsp70 and Bag-1. NLS, nuclear localization sequence; 
Ub, ubiquitin-like domain. 
 
 
C.1.5.1 Primary sequence of the Bag-1 isoforms 
Bag-1, also known as Rap46/Hap46, was first identified in the mammalian cytosol 
by virtue of its interaction with the anti-apoptotic protein Bcl-2 and shown to promote cell 
survival (Takayama et al., 1995). There are three Bag-1 isoforms in the mammalian 
cytosol which arise from a single mRNA by alternative translation initiation (Figure 4) 
(Yang et al., 1998). Thus, they only differ in their N-terminal sequence. All Bag-1 
isoforms contain a C-terminal Bag domain, which mediates binding to Hsp70, and a 
ubiqutin-like domain (Takayama et al., 1997; Höhfeld and Jentsch, 1997; Zeiner et al., 
1997; Petersen et al., 2000). Furthermore, the Bag-1 isoforms designated with S, M, and 
L contain a certain number of degenerate repeats of the hexapeptide motif TRSEEX 
(human S-isoform: 4 repeats, human M- and L-isoform: 10 repeats) at their N-termini. 
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These are predicted to form a a-helical structure. Bag-1L additionally harbors a nuclear 
localization sequence. Bag-1 was predicted to be all a-helical and binds to Hsp70 as a 
monomeric protein with a 1:1 stoichiometry (Stuart et al., 1998). 
 
C.1.5.2 Cellular function of Bag-1 
Besides binding to the cell death inhibitor Bcl2, several other client proteins of 
Bag-1 have been identified mainly by the use of immunoprecipitation from cell lysates. 
Bag-1 binds and activates the protein kinase Raf-1 mediating stress signalling in an 
Hsp70-dependent manner (Wang et al., 1996; Song et al., 2001). Futhermore, it binds to 
several growth factor receptors, especially hepatocyte and platelet-derived growth factors 
(HGF and PDGF) receptors (Bardelli et al., 1996), the retinoic acid receptor (Liu et al., 
1998), and the glucocorticoid receptor (Kullmann et al., 1998). Some of these interactions 
may be indirect via an interaction with Hsp70 which cannot be excluded based on the 
techniques applied. Nevertheless, all these interactions enhance the protection from 
apoptosis by inhibiting retinoic acid-induced cell death, by increasing the anti-apoptotic 
potential of HGF and PDGF, and by negative regulation of glucocorticoid receptor action, 
respectively. Downregulation of the glucocorticoid receptor was shown to involve a 
nuclear localization of Bag-1 in complex with the hormone-bound receptor mediated by 
the TRSEEX repeats dependent on the number of repeats (Schneikert et al., 1999). 
Although the effect of Bag-1 on cell death has been established, the mechanism of action 
remains enigmatic. 
 Bag-1M was also shown to have rather unspecific DNA binding properties thus 
stimulating transcription upon overexpression in cells (Zeiner et al., 1999). Heat stress 
induces a relocalization of Bag-1M to the nucleus. DNA binding and transcriptional 
enhancement is dependent on an N-terminally located motif consisting of basic amino 
acids, but is independent of the Bag domain which mediates the interaction with Hsp70. 
 The effect of Bag-1 on Hsp70, especially its ATPase activity, has been discussed 
controversially. Several lines of evidence exist which point towards a nucleotide 
exchange factor activity for Bag-1. It was originally observed to stimulate the steady state 
ATPase rate of Hsp70 only in the presence of Hsp40 and accelerate the release of bound 
ADP (Höhfeld and Jentsch, 1997). Others did not observe such an effect but proposed an 
activity similar to a J-domain-mediated acceleration of the ATPase however uncoupling 
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nucleotide hydrolysis from substrate release (Bimston et al., 1998). In the latter study, a 
Hsp40-independent stimulation of the Hsp70 ATPase rate by Bag-1 was observed without 
acceleration of nucleotide exchange. Addition of Hsp40 to the assay resulted only in an 
additive effect. The discrepancy between the two observations may be explained by the 
use of purified proteins from different sources (proteins expressed in insect cells and E. 
coli, respectively). 
 Furthermore, there has been a controversy about the effect of Bag-1 on substrate 
binding by Hsp70. In a native gel assay for analysis of substrate/chaperone complexes, it 
has been shown that Bag-1 prevents ATP-dependent substrate release from Hsp70 
(Bimston et al., 1998). Yet, using gel filtration for the analysis of such complexes or 
immunoprecipitation, the opposite effect has been demonstrated for Bag-1, namely the 
dissociation of substrate/Hsp70 complexes in a ATP-dependent manner (Lüders et al., 
2000; Zeiner et al., 1997). 
The effect of Bag-1 on protein folding is as yet unclear since positive and negative 
effects have been observed in vitro and in vivo depending on the experimental setup and 
Bag-1 isoform used (Takayama et al., 1997; Kanelakis et al., 1999; Terada and Mori, 
2000; Nollen et al., 2000; Nollen et al., 2001; Lüders et al., 2000). Nevertheless, the 
effect seems to be distinct from the one of GrpE on protein folding by the DnaK/DnaJ 
system. In the latter case, GrpE is necessary for proper folding whereas Bag-1 seems to 
be dispensible for at least some Hsp70 chaperone actions (Minami et al., 1996). 
 Recently, an association of Bag-1 with the proteasome has been demonstrated in 
vitro suggesting a link between the protein folding and degradation machinery (Lüders et 
al., 2000). Nevertheless, the molecular basis and implications for the situation in the cell 
remain to be established. 
 
 
C.1.5.3 Other Bag proteins 
 Several other human Bag-1-related proteins have recently been identified by yeast 
two-hybrid and l-phage cDNA screening (Takayama et al., 1999), including the human 
proteins Bag-2, Bag-3, Bag-4, and Bag-5, but also Bag proteins in the invertebrate 
C. elegans and the fission yeast S. pombe, all containing a conserved C-terminal domain 
C.1 Introduction 28
responsible for Hsp70 binding but with diverse N-termini. Figure 5 shows a schematic 
representation of the mammalian Bag proteins. 
 The other mammalian Bag homologs lack the ubiquitin-like domain but contain 
different domains, e.g. a WW-domain in the case of Bag-3 (also known as CAIR-1/Bcl-2-
binding protein Bis). WW-domains are protein-protein interaction domains similar to Src 
homology 3 (SH3) domains (Bork and Sudol, 1994; Zarrinpar and Lim, 2000). 
Furthermore, Bag-3 was first identified by virtue of its synergistic effect on Bcl2-
mediated prevention of apoptosis (Lee et al., 1999). Bag-3 was found in a ternary 
complex with Hsp70 and phospholipase C-g which is released from Bag-3 upon EGF 
stimulation of the cells. Binding between phospholipase C-g and Bag-3 is mediated by 
PxxP motifs in Bag-3 which are recognized by the SH3 domain of the lipase (Doong et 
al., 2000). The exact role of Hsp70/Bag-3 complexes remains to be established but the 
divergent N-termini of homologs of the Bag family indicate specialized cellular functions 
or a certain targeting of Bag proteins. 
 So far, no Bag proteins have been identified in D. melanogaster, A. thaliana and 
S. cerevisiae. 
 
 
Figure 5. The family of mammalian Bag proteins. 
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C.1.6 Aim of the project 
 The main focus of the project was the mechanism by which the cochaperone 
Bag-1 regulates Hsp70. At the beginning of the work, contradictory results had been 
published regarding Bag-1 function. Specifically, it was unclear whether Bag-1 acts as a 
nucleotide exchange factor for Hsp70 or modulates a different step of the Hsp70 ATPase 
cycle. 
 Unlike previous work addressing this question, a structural approach was taken to 
analyze the function of Bag-1 in the Hsp70 ATPase cycle. Thus, the immediate 
experimental goals were the identification of folded domains of Bag-1 and Hsp70 that 
would crystallize as a stable complex, and the solution of the molecular structure of this 
complex using X-ray diffraction data. The structure of the Hsp70/Bag-1 complex was to 
be compared with the known structures of Hsp70/DnaK with bound nucleotide, or in 
complex with the bacterial nucleotide exchange factor GrpE. Once a hypothesis about the 
Bag-1 mechanism of action was developed from the structural model, this hypothesis was 
to be tested experimentally by site-directed mutagenesis and biochemical assays. Finally, 
the structural information was also to be used to identify as yet unknown members of the 
Bag family of cochaperone proteins. 
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C.2 Material and Methods 
 
 
C.2.1 Chemicals 
All chemicals were of quality pro analysi and were purchased from Fluka (Buchs, 
Switzerland), Merck (Darmstadt, Germany), Sigma-Aldrich (Steinheim, Germany) and 
USB (Cleveland, USA) if not stated otherwise. Solutions were prepared with deionized, 
double-destilled and sterile-filtered water. Concentrations in percent of liquids are given 
as (v/v) and of solid chemicals as (w/v). 
 
Amersham (Buckinghamshire, England): a32P-ATP. 
Roche/Boehringer Ingelheim (Mannheim, Germany): ADP, ATP, Ampicillin. 
Green Hectares (Wisconsin, USA): Rabbit reticulocyte lysate. 
Life Technologies/GibCo (Karlsruhe, Germany): T4 ligase buffer. 
New England Biolabs (NEB, Beverly, USA): DH5a and BL21pLysS E. coli cells, 
restriction enzymes and buffers, VENT DNA polymerase and thermopol buffer, T4 DNA 
ligase. 
Perkin Elmer (Weiterstadt, Germany): ABI Prism Big Dye cycle sequencing kit. 
Promega (Mannheim, Germany): TNT T7 Coupled Reticulocyte Lysate System. 
Roche (Mannheim, Germany): Expand Long Template PCR Kit. 
Stratagene (La Jolla, USA): QuickChange Site-Directed Mutagenesis Kit. 
 
 
C.2.2 Instruments 
ADSC (Povay, USA): Quantum-4 CCD detector. 
Beckman (Munich, Germany): Centrifuges J-6B, Avanti J-25, GS-6R, and Optima LE-
80K ultracentrifuge with 45Ti rotor, UV-VIS-spectralphotometer DU 640, pH meter F34. 
BioRad (Hercules, USA): Econo columns, gel electrophoresis system for protein and 
DNA gels. 
Charles Supper Company (USA): Double mirror focusing optics system 7616. 
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Eppendorf (Cologne, Germany): Centrifuges 5415C and 5417R. 
European Synchrotron Radiation Facility (ESRF, Grenoble, France): Synchrotron station 
ID14-4 (EMBL). 
Fuji (Stamford, USA): Phosphoimager Fuji Film FLA-2000. 
Hampton Research (Laguna Niguel, USA): PEG ion screen, siliconized cover slides, 
VDX crystallization plates. 
Heath Scientific Co Ltd. (Bletchley, Englang): MicroCal VP Isothermal Titration 
Calorimeter. 
MarResearch (Hamburg, Germany): Image Plate MAR300, MARCCD detector. 
Millipore (Eschborn, Germany): Amicon Centriprep concentrators, Milli-Qplus PF, 
sterile filters 0.22 mM Millex-HA. 
Misonix Inc. (New York, USA): Sonicator Ultrasonic Processor XL. 
Olympus (Hamburg, Germany): Stereomicroscope SZH10. 
Perkin Elmer (Weiterstadt, Germany): GenAmp 2400 thermocycler. 
Pharmacia (Freiburg, Germany): FPLC system ÄKTAexplorer100, columns HiLoad 
26/60 Superdex 75 and Superdex 200, Fast Desalting column HiPrep 26/10, Resource Q. 
Precision Scientific (Chicago, USA): Precision incubator 815-BOD. 
Qiagen (Valencia, USA; Hilden, Germany): NiNTA Superflow matrix, Plasmid Midi kit, 
QIAprep Spin Mini prep kit, QIAquick PCR purification and gel extraction spin kit. 
Rainin (Woburn, USA): Gilson pipettes P2, P10, P100, P200, P1000. 
Rigaku (Berlin, Germany): Rotating anode X-ray generator RU-200. 
Savant (via Life Science Int., Frankfurt, Germany): Slab gel dryer SGD 2000. 
 
 
C.2.3 Media and buffers 
C.2.3.1 Media 
· Luria-Bertani (LB) medium:  10 g/l Bactotryptone 
      5 g/l Bactoyeast extract 
      5 g/l NaCl 
 (for plates, medium was supplemented with 15 g/l agar and antibiotics) 
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· M9 medium:    200 ml M9 salt stock solution 
2.0 ml 1M MgSO4 
20 ml 20% glucose solution 
0.1 ml 1M CaCl2 
ddH2O to 1 l final volume. 
o M9 salts stock solution: 64 g Na2HPO4 x 7 H2O 
15 g KH2PO4 
2.5 g NaCl 
5.0 g NH4Cl 
ddH2O to 1 l final volume. 
· Terrific Broth (TB) medium:  12 g/l Bactotryptone 
      23.9 g/l Bactoyeast extract 
      8 ml/l glycerol 
      2.2 g/l KH2PO4 
      9.4 g/l K2HPO4 
· YPD medium:    20 g/l Difco peptone 
10 g/l Bactoyeast extract 
ddH2O to 1 l final volume, adjust pH to 5.8. 
Add glucose (dextrose) to 2% final. 
 
 
C.2.3.2 Buffers 
· ATPase buffer: 20 mM HEPES-KOH pH 7.6, 50 mM KCl, 5 mM MgAc2 
(prepared as 10x stock solution). 
· Buffer B: 25 mM HEPES-KOH pH 7.5, 100 mM KAc, 5% glycerol. 
· Buffer G: 25 mM HEPES-KOH pH 7.5, 100 mM KAc, 5 mM MgAc2. 
· Buffer C: 25 mM HEPES-KOH pH 7.5, 100 mM KAc, 1% NP40, 1% Na- 
deoxycholate, 0.1% SDS. 
· NiNTA wash A: 25 mM KH2PO4, 500 mM KCl, 20 mM imidazole, pH 8.0. 
· NiNTA wash B: 25 mM KH2PO4, 500 mM KCl, 20 mM imidazole, pH 6.0. 
· NiNTA elution buffer: 12.5 mM KH2PO4, 250 mM KCl, 500 mM imidazole, pH 
7.5. 
· TB1: 100 mM RbCl2, 50 mM MnCl2, 30 mM KAc, 10 mM CaCl2, 15% glycerol, 
pH 5.8 (adjusted with 0.2 M HOAc); sterile filter. 
· TB2: 75 mM CaCl2, 10 mM RbCl2, 10 mM MOPS (or PIPES), 15% glycerol, 
pH 6.5 (adjusted with KOH); sterile filter. 
· TBE (10x stock): 890 mM Tris base, 890 mM boric acid, 20 mM EDTA. 
· TEV buffer: 50 mM Tris-HCl pH 8.0, 5% glycerol, 20 mM NaCl. 
· TLC running buffer: 0.5 M formic acid, 0.5 M LiCl. 
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C.2.4 Plasmids and bacterial strains 
C.2.4.1 Plasmids 
The following plasmids have been used for recombinant expression of native 
proteins (Table 1): 
 
Table 1. Plasmids used in this study. 
ORF Vector Restrict. sites Reference 
bag-1M human pProEx HTa* KasI/HindIII this study 
bag-1M(151-263) human pProEx HTa* KasI/HindIII this study 
bag-1M(151-263) human E212A pProEx HTa* KasI/HindIII this study 
bag-1M(151-263) human E219A pProEx HTa* KasI/HindIII this study 
bag-1M(151-263) human R237A pProEx HTa* KasI/HindIII this study 
hsp70 human pProEx HTa* EcoRI/XhoI this study 
hsc70 human pProEx HTa* KasI/XhoI this study 
hsc70 human pET3a NdeI/BamHI Minami et al., 1996 
hsc70 human R261A pET3a NdeI/BamHI this study 
hsc70(5-381) bovine pProEx HTa* KasI/XhoI this study 
hsp40 human pQE9** - Minami et al., 1996 
snl1 S. cerevisiae (40-160) pProEx HTa* KasI/XhoI this study 
snl1 S. cerevisiae (49-160) pProEx HTa* KasI/XhoI this study 
Tobacco etch virus (TEV) protease -** - Parks et al., 1994 
*: N-terminal His 6-purification tag, cleavable with TEV protease 
**: N-terminal His 6-purification tag 
 
 
C.2.4.2 Competent E. coli cells using the RbCl-method 
 Competent cells were prepared as described (Hanahan, 1983). LB medium (55 ml) 
was inoculated with a single colony of the desired bacterial strain and grown to an OD600 
of 0.22-0.5 by incubation at 37°C under shaking. Cells were chilled on ice. Cells were 
pelleted by centrifugation for 20 min at 1000xg at 4°C and resuspended in 7 ml ice-cold 
TB1 buffer. TB1 buffer (19 ml) was added and suspensions were mixed well. After 
incubation for 5 min on ice, cells were centrifuged as before and resuspended in 2 ml ice-
cold TB2 buffer. Cell suspensions were chilled on ice for 15 min, and were aliquoted into 
prechilled tubes (100 ml/tube). After 15 min on ice, aliquots were flash-frozen in liquid 
nitrogen, and stored at -80°C. 
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C.2.4.3 Molecular cloning using polymerase chain reaction (PCR) 
Plasmids produced during this study were cloned using polymerase chain reaction 
(PCR) methods followed by restriction digestion and ligation. The standard PCR protocol 
is summarized in table 2. 
 
Table 2. Standard protocol for polymerase chain reaction (PCR). 
Reaction mixture Reaction 
1.2 mg primer I (sense) 
1.2 mg primer II (antisense) 
10 ml 10x Thermopol buffer (NEB) 
80 ng template DNA 
250 mM dNTPs 
1 ml VENT DNA polymerase (NEB) 
ddH2O to 100 ml final volume 
1st cycle: 
25 cycles: 
 
 
last cycle: 
95°C 
95°C 
50°C 
72°C 
72°C 
4°C 
3 min 
1.5 min 
1 min 
1 min/kb 
10 min 
 
 
The amplified PCR products were analyzed by agarose gel electrophoresis (1% 
agarose in TBE buffer supplemented with 10 mg/ml ethidiumbromide) and purified by 
anion exchange chromatography (QIAquick PCR purification kit, Qiagen) following the 
manufacturers’ instructions. Purified PCR products and the target vector were digested 
over night at 37°C in a 50 ml reaction volume containg the appropriate 10x restriction 
buffer (NEB) and 2 ml of each restriction enzyme (NEB). The vector was additionally 
dephosphorylated with 5 Units calf instestinal phosphatase for 1 hour. All reaction were 
stopped by heat treatment (65°C for 30 min). DNA fragments were separated by 
preparative agarose gel electrophoresis and purified from agarose slices using anion 
exchange chromatography (QIAquick Gel extraction kit, Qiagen) following the 
manufacturers’ instructions. Ligation reactions containg 2 ml vector DNA, 5 ml insert 
DNA, 2 ml 5x ligase buffer (Life Technologies/GibCo), and 100 Units T4 ligase (NEB) 
were incubated over night at 16°C. 4 ml of the ligation reaction were used for 
transformation of chemical competent E. coli DH5a cells. Cells were incubated for 30 
min on ice, followed by a heat shock for 70 sec at 42°C. After incubation for 2 min on 
ice, cells were resuspendend in LB medium and incubated for 1 hour at 37°C, followed 
by plating on LB medium plates containing antibiotics for selection of transformants. 
After incubation for 20 hours at 37°C, 5 ml LB medium cultures supplemented with 
antibiotics were inoculated with single colonies and cultures were grown over night at 
37°C. Plasmids were isolated from cell pellets using anion exchange chromatography 
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(Mini Prep Kit, Qiagen) following the manufactorers’ instructions. Plasmids were 
analyzed by restriction digestion and analytical agarose electrophoresis. 
 Some coding regions were amplified using yeast genomic DNA or a human brain 
cDNA library as template. For these reactions, the Expand Long Template PCR System 
(Roche, Germany) was used (Table 3). Amplified DNA fragments were processed as 
described above. 
 
Table 3. Expand Long Template PCR. 
Reaction mixture Reaction 
1.2 mg primer I (sense) 
1.2 mg primer II (antisense) 
10 ml 10x buffer 1 (Roche) 
200 ng template DNA 
250 mM dNTPs 
1 ml polymerase mix (Roche) 
ddH2O to 100 ml final volume 
1st cycle: 
33 cycles: 
 
 
last cycle: 
94°C 
94°C 
65°C 
68°C 
68°C 
4°C 
3 min 
10 sec 
30 sec 
1 min/kb 
7 min 
 
 
For recombinant expression of native proteins, the bacterial strain E. coli 
BL21(DE3)pLysS (Novagen) was used. This strain contains the plasmid pLysS 
containing the gene for the expression of T7 lysozyme and a gene for chloramphenicol 
resistance. After induction with IPTG, lysozyme is expressed which helps efficient cell 
breakage by autolysis. 
 
 
C.2.4.4 Site-directed mutagenesis 
 Site-directed mutagenesis was performed using the QuickChange System 
(Stratagene) following the manufacturers’ instructions. The system allows site directed 
mutagenesis using double stranded DNA as a template. The application of polymerase 
PFU turbo together with a complementary set of sense and antisense primer, both 
carrying the desired mutation, generates a mutated plasmid. Methylated, nonmutated 
parental DNA is digested by treatment with the restriction enzyme Dpn I. 
The following PCR reactions were perfomed for single amino acid changes (Table 
4). PCR products were analyzed by agarose gel electrophoresis. Parental DNA template 
was digested by addition of DpnI (1 ml Dpn I in 40 ml PCR reaction) for 1 hour at 37°C. 
Transformation into supercompetent E. coli XL1-Blue cells was performed by incubation 
with 1 ml circular, nicked double-stranded DNA for 30 min on ice, followed by heat 
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shock for 45 sec at 42°C. After 2 min on ice, cells were incubated for 1 hour at 37°C in 1 
ml of LB medium, and then plated on LB plates supplemented with the appropriate 
antibiotic. Cultures were inoculated with single colonies for isolation of plasmid DNA as 
described before. Success of mutagenesis was confirmed by DNA sequencing 
(Medigenomix, Munich, Germany). 
 
Table 4. PCR protocol for site-directed mutagenesis. 
Reaction mixture Reaction 
125 ng mutagenic primer (sense) 
125 ng mutagenic primer (antisense) 
5 ml 10x reaction buffer (Stratagene) 
25-100 ng template DNA 
250 mM dNTPs 
1 ml PFU turbo polymerase (Stratagene) 
ddH2O to 50 ml final volume 
1st cycle: 
16 cycles: 
 
 
last cycle: 
95°C 
95°C 
55°C 
68°C 
68°C 
4°C 
30 sec 
30 sec 
1 min 
2 min/kb 
20 min 
 
 
 
C.2.5 Biochemical methods 
C.2.5.1 SDS polyacrylamide gelelectrophoresis (SDS-PAGE) 
 Proteins were analyzed by SDS-PAGE under denaturing, reducing conditions 
(Laemmli, 1970). Samples were prepared by addition of 4x concentrated sample buffer 
(final concentrations: 2% SDS, 0.35 M b-mercaptoethanol, 60 mM Tris-HCl pH 6.8, 10% 
glycerol, and 0.005% bromphenole blue). Samples were incubated for 4 min at 95°C prior 
to loading of the gels. For the present study, seperating gels were used with 12.5% or 
15% polyacrylamide, and stacking gels conatining 5% polyacrylamide (Table 5). 
Electrophoresis was carried out at constant voltage (200 V) in electrophoresis buffer (50 
mM Tris-HCl pH 8.3, 380 mM glycine, 0.1% (w/v) SDS). 
 
Table 5. Preparation of SDS-PAGE gels. 
 Seperating Gel Stacking Gel 
% Acrylamide (AA) 12.5% 15% 5% 
30% AA/BisAA 6.8 ml 8.5 ml 0.83 ml 
1.875 M Tris -HCL pH 8.8 3.5 ml 3.5 ml - 
0.6 M Tris -HCl pH 6.8 - - 0.5 ml 
ddH2O 6.4 ml 4.7 ml 3.6 ml 
10% SDS 167 ml 167 ml 50 ml 
10% Ammoniumpersulfate 100 ml 100 ml 50 ml 
TEMED* 10 ml 10 ml 5 ml 
*: N,N,N’,N’-tetramethylethylendiamine (TEMED) 
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C.2.5.2 Staining methods for protein gels 
 After SDS-PAGE, gels were stained using a Coomassie solution (0.1% Coomassie 
Brilliant Blue R-250, 30% methanol, 10% acetic acid) and destained by incubation in 
destain solution (30% methanol, 10% acetic acid). 
For a more sensitive detection, a silver staining protocol for proteins was used. 
The protocol of the staining procedure is listed below and was carried out at room 
temperature: 
· 2x10 min  30% ethanol 
10% acetic acid 
· 15 min  30 ml ethanol 
10 ml 4M NaAc 
300 ml acetic acid 
2 ml 25% glutaraldehyde 
0.1 g Na2S2O3· 5H2O 
ddH2O to 100 ml final volume 
· 5x10 min  ddH2O 
· 1x15 min  0.1 g AgNO3 
25 ml 37% formaldehyde 
ddH2O to 100 ml final volume 
· development 2.5% Na2CO3 (anhydrous) 
40 ml 37% formaldehyde 
ddH2O to 100 ml final volume 
· stop reaction 5% acetic acid 
 
 
C.2.5.3 Protein expression and purification 
 All proteins were overexpressed in E. coli BL21(DE3)plysS (Novagen) in terrific 
broth (TB) medium supplemented with antibiotics (100 mg/l Carbenicillin or 
Ampenicillin, or 50 mg/l Kanamycin). Protein expression was induced by addition of 1 
mM IPTG at an OD600 of 1.0. Cells were harvested either after expression for 4 hours at 
37°C or for 15 hours at 18°C by centrifugation for 1 hour at 5000xg. A selenomethionine-
labeled derivative of rat Hsc70(5-381) was expressed in the methionine auxotroph E. Coli 
strain B834(DE3)pLysS (Novagen) grown in minimal medium M9 supplemented with 50 
mg/l D,L-selenomethionine and 50 mg/l of all other amino acids but lacking methione. 
Induction and expression were carried out as described before. Cells were resuspendend 
in NiNTA wash A buffer, shock frozen in liquid nitrogen, and stored at -80°C. 
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All purifications were carried out at 4°C using a ÄKTAexplorer100 FPLC system 
(Pharmacia). Flow rates were in accordance with the column-specific instructions. Cell 
suspension were thawed in a water bath at 25°C until completion. Addition of lysozyme 
facilitated the lysis process. Furthermore, benzonase (Merck) was added. After an 
additional 20 min at 25°C, suspensions were sonicated for 1 min on ice. Cell debris was 
removed by ultracentrifugation at 80,000xg for 30 min at 4°C and filtration of the 
supernatants. Filtrates were incubated with NiNTA affinity matrix (Qiagen) for 45 min at 
4°C. The resin was washed with 5 column volumes NiNTA wash A buffer and 5 column 
volumes NiNTA wash B buffer. Proteins were eluted form the matrix by incubation with 
NiNTA elution buffer for 15 min at 4°C. Eluates were either dialyzed over night against 
TEV buffer or buffer exchange was achieved by chromatography using a fast desalting 
column (Pharmacia). The affinity tag of the proteins was removed using tobacco etch 
virus (TEV) protease (1 OD280 TEV protease:40 OD280 His6-protein for 2 hour at 25°C, 
then at 4°C over night). The cleaved His6-tag and uncleaved fusion protein was removed 
by chromatography on NiNTA, and the cleaved product was recovered in the flow 
through. If neccessary, proteins were further purified by anion exchange chromatogrphy 
on a 6 ml Resource Q column (Pharmacia) via a gardient elution from 10 mM NaCl to 1 
M NaCl (in Tris-HCl pH 7.5) over 15 to 20 column volumes. Fractions were analyzed by 
SDS-PAGE and Coomassie staining. Pooled fractions containing the desired product 
were concentrated using Amicon Centriprep concentrators (Millipore) following the 
manufactorers’ instructions. Finally, all proteins were subjected to size exclusion 
chromatography on Superdex75 or Superdex200 colums (Pharmacia) equilibrated with 
buffer G. Proteins were shock-frozen in liquid nitrogen at concentrations between 5-20 
mg/ml, and stored at -80°C. 
For crystallization trials, a stable, nucleotide-free complex of rat Hsc70(5-381) 
and human Bag-1M(151-263) (the Bag domain) with a 1:1 stoichiometry was formed 
after chromatography on NiNTA matrix and TEV protease treatment. The complex was 
purified to homogeneity by chromatography on a Resource Q column (Pharmacia) 
followed by gel filtration (in 10 mM HEPES-KOH pH 7.5, 25 mM KCl, and 5 mM DTT) 
as described above. The complex was concentrated to 40 mg/ml by ultrafiltration. The 
final storage buffer contained no salts (10 mM HEPES-KOH pH 7.5, 5 mM DTT). 
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C.2.5.4 Purification of Hsc70 from bovine brain 
 Cow brains (500-600 g) were cleaned off to remove membranes, extra blood 
vessels and fat. The brains were homogenized in a blender at medium speed in 1.5 l DE52 
equilibration buffer (20 mM Tris-HCl pH 7.5, 0.1 mM EDTA, and protease inhibitors). 
Homogenate was centrifuged at 5,000xg for 10 min. Supernant was filtered and 
centrifuged at 100,000xg for 30 min. Filtrate of the supernatant was mixed with 200 ml 
DE52 matrix (Whatman) and incubated for 1 h under stirring at 4°C. The mixture was 
poured into a column (Pharmacia) and washed with 1 l of DE52 equilibration buffer. 
Proteins were eluted with 400 ml of 150 mM NaCl, 20 mM Tris-HCl pH 7.5, and 0.1 mM 
EDTA supplemented with protease inhibitors. DE52 eluate was adjusted to 3 mM MgCl2, 
and loaded on a 25 ml ATP agarose column (C8 linkage, Sigma), equilibrated with 20 
mM NaCl, 20 mM Tris-HCl pH 7.5, and 3 mM MgCl2. The matrix was washed with 50 
ml equilibration buffer, then with 50 ml 500 mM NaCl, 20 mM Tris-HCl pH 7.5, and 3 
mM MgCl2. Proteins were eluted with 150 ml equilibration buffer containing 3 mM ATP. 
The pooled fractions containg Hsc70 were loaded on a 20 ml hydroxyapatite column 
(BioRad) equilibrated in 20 mM KH2PO4 pH 7.5. The column was washed with 100 ml of 
equilibration buffer. Elution was carried out with a 200 ml linear gradient of 20 mM to 
300 mM KH2PO4 pH 7.5. The pooled protein peak was concentrated, and aliquots were 
frozen in liquid nitrogen. 
 
 
C.2.5.5 Determination of protein concentration in solution 
Protein concentrations were determined using either the Bradford reagent (Pierce) 
(Bradford, 1976) and a BSA standard dilution serie measuring OD595, or by measuring 
OD280 and applying the Lambert-Beer equation using the theoretical extinction coefficient 
(Pace et al., 1995; Wetlaufer, 1962). Extinktion coefficients were determined using the 
ProtParam tool at the Expasy server (http://www.expasy.ch). 
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C.2.5.6 Limited proteolysis and mass spectroscopy 
 For the determination of stably folded domains, proteins were partially 
proteolyzed by incubation with increasing amounts of the unspecific proteases subtilisin 
or proteinase K. Reactions contained 20 mM HEPES-KOH pH 7.4, 20 mM (NH4)2SO4, 
10 mM MgSO4, and 50 mg protein in a final volume of 100 ml. Subtilisin was added in 
final concentrations ranging from 0.001 mg/ml to 10 mg/ml, proteinase K was added 
from 0.001 mg/ml to 1 mg/ml. Reactions were incubated for 30 min on ice. Proteolyis 
was stopped by addition of 4 mM PMSF (final concentration). Reactions were analyzed 
by SDS-PAGE followed by Coomassie staining and by mass spectroscopy (electrospray 
ionisation mass spectroscopy (ESI-MS) service (MPI for Biochemistry, Martinsried). 
 
 
C.2.5.7 Isothermal titration calorimetry (ITC) 
 Isothermal titration calorimetry (Wiseman et al., 1989; Pierce et al., 1999) was 
used to measure binding constants (KD) in solution and to assay the stoichiometry of 
complex formation between Bag-1M, Hsc/Hsp70, and their respective domains. The latter 
value was used to describe the fitness of the proteins used for functional assays and 
crystallography. During the titration of two protein solutions, the heat generated or 
consumed upon protein-protein interaction is measured at constant temperature. The 
amount of heat evolved on addition of ligand can be represented by the equation 
 
Q = V0DHb[M]tKa[L] / (1 + Ka[L]) 
 
where V0 is the volume of the cell, DHb is the enthalpy of binding per mole of ligand, 
[M]t is the total macromolecule concentration including bound and free fractions, Ka is 
the binding constant, and [L] is the free ligand concentration. For a ligand L binding to 
sites on a macromolecule, the binding constant is 
 
Ka = [filled sites] / [empty sites][L] 
and 
 
DG0 = -RT lnKa = DH0-TDS0 
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where DG0, DH0 and DS0 are the free energy, enthalpy, and entropy change for single site 
binding. The parameters K, DH0, and stoichiometry are determined directly in a single 
experiment by non-linear least squares fit of the calorimetric tritration data. DG0 and DS0 
may then be calculated. 
Calorimetric isothermal titration measurements were carried out at T=25°C by 
titration of 100 mM protein with 1 mM ligand in buffer G (25 mM HEPES-KOH pH 7.5, 
100 mM KAc, and 5 mM MgAc2) by injections of 10 ml with a 400 sec spacing between 
each injection. When indicated, buffers were supplemented with 5 mM ADP or ATP 
(cuvette and syringe solutions). Constants (KD) were determined by integrating heat 
effects normalized to the amount of injected protein and curve fitting based on a 1:1 
binding model using the Origin software package. Stoichiometry factors (N) typically 
ranged between 0.85 and 1.05 (syringe:cuvette). 
 
 
C.2.5.8 ATPase assay 
 Rates of ATP hydrolysis have been determined as described before (Liberek et al., 
1991). The ATPase activity was determined from the amount of a32P-ATP hydrolyzed. 
The final reaction mixture contained 20 mM HEPES-KOH pH 7.6, 50 mM KCl, 5 mM 
MgAc2, and 2 mM ATP supplemented with 1 mCi a32P-ATP with a specific activity of 
400 Ci/mmole in a final volume of 30 ml. Reactions were initiated by addition of ATP to 
the mixtures containing the various proteins at 3 mM final concentration. Samples (1 ml) 
were analyzed by thin layer chromatography (TLC) on polyethyleneimine (PEI)-cellulose 
(Merck) in 0.5 M formic acid/0.5 M LiCl (1:1, v/v). TLC sheets were dried using a blow 
dryer. The ATP and ADP spots were quantified by phoshoimaging (Fuji Film FLA-2000) 
using the MacBas software package. 
 
 
C.2.5.9 Covalent coupling of antibodies to Protein G beads 
Antibodies against the c-myc (EQKLISEEDL) epitope were covalently coupled to 
Protein G sepharose (Pharmacia) using the following protocol. Protein G beads (1 ml) 
were washed three times with PBS (10 ml). Washed beads were mixed with antibody 
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solution (1 ml of a 1 mg/ml polyclonal serum or 10 ml of cell culture supernatant) and 
incubated for 1 hour at room temperature with gentle rocking. Beads were washed two 
times with 10 volumes of 0.2 M Na-borate pH 9.0 by centrifugation at 3000xg for 5 min. 
Beads were resuspended in 10 volumes 0.2 M Na-borate pH 9.0. An aliquot (10 ml) was 
removed for later analysis of coupling efficiency. Solid dimethylsuberimidate (10 mM 
final concentration; 5.5 mg/1 ml) was added to the suspension. The solution should be 
approximately at pH 8.3. Beads were incubated for 30 min at room temperature with 
gentle rocking. Again, an aliquot (10 ml) was removed. The reaction was stopped by 
incubating the beads with 10 volumes 0.2 M ethanolamine pH 8.0 with gentle mixing. 
Beads were washed with 10 volumes 0.2 M ethanolamine pH 8.0 and finally resuspended 
in PBS/0.02% Na-azide. The coupling efficiency was determined by boiling the samples 
removed during the procedure in SDS-PAGE sample buffer and SDS-PAGE analysis. 
The heavy chain of the antibody (around 55 kDa) should be seen in the smaple taken 
before the addition of the crosslinker, and should be absent after crosslinking. 
 
 
C.2.5.10 Preparation of yeast lysates 
 Yeast lysates have been prepared as described (Hartley et al., 1996). YPD medium 
(6x 500 ml) was inoculated with 100 ml of a starter culture grown to stationary phase. 
Cultures were grown at 30°C with vigorous agitation (150 rpm) until a cell density of 
OD600=1 was reached (normally between 14 and 16 hours depending on the strain). Cells 
were harvested by centrifugation at 4400xg for 5 min at 4°C. Cells were washed with 200 
ml cold sterile water and centrifuged as before. Dry cell pellets were weighed. Cells were 
resuspended in half volume to weight of cold lysis buffer (20 mM HEPES-KOH pH 7.4, 
100 mM KAc, 2 mM MgAc2, and 2 mM DTT, supplemented with protease inhibitors). 
Cells were transferred to sterile 50 ml Falcon tubes kept on ice, not exceeding 12 ml per 
tube. Acid-washed glass beads were added to just below the meniscus, followed by an 
incubation for 15 min on ice. Mixtures were repeatedly agitated vigorously by hand for 
30 seconds, followed by chilling on ice for 1 min. The degree of disruption was estimated 
microscopically. After 70-80% lysis, liquid was withdrawn with a plastic pipette and 
transferred to a sterile Corex tube. Glass beads were washed with 1 ml cold lysis buffer. 
Wash buffer and lysates were pooled with the lysate. Lysates were centrifuged at 
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30,000xg for 10 min at 4°C. The opaque-yellow lysate was withdrawn using a sterile, 
cold glass pipette without contaminating it with the top lipid layer or flocculent material. 
The lysate was centrifuged at 100,000xg for 30 min at 4°C. Supernatants were 
supplemented with 20% glycerol and frozen in liquid nitrogen in aliquots. 
 
 
C.2.5.11 Western blotting 
 Immunoblotting was performed following the protocol of Towbin et al. (1979). 
Briefly, proteins were separated by SDS-PAGE and transferred to nitrocellulose in a tank 
blot system (Biorad) in 25 mM Tris, 192 mM glycin and 20% methanol, pH 8.4 at 
constant current (320 mM) for two hours at 4°C. Nitrocellulose membranes were blocked 
with 5% milk powder in PBS/0.1% Tween20 for 1.5 hours at room temperature or 
overnight at 4°C. Blots were washed 3 times with PBS/0.02%, followed by incubation 
with the primary antibody in PBS/0.02% Tween20 for 1 hour at room temperature. Blots 
were washed 5-times with PBS/0.02% Tween. Incubation with the secondary, horse-
reddish peroxidase-coupled antibody in PBS/0.02% Tween20 was carried out for 30 min 
at room temperature. Blots were washed as before, followed by additional three washes 
with destilled H2O. Detection was achieved by using the chemiluminescence kit ECL 
(Amersham) followed by exposure to X-ray films (Fuji Film). 
 Primary antibodies used for detection of S. cerevisiae Ssa and Ssb proteins were a 
generous gift of Elizabeth A. Craig (Madison, USA) (Lopez-Buesa et al., 1998). 
Antibodies recognize the C-terminal 80 and 56 amino acids, respectively. As secondary, 
species-specific antibody, an goat a-rabbit specific antiserum directly conjugated with 
horse reddish peroxidase (Sigma) was used. 
 
 
C.2.5.12 Pull downs using His6-tagged proteins bound to NiNTA beads 
 His6-tagged proteins (60 mg) were bound to NiNTA resin (25 ml of a 1:1 slurry) in 
buffer B in micro spin colums (MoBiTec, Germany) for 20 min at room temperature. 
Beads were washed twice with buffer B supplemented with 200 mM KAc and an 
additonal wash with buffer B. Control beads without bound proteins were processed 
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equally. Beads were resuspended in 200 ml buffer B. Reactions were supplemented with 
200 ml yeast lysates. Binding was performed either in the presence of apyrase (4 
Units/ml), 5 mM ATP/Mg2+, or 5 mM ADP/Mg2+. Reactions were incubated for 20 min at 
room temperature. Beads were washed 3-times with the respective binding buffer (buffer 
B, buffer B containing 5 mM ATP/Mg2+, or buffer B containing 5 mM ADP/Mg2+). 
Bound proteins were eluted from the resin with 2x SDS-PAGE sample buffer and 
analyzed by SDS-PAGE and Western blotting. 
 
 
C.2.5.13 Substrate release assay 
Hsc70 release from substrate was measured as described (Young and Hartl, 2000). 
The principle of the experimental setup is depicted in Figure 6. 
 
 
 
Figure 6: Principle of substrate release assay. 
 
 
Rabbit reticulocyte lysate (RL) (Green Hectares) was desalted into buffer B (25 
mM HEPES-KOH pH 7.5, 100 mM KAc and 5% glycerol) by chromatography on a 
NAP5 column (Pharmacia) following the manufactorers’ instructions. Radiolabeled 
Hsc70 was generated by in vitro translation of Hsc70 cDNA from a T7 promoter (pET3a 
vector backbone) using the TNT T7 system (Promega). All reagents except DNA and 
C.2 Material and Methods 45
RNase guard were included in the system kit. Reactions were set up as follows and 
incubated for 90 min at 30°C: 
 
TNT reaction:  25 ml reticulocyte lysate (Promega) 
     2 ml TNT reaction buffer 
     1 ml T7 polymerase 
     1 ml amino acid mix lacking methionine 
     4 ml 35S-methionine 
     1 mg DNA (hsc70human in pET3a) 
     ddH2O to 50 ml final volume. 
 
After 60 min of transcription/translation, purified, myc-tagged ligand binding 
domain of the glucocorticoid receptor (LBD) (200 mg, kindly provided by J. C. Young) 
was partially denatured for 5 min in 1% SDS, 50 mM Tris-HCl pH 7.5 at room 
temperature. The solution was diluted 200fold into buffer C (100 mM K-acetate, 25 mM 
HEPES-KOH pH 7.5, 1% NP40, 1% Na-deoxycholate, 0.1% SDS). Anti-myc monoclonal 
antibodies, covalently coupled to Protein G Sepharose (Pharmacia) (50 ml of a 1:1 slurry) 
were added to the partially unfolded LBD and incubated for 30 min at 25°C. 
Immunepellets were washed twice with 1 ml buffer B. Reactions were supplemented with 
radiolabeled Hsc70 from the in vitro translation reaction, 10 mM MgAc2, 2 mM ATP, 
500 ml buffer B, and 500 ml desalted reticulocyte lysate (Green Hectar). Steady-state 
binding of Hsc70 and cofactors to the LBD was attained after 10 min at room 
temperature. The immunoprecipitation reaction was split into 10 reactions, and each 
aliquot was washed twice with buffer B. 
For the release reaction, immunepellets were resuspended in 100 ml buffer B 
containing additions as indicated. After 10 min at room temperature, beads and 
supernatant were separated. Supernatants were precipitated with trichloroacetic acid 
(12.5% final; spin for 30 min at 20,000xg at 4°C). Proteins bound to the beads were 
eluted with 2xSDS-PAGE sample buffer. Pellet fractions and eluates from beads were 
analyzed by SDS-PAGE. Quantification of the radiolabeled gel was performed by 
phoshoimaging (Fuji Film FLA-2000). Release of Hsc70 from the immunepellets was 
normalized to the amount of input radiolabeled Hsc70. 
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C.2.6 X-ray crystallographic Methods 
 An adequate description of the theory of X-ray crystallography and its 
experimental application is too extensive to be covered in the format of this thesis. 
Therefore, only a summary of the diffraction theory and the different steps for X-ray 
analysis will be given. A more detailed description of the methods and theories can be 
found in textbooks by Drenth (1994), Massa (1994), McRee (1993), Giacovazzo (1992), 
McPherson (1982), Buerger (1977), Blundell and Johnson (1976), and Woolfson (1970). 
 
 
C.2.6.1 Theory of X-ray diffraction 
 When X-rays impinge on a crystal their electromagnetic field excites the electrons 
within the crystal which will oscillate with the same frequency as the incident wave. 
Oscillating electrons scatter the radiation and they emit radiation of the same frequency as 
the incident radiation but with a phase shift of 180° (Thomson scattering). The overall 
intensity adds up to zero (destructive interference) if the path difference is not an integral 
multiple of the wavelength (see below). Periodicity is a prerequisite of constructive 
interference (path difference is an integral multiple of the wavelength). This requirement 
is given in a crystal. The wave scattered by a crystal can be described as a summation of 
waves, each scattered by electrons in the crystal. The aim of structure analysis by X-ray 
diffraction is to derive the electron density distribution as a function of the scattering 
information. This is achieved by Fourier transformation. 
 Geometric conditions that produce reflexes (constructive interference) by 
diffraction of X-rays at a crystal can be described by the Laue conditions: 
 
lhssa o =- )(
vvv
  lkssb o =- )(
vvv   llssc o =- )(
vvv   
 
where h, k, and l are integer, l is the wavelength of the X-rays, av , b
v
 and cv  are unit cell 
vectors, sv  and 0s
v
 are unit vectors in the direction of the impinging and diffracted ray, 
respectively. 
Bragg described these equations in a scalar form. A set of parallel planes with the 
index hkl and interplanar spacing dhkl produces a diffracted beam when X-rays of the 
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wavelength l impinge upon the planes at an angle q and are reflected at the same angle, 
only if q meets the condition 
 
2dhklsinq = nl 
 
where n is an integer. A geometric construction of Bragg’s law is shown in Figure 7. If 
the difference in pathlength for rays reflected from successive planes is equal to an 
integral number of l of the impinging X-ray, then reflected rays emerge from the crystal 
in phase with each other, interfering constructively to produce a strong reflected beam. 
An interference picture characteristic for the highly ordered, crystalline system is 
obtained. At other q not fulfilling Bragg’s equation, the reflected rays are out of phase 
and interfere destructively; no beam emerges at that angle. 
 
 
Figure 7. Geometric construction of Bragg’s law. If the additional distance traveled by 
the more deeply penetrating ray R2 is an integral multiple of l, then rays R1 and R2 
interfere constructively. The eqautions sinq=BC/AB and BC=ABsinq=dhklsinq are valid 
since ABC is a right triangle. 
 
 
The Ewald construction transfers Bragg’s law to the reciprocal space (Figure 8). 
The origin of the reciprocal lattice is defined as the intersection of the undiffracted ray 
and the Ewald sphere, a sphere with radius 1/l. The imaginary reciprocal lattice is in 
inverse relationship with the real crystal lattice. Each periodical distance between lattice 
planes in the real space corresponds to a vector in the reciprocal space perpendicular to 
the reflecting plane. The absolute value of the distance between the lattice planes in a 
crystal and these vectors are reciprocal to each other. If a point of the reciprocal lattice 
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lies on the surface of the Ewald sphere, then Bragg’s law is satisfied and a reflection can 
be detected. 
The result of a crystallographic data collection is a list of intensities for each point 
in the three-dimensional reciprocal lattice, the diffraction pattern of a crystal. As 
described above, there is a inverse relationship between the real and the reciprocal lattice. 
Each reflection is explicitly defined by the Miller indices (h, k, and l) with respect the 
crystal metric. In the process of structure determination, the diffraction pattern (reciprocal 
space), providing parameters hkl and their intensities Ihkl, is converted to information 
about the real space. 
 
 
Figure 8. The Ewald construction as a tool to construct the direction of the scattered 
beam. A circle with radius 1/l is drawn around the crystal M. In the three-dimensional 
space, this will be a sphere. The origin of the reciprocal lattice is at O*. 0s
v
 indicates the 
direction of the incident beam; sv  indicates the direction of the scattered beam. 
 
 
Each lattice point Phkl is assigned to a scattering vector S
v
 (with 0S ss
vvv -= ; see 
above). S
v
 can be described with the unit cell vectors (translation vectors) of the 
reciprocal space *a
v
, *b
v
, and *c
v
 with 
 
*** ++= clbkah v
vvvS  
 
where the correlation of the translation vectors of the real space and the ones in reciprocal 
space can be expressed with 
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 An impinging X-ray is scattered by an electron cloud of an atom dependent on the 
number of electrons and their position in the cloud. The electron density at position rv  is 
denoted by r(rv ). The scattered wave is calculated by adding up all individual 
contributions within the volume of an atom by 
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where f  is the atomic scattering factor and i is the imaginary number 2
1
)1(- . 
 Scattering from a unit cell with n atoms at positions jr
v
 (j=1, 2, 3,....,n) with 
respect to the origin of the unit cell is obtained by summation of the contribution of each 
atom with the origin transfrerred to the origin of the unit cell (the phase angles change by 
S2
vv ×jrp ). The total scattering from the unit cell is 
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where )SF(
v
 is called the structure factor, a function of the electron density distribution in 
the unit cell. To obtain the scattering by a crystal consisting of a large number of unit 
cells in each direction, the structure factors are added with respect to a single origin and is 
described by 
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where n1, n2, and n3 are the number of units cells in the a
v -, b
v
-, and cv - direction, 
respectively, and where cvbuat v
vv ×+×+×  is the origin of an individual unit cell (t, u, and v 
are whole numbers). Instead of summing over all seperate atoms, an integral over all 
electrons in a unit cell can be used. The structure factor is then described by 
 
ò ×=
cellunit 
cellunit ]Sexp[2)()S(F dvrr
vvvvv pr . 
 
With V being the volume of the unit cell and with 
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 can also be written as )(F hkl
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 is a Fourier transform of )(xyzr  and vice versa. Therefore, )(xyzr  can be written 
as a function of )(F hkl
v
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Because 
2
)()(I hklFhkl µ  the structure factor amplitudes )(hklF  of the 
reflexion (hkl) can be derived from the intensities I(hkl) but the phase angles a(hkl) 
cannot be measured straightforwardly. Phase information has to be assigned to each 
structure factor amplitude. Calculation of phase information is achieved by the structural 
model, an assumed electron density distribution, which will provide theoretical structure 
factor amplitudes calcF  containing the phases a(hkl)calc. These are transferred to the 
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observed amplitudes and allow a calculation of the electron density distribution under 
consideration of the experimental data. Methods to obtain phase information will be 
described briefly in the chapter ‘Structure solution’. 
 
 
C.2.6.2 Structure determination using X-ray diffraction 
 In Figure 9, the necessary steps of structure determination by X-ray analysis are 
outlined. All steps will be described briefly in the following paragraphs. 
 
 
Figure 9. Flow chart of structure determination by X-ray analysis 
 
 
C.2.6.3 Protein crystallization 
 The basis for X-ray structure analysis is the existence of suitable crystals which 
provide high resolution diffraction patterns. Under certain circumstances, molecules - 
here proteins - will enter the crystalline state from solution. Individual molecules adopt 
one or a few identical orientations thereby forming a orderly three-dimensional array of 
molecules, held together by non-covalent interactions. Prerequisite for crystallization is a 
crystal seed obtained by slow, controlled precipitation from an aqueous solution. Proper 
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conditions for optimal crystallization have to be determined empirically by testing a 
multi-dimensional set of condition, for example choice and concentration of precipitant, 
pH, temperature, protein concentration and homogeneity, ionic strength, additives such as 
detergents or alcohols, and sample volume (McPherson, 1990). To find suitable starting 
conditions, so called ‘sparse-matrix screens’ are used (Jancarik and Kim, 1991) which are 
commercially available. These screens contain a limited number of conditions which have 
been chosen after a statistical evaluation of known crystallization conditions. In the next 
steps, the starting condition is reproduced and optimized by varying the different 
parameters and/or including new ones. Methods for crystal growth are the sitting or 
hanging drop method, crystallization under oil, or crystallization by microdialysis 
(reviewed in Ducruix and Grige, 1992). 
 
 
 
Figure 10. Principle of crystallization by the hanging drop method. 
 
 
 In the present study, protein crystallization was exclusively achieved by the vapor 
diffusion method in hanging drops (McPherson, 1982) (Figure 10). Purified proteins were 
mixed with precipitant solution in a 1:1 ratio, and the solution was suspended as a drop 
from a siliconized glass cover slip above the precipitant solution. The chamber was sealed 
with grease. Equilibrium was reached by diffusion of vapor between protein solution and 
precipitant solution. Sparse-matrix screens of precipitant solutions were obtained from 
Hampton Research. Protein concentrations ranged from 5 to 40 mg/ml. Optimization of 
starting condition for crystal growth was achieved by varying temperature, buffer and pH, 
salt concentration, precipitant and protein concentartion. Futhermore, additives 
(cryoprotectant and alcohols) and seeding techniques (mainly micro-seeding) were tested. 
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C.2.6.4 Data collection and data reduction 
 As described above, reflexes of a X-ray scattered on a crystal can be measured if 
the conditions described by Bragg and Laue are fulfilled. This is achieved by the 
oscillation of a crystal centered in a X-ray beam. During the rotation (Dw between 0.5° 
and 2°), the diffraction patterns are recorded by an area detector. The goal of data 
collection is a set of consistently measured, indexed intensities for as many of the 
reflections as possible. For higher consistency of the diffraction properties of a crystal 
during data collections, the crystal is cooled continously. In the present study, rotating 
copper anodes and synchrotron radiation were used as X-ray sources. The latter one is 
favorable for reasons of higher intensity and minor divergence of the radiation, and the 
free choice of the wavelength within in the continous synchrotron spectrum. 
 After collection of diffraction patterns, the raw intensities of the reflections must 
be processed to improve their consistency and to maximize the number of observations 
which are sufficiently accurate for structure solution. This process is called ‘data 
reduction’. The quality of data reduction is estimated by comparing symmetry-equivalent 
intensities which is described in the Rsym value (the ‘reliability index’). 
 
 Crystals were shock frozen in liquid nitrogen. In some cases, the drop containing 
crystals was overlayed with paraffin oil to improve freezing properties. Data collection 
was carried out on a single crystal at 100 K in a continuous stream of liquid nitrogen 
(Oxford Cryostream). Proper cryogenic conditions were achieved by co-crystallization 
with glycerol or xylitol. Data sets were collected at the following X-ray sources (Table 6). 
 
Table 6. X-ray sources used for data collection. 
X-ray source Location Beamline Data set Detector 
Rotating anode RU-200 (Rigaku), 
mirror system (Supper) 
Martinsried - native Image plate MAR300 
DESY Hamburg BW6 MAD MARCCD 
ESRF Grenoble ID14-4 native ADSC Quantum-4 
 
 Data reduction was carried out using the software packages DENZO and 
SCALEPACK (Otwinowski and Minor, 1997). 
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C.2.6.5 Structure solution 
 Structure solution is achieved when the first structure model has been found or, 
equivalent to that, the correct phase information has been obtained. For small molecules, 
phases can be obtained by direct methods without any further experimental analysis 
(Karle and Hauptmann, 1950, Harker and Kasper, 1948). For protein structures, this 
method is only applicable to very small molecules (< 1000 non-hydrogen atoms) and 
requires a very high resolution (< 1.2 Å). 
 For solving larger protein structures, experimental methods have been established 
to obtain phase information neccassary for structure solution: Multiple isomorphous 
replacement (MIR), multiple anomalous dispersion (MAD), and molecular replacement 
(MR). In some cases, a combination of the different phasing methods can be applied. 
 In MIR experiments, heavy metal atoms (for example Hg, Pt, Au) are attached to 
the protein molecules in the crystal. Usually, the crystal is soaked in solutions containing 
heavy metal compounds (usually salts). The reflection intensities of these heavy metal 
derivatives of the crystals will be significantly different from the native ones. Such a 
crystal is called an isomorphous derivative if the unit cell parameters and the crystal 
packing are not different from the native crystal, a prerequisite for applying structure 
solution by MIR techniques. Under these conditions, the changes in reflex intensities are 
solely due to the incorporation of the heavy metal atoms. The position of the heavy metal 
atoms will be located in the unit cell of the crystal derivative by applying the patterson 
function with the observed differences in reflex intensities (Patterson, 1934; Patterson 
1935) or by direct methods. For MIR experiments, at least two different derivatives are 
required for successful solution of the phase problem. 
 Phasing by MAD techniques depends on the presence of sufficiently strong 
anomalous scattering atoms in the protein structure itself. This can be achieved by 
incorporation of non-natural amino acid derivatives (for example selenomethionine). The 
technique takes advantage of the heavy atom’s capacity to absorb X-rays of a specified 
wavelength. It results in an inequality of the intensities of symmetry-related reflections 
(Friedel’s law, hkl equals –h –k – l, does not hold). This inequality is called anomalous 
scattering (also: anomalous dispersion). Anomalous scattering can be measured at X-ray 
wavelength near the absorption edge of the heavy atom (the sudden drop of absorption at 
wavelengths just below their characteristic emission wavelength). On the other hand, 
absorption edges of the light atoms are not near the X-ray wavelengths, and therefore do 
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not contribute to the anomalous scattering. The differences in intensities are measured at 
wavelengths around the absorption edges of the heavy atom incorporated into the 
molecules. Data sets are collected at at least two different wavelengths (preferably three). 
MAD experiments can be performed using a single crystal and therefore, the phase 
information is very accurate up to the resolution limits since problems regarding 
isomorphism of the crystal will usually not occur. 
 Molecular replacement can be used as phasing technique if structural similarities 
indicated by sequence homology between the desired structure and an already known one 
can be expected (Rossmann, 1972; Huber, 1965; Rossmann and Blow, 1962; Hoppe, 
1957). This method requires the correct placement of the known structure (as search 
model) in the unit cell of the desired crystal structure. Structure solution will be achieved 
by determination of the orientation and translation of the search model in the unit cell. 
 After determination of the experimental phases, the density maps are calculated by 
Fourier transformation. Improvement of the phases by density modifications is often 
neccessary to obtain a interpretable electron density map. This is achieved by introducing 
boundary conditions, for example the continuity of a polypeptide chain, maxima of 
electron density at atom positions at high resolution (Cowtan and Main, 1993), or the 
observation of high electron density in proteinaceous areas and low density in solvent 
areas of the unit cell. 
 
 In this study, structure solution was achieved by MAD experiments on a single 
crystal of selenomethione-containing protein using the software package SOLVE 
(Terwilliger and Berendzen, 1999) followed by density modification using the program 
DM (CCP4, 1994). 
 
 
C.2.6.6 Model building and refinement 
After calculation of the phases, the electron density map has to be interpreted. 
Using the known protein sequence and other informations (for example search models 
from molecular replacement solutions or similar structures as template), an approximate 
model is built in accordance with the density. At very high resolutions, the model can be 
built automatically (partially or completely) using special software packages (for example 
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wARP (Perrakis et al., 1997)). In the refinement process, model parameters (position of 
atoms, temperature factors of the atoms) are optimized aimig for a maximal agreement of 
the structural model with the experimental information. Boundary conditions regarding 
stereochemical properties e.g. torsion angles and bond lengths are introduced (Engh and 
Huber, 1991; Branden and Jones, 1990; Konnert and Hendrickson, 1980; Jack and Levitt, 
1978). Iterative cycles of model building and refinement are performed until no further 
optimization of the model is achieved. The quality of the model can be expressed by 
several statistical factors (Dodson et al., 1996; Brünger, 1992). 
 
 Model building and correction was carried out using the graphical interface O 
(Jones et al., 1991). The model was refined using the program package CNS (Brünger et 
al., 1998) in consideration of steterochemical boundary conditions. 7-10% of all reflexes 
were excluded from the refinement process, and were used for calculation of the Rfree 
value as a criterium for model quality (Kleywegt and Brünger, 1996; Brünger, 1992). In 
the final stage of refinement, water molecules were introduced into the model 
automatically by peak analysis of the Fo-Fc difference density followed by manual 
inspection using the graphics interface. 
 
 
C.2.6.7 Analysis and presentation of structure models 
 The structure was analyzed using the programs PROCHECK (Laskowski et al., 
1993), LIGPLOT (Wallace et al., 1995), and SWISS-PDBVIEWER (Guex and Peitsch, 
1997). Interaction surfaces and route mean square deviations of superpositions were 
calculated using CNS (Brünger et al., 1998). Presentations of the structure and its 
properties were obtained with the progamms GRASP (for calculation and presentation of 
the accessible surface and its electrostatic potential) (Nicholls et al., 1993), Bobscript 
(Esnouf, 1999) and RASTER3D (Merrit and Bacon, 1997) for ribbons and ball-and-stick 
presentations. 
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C.3 Results 
 
 
C.3.1 Domain structure of Bag-1M and Hsc70 
 A rational approach was chosen to define stably folded domains of Bag-1 since 
preliminary crystallization trials with the full length proteins failed (unpublished 
observation, Christine Schneider and Ismail Moarefi). Biochemical characterization 
revealed the functionality of the obtained fragments. 
 Recombinantly expressed human Bag-1M was used as the starting material for 
limited proteolysis with the unspecific proteases subtilisin and proteinase K. Incubation 
with increasing amounts of the enzyme resulted in the appearence of a stable protein 
fragment of approximately 14 kDa in both reaction series. The exact molecular weight 
and the domain borders were determined by electrospray ionisation mass spectroscopy 
followed by analysis using the software package PAWS with the obtained molecular 
masses and the primary sequence of Bag-1M as inputs. The fragment was identified as 
the C-terminal Bag-domain of Bag-1M consisting of residues 151 to 263 (see Figure 4) 
(data kindly provided by Christine Schneider). The respective expression construct was 
cloned and used for overexpression in E. coli cells. The fragment was purified using 
standard chromatography techniques. During the purification, the His6-purification tag 
encoded by the vector used for cloning was removed by TEV protease treatment resulting 
in the exact product obtained by treatment with subtilisin or proteinase K. 
 For crystallization and biochemical assays, the main cytosolic form of Hsp70, the 
heat shock cognate protein 70 kDa (Hsc70), was used. The Hsc70 ATPase domain was 
optimized for crystallization purposes based on the known structure. Unstructured regions 
were omitted from the final construct, which consists of amino acids 5 to 381 of rat 
Hsc70 (see Figure 4). 
 
 
C.3.2 Characterization of the isolated Bag domain 
 The stable Bag domain was analyzed with respect to its binding and action on 
Hsp70. Assays were perfomed addressing the binding behavior of Bag-1M and its Bag 
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domain to Hsp70 and the isolated ATPase domain, respectively, their influence on the 
ATPase rate and substrate binding of Hsp70. Bag domain activities were always 
compared to the respective effects observed with the full length protein Bag-1M. 
Isothermal titration calorimetry (ITC) was used to measure the binding constants 
for the interaction of Bag-1 and Hsp70 and their respective interacting domains in 
solution. All proteins were expressed recombinantly and were purified as described 
above. The binding reactions were performed in buffer containing physiological salt 
concentration. Futhermore, the effect of nucleotide on binding was tested. In Figure 11, 
an example of an ITC measurement is shown (cuvette: 100 mM Hsc70, syringe: 1 mM 
Bag-1M; both in buffer G). 
Stoichiometry factors (N) typically ranged between 0.85 and 1.05 representing 1:1 
binding of Hsp70 to Bag-1 and the respective domains. Futhermore, this value also 
reflects the functionality of the proteins used in the titration, and later on for 
crystallization, given the specific stoichiometry for the Hsp70/Bag-1 interaction of 1:1 
(Stuart et al, 1998). The construct comprising the minimal Bag domain had the same 
affinity for Hsc70 or its ATPase domain as the Bag isoform Bag-1M (KD 1-3 mM; Table 
7). Binding affinities were substantially reduced (about 7- to 10-fold) in the presence of 
ADP or ATP in agreement with the binding characteristics of the full-length proteins 
(Stuart et al., 1998). Furthermore, no binding of the Bag domain to the E. coli homolog of 
Hsc70, DnaK, was observed. 
 
Table 7. Thermodynamic Analysis of Bag-1/Hsc70 Interaction.* 
KD (mM)**  
Bag-1M Bag domain 
Hsc70(5-381) 2.8 ± 0.2 3.6 ± 0.9 
27.3 ± 1.0 [ADP]*** 
25.5 ± 0.9 [ATP]*** 
Hsc70 0.75 ± 0.07 1.1 ± 0.1 
DnaK n.d. no binding 
* Calorimetric isothermal titration measurements were carried out at T=25°C by 
titration of 100 mM Hsc70 or its ATPase domain with 1 mM Bag-1M or Bag domain in 
buffer G (25 mM HEPES-KOH pH 7.5, 100 mM KAc, and 5 mM MgAc2). 
** indicated errors represent goodness of fit. 
*** 5 mM nucleotide was present in both protein solutions. 
 
Next, the effect of Bag-1 and the isolated Bag domain on the ATPase activity of 
Hsp70 was tested. The source of Hsc70 for these studies was protein purified from bovine 
brain, material of high purity (> 98%) and activity. Hsp40-dependent ATP hydrolysis of 
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Hsc70 is stimulated 10-fold in the presence of the Bag domain or Bag-1M (Figure 12A). 
No stimulation was observed in the absence of Hsp40. Bag-1M and Hsp40 do not possess 
an intrinsic ATPase activity (data not shown). 
 
 
Figure 11. Isothermal titration calorimetry. Bag-1M (1 mM) was titrated into a solution 
of human Hsc70 (0.1 mM). Dissociation constants (KD) were determined by integrated 
heat effects normalized to the amount of injected protein and curve fitted based on a 1:1 
binding model. 
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Figure 12. Functional characterization of Bag-1M and the Bag domain. (A) Bag-1M and 
the Bag domain stimulate the ATPase activity of Hsc70 in a Hsp40-dependent manner. 
Hsc70 (3 mM) was incubated at 30°C with Hsp40 (3 mM) and Bag-1M or isolated Bag 
domain (3 mM) as indicated. The amount of ATP hydrolyzed was quantified (see Material 
and Methods). (B) Bag-1M and the Bag domain stimulate Hsc70 release from substrate 
polypeptide in a nucleotide-dependent manner. Release of 35S-Met-labeled Hsc70 from 
partially denatured immobilized ligand binding domain (LBD) of the glucocorticoid 
receptor was measured upon incubation with ovalbumine, Bag-1M or Bag domain (5 mM 
each) for 10 min at 25°C in the presence or absence of MgATP (2 mM) (see Material and 
Methods). S, supernatant fractions containing released Hsc70; P, pellet fractions 
containing LBD-bound Hsc70. Supernatants and pellets were analyzed by SDS-PAGE 
followed by phosphoimaging. The bar diagram shows the amounts of Hsc70 released 
from LBD expressed in percent of total bound Hsc70. Error bars represent standard mean 
deviations of three independent experiments. 
 
 
Opposite effects of Bag-1 on the binding of substrate to Hsp70 have been 
described in the literature. On the one hand, stabilization of Hsp70/substrate complexes 
by Bag-1 has been observed using a native PAGE assay (Bimston et al., 1998). On the 
other hand, Bag-1 has been shown to promote substrate release from Hsp70 as analyzed 
by gel filtration and immunoprecipitations (Lüders et al., 2000; Zeiner et al., 1997). While 
previous immunoprecipitation experiments examined the equilibrium binding of Hsp70 to 
substarte, an in vitro assay has been recently established to specifically analyse the 
dissociation of chaperone/substrate complexes (Young and Hartl, 2000). Using this novel 
assay, the effect of Bag-1 on complexes of Hsp70 with substrates was tested. Immune-
isolated complexes of Hsp70 with a model substrate (partially denatured glucocorticoid 
receptor ligand binding domain, LBD) were incubated with various forms of Bag-1 
cochaperones, and the amounts of Hsp70 released were quantified. In the presence of 
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ATP, the Bag domain and Bag-1M triggered efficient release of radiolabeled Hsc70 from 
the LBD, whereas little release was observed with ovalbumin (Figure 12B). This is 
consistent with the previously published observations from gel filtration experiments and 
immunoprecipitations of Hsc70/substrate complexes (Lüders et al., 2000; Zeiner et al., 
1997). Bag-dependent dissociation of the Hsc70/LBD complex required ATP as Bag-1 in 
the absence of nucleotide did not trigger substrate release (Figure 12B). Addition of ADP 
or ATP alone without Bag-1 did not release Hsc70 from substrate above control reactions 
lacking nucleotides (Figure 13A). 
Bag-1 has also been reported to compete with the cofactor p48/Hip in binding to 
the ATPase domain of Hsp70 and to oppose its influence on ATPase hydrolysis and 
protein folding by Hsp70 (Gebauer et al., 1997; Höhfeld and Jentsch, 1997; Lüders et al., 
1998). p48/Hip was also present in the substrate/chaperone complexes (Figure 13B) 
(Young and Hartl, 2000). In this experiment, radiolabeled p48/Hip was translated to 
monitor and quantify its fate upon the different incubations. In parallel, the experiment 
was carried out with radiolabeled Hsp70, as described above (Figure 13A). Treatment of 
the immune pellets with control proteins or nucleotides alone did not release the 
cochaperone from the pellets. Efficient release of p48/Hip was only observed when Bag-
1M or the Bag domain was present. This reaction was independent of nucleotide. 
Furthermore, Hip binding to the ATPase domain of Hsp70 was salt sensitive, comparable 
to other TPR-mediated interactions, e.g. that of p60/Hop with the C-termini of Hsp70 and 
Hsp90 (Young and Hartl, 2000). 
Taken together, the Bag domain used for crystallization was fully functional with 
repect to binding properties and action on Hsp70 reported earlier (Höhfeld and Jentsch, 
1997; Stuart et al., 1998; Lüders et al., 2000). In all assays, the isolated domain accounts 
for the effects of Bag-1M on Hsp70 activity. 
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Figure 13. p48/Hip release from LBD/chaperone complexes. (A) Bag-1M and the Bag 
domain stimulate Hsc70 release from substrate polypeptide in an ATP-dependent manner. 
Release of 35S-Met-labeled Hsc70 from partially denatured LBD was assayed as before 
(Figure 12). (B) Bag-1M and the Bag domain stimulate p48/Hip release from Hsc70 in a 
nucleotide-independent manner. Release of 35S-Met-labeled p48/Hip from the complexes 
was assayed as for Hsc70 release. Error bars represent standard mean deviations of three 
independent experiments. 
 
 
C.3.4 Crystallization, data collection and processing 
 For crystallization trials, proteins were expressed and purified as described in 
Materials and Methods. Complex formation between the human Bag domain of Bag-1M 
with the ATPase domain of rat Hsc70 (100% identical to the human primary sequence) 
was performed by incubating a mixture of the two proteins, using a slight excess of Bag 
over the ATPase domain (Bag domain:Hsc70 ATPase domain 1.5:1). The complex was 
further purified to homogeneity by anion exchange chromatography and gel filtration. A 
selenomethionine-labeled derivative of the ATPase domain was produced in the E. coli 
strain B834(DE3)pLysS, and incorporation of the heavy metal derivative was confirmed 
by electrospray ionisation mass spectroscopy (data not shown). Substitution of 
methionine by selenomethionine was quantitative (6 out of 6 sites). 
 
Table 8. Crystal growth conditions. 
Initial conditions 
(PEG ion screen) 
Optimized conditions 
(native, in house) 
Optimized conditions 
(native, ESRF) 
Optimized conditions 
(SeMet-derivative) 
0.2 M Na-K-tartrate 0.05-0.1 M Na-K-tartrate 0.05 M NaCl 0.05 M Na-K-tartrate 
20% PEG3350* 14-16% PEG3350** 10-12% PEG3350 16% PEG3350 
 20% glycerol 20% glycerol 30% glycerol 
and  0.1 M Tris -HCl pH 8.5 0.1 M Tris -HCl pH 8.5 0.1 M Tris -HCl pH 8.5 
  5% ethanol  
0.2 M NaCl  (frozen in parafine oil) (no parafine oil) 
20% PEG3350*    
*: polyethylene glycol (average molecular weight 3350 Da) 
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 Initial conditions of crystal growth were obtained by the use of the sparse-matrix 
screen ‘PEG ion screen’ (Hampton Research) (Table 8). Washing of a single crystal in 
the crystal growth medium and dissolving it in water followed by SDS-PAGE analysis 
and silver staining revealed that the Hsc70/Bag-1 complex had been crystallized (Figure 
14B). Optimization of the crystal growth condition resulted in stable and sizeable cystals 
(0.25 x 0.15 x 0.15 mm3) with good diffraction properties (Table 9; Figure 14A and C). 
Crystal seeds appeared after 5 days, maximum crystal size was reached after day 7 at 
20°C. Crystals containing the selenometionine derivative of the ATPase domain were 
obtained under similar conditions, and showed similar properties with respect to growth 
and X-ray diffraction. 
 
 
Figure 14. Crystals of the Hsc70 ATPase/Bag domain complex. (A) Crystals growing in 
12% PEG3350, 50 mM NaCl, 20% glycerol, and 5% ethanol. Pictures were taken after 7 
days of crystal growth. (B) The Coomassie-stained gel shows the complex after 
purification by anion exchange chromatography and gel filtration (Input). Silver-stained 
gels present the content of a single crystal, washed in precipitant solution and dissolved in 
sample buffer. (C) Diffraction pattern of a single crystal of the Hsc70 ATPase/Bag 
domain complex, collected at the rotating Cu anode (in house). The resolution limit 
shown is 2.3 Å. 
 
 
 A preliminary data set was measured in-house using a rotating anode as X-ray 
source (U=50 kV, I=80 mA, CuKa:l=1.5418 Å) with a maximal resolution of 2.4 Å using 
a single crystal, shock-frozen in liquid nitrogen and constantly kept at 100 K in a nitrogen 
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stream during the measurement. A high resolution data set (15-1.9 Å) of a single, native 
crystal was collected at beamline ID14-4 at ESRF (Grenoble). The MAD data set (18-2.6 
Å) was collected at beamline BW-6 at DESY (Hamburg) with consecutive measurements 
at three wavelengths. These have been determined by collecting fluorescence spectra at 
energies around the absorption edge (K-edge) of selenium (l1=0.9786 (peak), l2=0.9792 
(inflection), l3=0.9500 (remote)) (Table 9). Diffraction properties of the crystals have 
been improved by (repeated) annealing of the crystal in the cryostream (rewarming of a 
flash-cooled crystal) (Harp et al., 1998). Data reduction was carried out with the software 
packages DENZO and SCALEPACK (Otwinowski and Minor, 1997). The space group 
C2 was unequivocally determined. 
 
Table 9. Data Collection, Phasing, and Refinement Statistics. 
Data Collectiona Native  SeMet 
Space Group 
Unit Cell 
C2 
a = 116.57 Å, b = 40.78 Å, c = 129.26 Å 
a = g = 90°, b  = 114.84° 
# Complexes / asym. unit  1 
X-ray source ESRF, ID14-4b DESY, BW6c,d 
Wavelength (Å) 
 
l = 0.9287 
 
l1 = 0.9786 
(peak) 
l2 = 0.9792 
(inflection) 
l3 = 0.9500 
(remote) 
Resolution (Å) 15-1.95 (2-1.95) 18-2.6 (2.67-2.60) 18-2.6 (2.67-2.60) 18-2.6 (2.67-2.60) 
I / sI 21.0 (3.6) 16.7 (5.9) 17.6 (7.0) 12.8 (7.0) 
Completeness (%) 99.5 (99.6) 98.2 (97.8) 98.1 (97.4) 98.1 (97.7) 
Rsym (%) 5.6 (27.0) 3.3 (10.5) 3.2 (9.6) 3.2 (9.0) 
MAD Phasinge 
Anomalous scatterer  Selenium (6 of 6 sites) 
Resolution (Å)  18-2.6 
Figure of merit   0.59 
Model Refinementf 
Resolution (Å) 15-1.9  
# reflections Rwork  / Rfree 40,599/3149  
Rwork  / Rfree (%)g 23.4/27.9  
# solvent molecules 359  
R.m.s.d. bond length (Å) 0.01  
R.m.s.d. angles (°) 1.4  
aValues as defined in SCALEPACK (Otwinowski and Minor, 1997); bEuropean Synchrotron Radiation Facility in Grenoble, 
beamline ID14-4; cDeutsches Elektronen Synchrotron in Hamburg, beamline BW6; dBijvoet pairs separated; eValues as 
defined in SOLVE (Terwilliger and Berendzen, 1999); fValues as defined in CNS (Brünger et al., 1998); gNo sigma cutoffs. 
 
 Phase information and structure solution was obtained automatically using the 
software package SOLVE (Terwilliger and Berendzen, 1999). After solvent correction 
with DM (CCP4, 1994), the known structure of the ATPase domain of Hsc70 was placed 
into the electron density, and the structure of the Bag domain was built manually. The 
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structure was refined with the program package CNS (Brünger et al., 1998). All statisitics 
of data collection, phasing and refinement are summarized in Table 9. 
The somewhat high Rfree of the final model can in part be attributed to significant 
radiation damage during the collection of the native data set that could only be partially 
corrected during data processing and scaling. The His6-tag of the Hsc70 ATPase is 
completely disordered and is not included in the final model. Furthermore, three loop 
regions in the ATPase domain and one loop in Bag were less structured and contain some 
residues which could only be built as alanines since there was no significant density for 
their side chains. Nevertheless, the geometry of the refined model is of good quality with 
respect to bond lengths and angles (standard deviation from the ideal values of 0.01 Å for 
bond length and 1.4° for bond angles) (Engh and Huber, 1991). Analysis of f-y-torsion 
angles using a Ramachandran plot (Ramachandran and Sasisekharan, 1968) showed all 
amino acids in most favored and allowed regions except Gln260, a residue at the extreme 
C-terminus of the Bag domain (Figure 15). Nevertheless, the residue was included in the 
final model since the quality of the final decreased when it was omitted. 
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Figure 15. Ramachandran plot of the final model of the Bag domain/Hsc70 ATPase 
domain complex structure. All amino acids are in mostly favored or allowed regions 
(except Gln260 of the Bag domain). 
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C.3.5 Crystal structure of the Hsc70 ATPase/Bag complex 
 The final model of the complex between the Bag domain and the ATPase domain 
of Hsc70 is shown as a ribbon representation (Figure 16A) and, in the same orientation, 
as a representation of the accessible surface (Figure 16B). The Bag domain is monomeric 
and forms an anti-parallel three-helix bundle. Helices 2 and 3 contact the subdomains IB 
and IIB of the ATPase (Figure 16A and B) whereas helix 1 does not contact the ATPase 
domain. The contact within the heterodimer cannot be explained by crystal packing 
effects which mainly involve helix 1 of the Bag domain and areas of the ATPase domain 
not involved in Bag binding (data not shown). Upon crystallization, a disulfide bridge 
between Cys259 at the very C-terminus of the Bag domain and Cys201 was formed 
resulting in a short, non-regular stretch in helix 2, in an area not relevant for Hsc70 
binding. However, binding of the Bag domain to Hsc70 was not affected by reducing 
agents as observed in binding studies (ITC in buffer supplemented with a glutathione 
redox system; data not shown). 
 
 
Figure 16. The Bag-domain/Hsc70 complex. (A) The backbones of the Bag domain (red) 
and the ATPase domain of Hsc70 (green) shown in a ribbons representation generated 
with the program Bobscript (Esnouf, 1999). (B) The electrostatic potential of the Bag 
domain/Hsc70(5-381) complex modeled onto the accessible molecular surface as 
calculated and visualized by GRASP (Nicholls et al., 1993). Red and blue indicate 
negative and positive charges, respectively. Orientation as in (A). 
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The consequence of Bag-1 binding to the Hsp70 ATPase domain is a 14-degree 
rotation of subdomain IIB about a hinge in the region of Leu228 and Leu309 relative to 
the structure of Hsc70 with ATP bound (Figure 18A and 27) (Flaherty et al., 1990). In 
this region, the highest root mean square deviation (rmsd) between the two structures is 
observed (Figure 17). The route mean square deviation (rmsd) of the superposition is 
shown as a function of residue number of Hsc70 as calculated with the program module 
from the CNS software package. Significant differences between the two structures are 
solely seen in residues of subdomain IIB of the ATPase. This is in agreement with a 
calculation of the rmsds for the different subdomains as calculated using the SwissPDB 
viewer program (see inset of Figure 17). Figure 18A shows the superposition of the ATP-
bound and the Bag-bound ATPase. The color code represents the rmsd of the 
superposition. Furthermore, there was no significant density in the Bag-containing 
complex which could account for bound ADP or ATP (Figure 18B). All attempts to soak 
crystals in nucleotide-containing precipitant solutions resulted in rapid destruction of the 
crystals, indicating that Bag binding is incompatible with nucleotide binding. This is also 
supported by the affinity measurements in the presence and absence of nucleotide (Table 
7). 
 
 
Figure 17. Route mean square deviation (rmsd) of the superposition of the ATPase 
domain in complex with ATP and the Bag domain. The bar diagram represents the rmsd 
values of the superposition of the two structures for each residue as calculated using CNS 
(Brünger et al., 1998). The inset shows the rmsd values for each subdomain as calculated 
with SwissPDB viewer. 
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Figure 18. Analysis of the Hsc70 ATPase/Bag domain structure in comparison to the 
nucleotide-bound structure. (A) Superposition of Hsc70(5-381) in complex with the Bag 
domain (grey) with the nucleotide-bound domain of Hsc70 (rmsd) (PDB code 3HSC). 
The color code represents the root mean square deviation (rmsd) of the superposition 
calculated and visualized by SwissPDB Viewer (blue, low degree of deviation; red, high 
degree of deviation). (B) Stereoview of a 2fo-fc simulated annealing omit map of the 
Hsc70 region involved in ATP binding and hydrolysis calculated in the absence of the 
indicated residues (contour level at 1 sigma). (C) Stereoview of the superposition of the 
sidechains in Hsc70 involved in ATP binding and hydrolysis. The nucleotide-bound state 
is drawn in grey, the conformation of the respective residues in the Bag domain/Hsc70(5-
381) complex is drawn in orange. 
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The high resolution crystal structure allowed the analysis of the conformational 
changes in positions that are critical for nucleotide binding and hydrolysis by 
superimposing relevant residues from Hsc70 bound to ATP (Flaherty et al., 1990) and 
Hsc70 bound to Bag. Figure 18B and C show Hsc70 residues responsible for ATP 
binding and hydrolysis in a ball-and-stick representation. A 2fo-fc simulated annealing 
omit map of the Hsc70 region involved in ATP binding and hydrolysis calculated in the 
absence of the indicated residues (contour level at 1 sigma) is also shown revealing the 
reliability and quality of the structural model (Figure 18B). The main changes in the 
ATPase domain induced by binding of the Bag domain occur in residues of subdomain IA 
and IIB that orient the adenosine moiety of the nucleotide (Figure 18C). The positions of 
other residues in the binding cleft and the residues involved in catalysis of ATP 
hydrolysis in subdomains IB and IIA are not significantly altered. The structural 
transition results in a movement of Glu268, Lys271, and Ser275 in domain IIB and 
Thr13, Thr14, and Tyr15 in subdomain IA away from their position in the nucleotide-
bound structure. This leads to an opening of the nucleotide binding cleft. Additionally, the 
sidechain of Arg272 assumes an alternative conformation when compared to the 
nucleotide-bound state. In the latter state, Arg272 and Arg342 form a clamp that fixes the 
adenine ring via hydrophobic interactions and the p-electron system of their guanidinium 
groups. 
 
 
C.3.6 Mutational analysis of the Bag/Hsc70 interaction 
In Figure 19A, the contacts of the Bag/Hsc70 interaction are presented in detail 
using the software package LIGPLOT (Wallace et al., 1995). Binding of the monomeric 
Bag domain to the ATPase domain is mediated by electrostatic interactions, mainly 
exploiting residues Glu212, Asp222, Arg237 and Gln245 in Bag-1 (Figure 19A). To 
further confirm the relevance of our structural model, we performed site-directed 
mutagenesis to produce single amino acid changes in some residues showing multiple 
interactions. These are shown as ball-and-stick presentation in Figure 19B. 
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Figure 19. Interactions between Hsc70 and the Bag domain. (A) The diagram was 
produced by LIGPLOT (Wallace et al., 1995). Red: residues of Bag-1M; green: residues 
of Hsc70. (B) Ball-and-stick presentation of residues targeted for site-directed 
mutagenesis. 
 
 
 Mutations Glu212Ala and Glu219Ala in the Bag domain resulted in a substantial 
reduction (about 8-fold) in binding affinities to the ATPase domain of Hsc70 (Figure 
20A). The mutation Arg237Ala affected the binding even more drastically showing a 
more than 10-fold reduction. The lower affinities to Hsp70 correlated with a reduced 
stimulation of the ATPase rate of Hsc70 (Figure 20B). Mutation of Glu212 and Glu219 
still showed about 50% of the wild type activity in stimulating the ATPase rate whereas 
mutation of Arg237 resulted in a loss of this function matching the differential effects of 
the different mutations on the binding constants. The same effect was observed in the 
substrate release assay (Figure 21). The partial stimulatory activity of the Bag domain 
containing Ala-substitution in Glu212 or Glu219 on the ATPase rate was sufficient for 
releasing about 50% of the Hsc70 from its substrate compared to the wild-type activity 
(Figure 21A). This activity is still dependent on the presence of ATP. The mutant 
Arg237Ala was almost completely impaired in its release activity, only showing 
background levels comparable to control reactions using buffer alone or ovalbumin 
(negative control). Arg261 in Hsc70 is one of the counterresidues of Glu212 and Glu219 
in Bag-1M. The mutation Arg261Ala in Hsc70 resulted in similar effects on the substrate 
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release activity when treated with wild-type Bag domain protein comparable to the effect 
of the two Bag mutants, Glu212Ala and Glu219Ala, on the release of wild-type Hsc70 
from LBD (Figure 21B). There was almost no additive effect when the mutants in Glu212 
or Glu219 of Bag were used together with mutant Hsc70. 
 
 
Figure 20. Mutants of Bag affecting the affinity to Hsc70 are impaired in stimulation of 
the ATPase activity of Hsc70. (A) Binding constants of the wild type Bag domain and 
mutant proteins to the ATPase domain of Hsc70 were measured by isothermal titration 
calorimetry as described in Material and Methods and Table 7. (B) ATPase rates were 
determined as described before (Figure 12). Error bars represent standard mean deviations 
of three independent experiments. 
 
 
 
Figure 21. Impaired substrate release from Hsc70 correlates with reduced stimulation of 
the ATPase rate by Bag proteins. Release of Hsc70 from its bound substrate (LBD) was 
measured as described before (Material and Methods and Figure 12). (A) Release of 35S-
Met-labeled wild-type Hsc70 from partially denatured immobilized LBD of the 
glucocorticoid receptor was measured upon incubation with the indicated proteins in the 
presence or absence of ATP. (B) Release of 35S-Met-labeled mutant Hsc70 (Arg261Ala) 
was measured as in (A). Error bars represent standard mean deviations of three 
independent experiments. 
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All residues of Bag which are involved in the interaction with Hsc70 are highly 
conserved in all known mammalian Bag proteins. Furthermore, they are conserved in Bag 
proteins from D. melanogaster, C. elegans, and S. pombe which have been discovered 
recently (Takayama et al., 1999). A structural alignment using the PSI-BLAST internet 
interface (http://www.ncbi.nlm.nih.gov) and the knowledge about the exact contact 
surface revealed the existence of Bag proteins in all eukaryotic species including S. 
cerevisiae and A. thaliana, organisms in which no Bag family members had been 
identified so far (Figure 22). The Bag protein in S. cerevisiae, Snl1p, will be the subject 
of further work as discussed below. Other highly conserved residues are probably 
involved in proper folding (e.g. packing interactions) of the Bag domain (highlighted in 
blue). 
 
 
Figure 22. Structure-based sequence alignment of Bag domain proteins from different 
species. Conserved residues forming the interaction surface with the Hsc70 ATPase 
domain are highlighted in red and residues important for packing interactions are shown 
in blue. (Accession numbers: human Bag-1M, Q99933; human Bag-3/CAIR/BIS, 
AAD16122; human Bag-4, AAD16123; human Bag-5, AAD16124; C. elegans Bag-1, 
AAD16125; S. pombe Bag-1B, AAD16127; S. cerevisiae Snl1p, NP_012248; D. 
melanogaster gene product, AAF49807; A. thaliana putative protein, CAB87278). 
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The existence of Bag proteins in all eukaryotic organisms strongly correlates with 
the conservation of Hsp70 within the residues responsible for Bag binding (Table 10). 
These residues are only conserved in the cytosolic forms of Hsp70 proteins but not in 
their paralogs from organelles (e.g. mitochondria or the endoplasmic reticulum) or 
bacterial homologs, proteins that either rely on GrpE as a nucleotide exchange factor 
(E. coli DnaK and mitochondrial Hsp70) or are thought to function independent of an 
exchange factor (BiP). 
 
Table 10. Conservation of Bag binding residues in Hsp70 proteins.a 
Bag 
binding 
residuesb 
Hsc70 
mouse 
BiP 
mouse 
mHsp70 
mouse 
Hsp70 
C. ele. 
Hsp70 
Dros. m. 
Ssa1 
S. cerv. 
Ssb1 
S. cerv. 
Hsp70 
A. thal. 
DnaK 
E. coli 
D46 P P P P P P P P P 
N57 P P R P P P P P R 
M61 P S T P P P L P T 
R258 P P M P P P P P D 
R261 P Q Q P P P P P A 
R262 P K P P P P P P M 
T265 P R E P P P P P L 
E283 P P N P P P P P D 
S286 P P Y P A P P P L 
D292 P P S P P P P P P 
Y294 P S N P P P E P H 
a, Accession numbers: mouse Hsc70, P08109; mouse BiP, P20029; mouse mitochondrial Hsp70, 
P38647; C.elegans Hsp70, P09446; D.melanogaster Hsp70, P02825; S.cerevisiae Ssa1, P10591; 
S.cerevisiae Ssb1, P11484; A. thaliana Hsp70, P22953; E. coli DnaK, P04475;b, Residues of rat Hsc70 
amino acid sequence involved in binding of the Bag domain (Sondermann et al., 2001). 
 
 Taken together, the Hsc70 ATPase/Bag domain structure elucidated the 
mechanism by which Bag proteins act on Hsp70. The functional relevance of the 
structural model was additionally confirmed by mutational analysis. Furthermore, 
structural alignments revealed the existence of Bag proteins in the cytosol of all 
eukaryotic species with a very high degree in conservation with respect to the established 
interaction surface. 
 
 
C.3.7 Characterization of the Bag protein Snl1p from S. cerevisiae 
 Because the overall homology of the S. cerevisiae protein Snl1p to Bag-1 is low, it 
did not produce a significantly high score in conventional BLAST searches. Therefore, a 
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characterization of its effect on Hsp70 was carried out to confirm its function as a Bag 
protein. Although all residues corresponding to the Hsp70-binding residues in Bag-1 are 
conserved, there is almost no similarity in the putative helix 1 and further upstream 
sequences between Snl1p and Bag-1. Snl1p harbors a predicted, single transmembrane 
domain at its N-terminus. The putative Bag domain is predicted to face the cytosol. By 
indirect immunofluorescence staining and cellular fractionation experiments, the protein 
was shown to be localized at the nuclear and endoplasmic reticulum membrane. In this 
work, homology of Snl1p to another nuclear pore transmembrane protein unrelated to the 
known Bag proteins had been proposed (Wente et al., 1999). 
 DNA encoding the cytosolic fragment of Snl1p, consisting of the putative Bag 
domain, was cloned into a vector for overexpression in E. coli using chromosomal yeast 
DNA as template for PCR-based cloning. Since the homology within helix 1 is poor and 
exact domain borders could not be unambiguously predicted, two constructs were 
produced varying in length at their N-termini. Proteins were overexpressed as His6-tagged 
fusions, and purified as described in Material and Methods. Both proteins were highly 
soluble. 
 Their effect on Hsp70 was analyzed using ATPase and substrate release assays. 
Both systems were heterogenic because they were based on mammalian Hsc70. 
Nevertheless, all residues of the interaction surface between Bag-1 and Hsp70 are 
conserved across the species borders (see Table 10). 
 Both proteins containing the cytoplasmic domain of Snl1p stimulated the ATPase 
rate of Hsc70 efficiently, comparable to the effect seen with the isolated Bag domain 
(Figure 23A) and Bag-1M (Figure 12). As seen before, this effect was highly dependent 
on the presence of Hsp40, and no effect of the Bag domain of Snl1p was seen when 
Hsp40 was omitted from the reaction. As observed with the Bag domain and Bag-1M, 
Snl1p also stimulated the release of Hsc70 from substrate in an ATP-dependent reaction 
(Figure 23B). The substrate release was as efficient as observed with the other Bag 
proteins. 
 The stimulation of the Hsc70 ATPase activity and substrate release, comparable to 
the effect of mammalian Bag-1, clearly establishes Snl1p as the first and probably the 
only Bag protein in S. cerevisiae. Furthermore, the primary sequence of Snl1p could be 
modeled on the tertiary structure of the Bag domain with the residues of helix 2 and 3 
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covering the full interaction surface of Bag and Hsc70 (Figure 24). This is in agreement 
with the structural alignment and functional similarity to other Bag proteins. 
 
 
Figure 23. Functional characterization of Snl1p. (A) Snl1p and the Bag domain stimulate 
the ATPase activity of Hsc70 in an Hsp40-dependent manner. ATPase rates were 
determined as described before (see Material and Methods and Figure 12). (B) Snl1p and 
the Bag domain stimulate Hsc70 release from substrate polypeptide in a nucleotide-
dependent manner. Release of 35S-Met-labeled Hsc70 from partially denatured 
immobilized ligand binding domain (LBD) of the glucocorticoid receptor was measured 
as decribed (see Material and Methods and Figure 12). Error bars represent standard mean 
deviations of three independent experiments. 
 
 Since the in vitro experiments with Snl1p were performed in a heterogenic system, 
the ability of the Bag domain of Snl1p to bind the yeast homologs of Hsp70, especially 
the main cytosolic isoforms Ssa and Ssb, was tested. The recombinantly expressed, His6-
tagged Bag domain of Snl1p, bound to NiNTA-agarose beads was allowed to interact 
with total yeast lysates and then recovered with associated proteins. These proteins were 
analyzed by SDS-PAGE, Coomassie staining or Western blotting with antibodies specific 
for either Ssa or Ssb proteins. 
 His6-Snl1p Bag domain associated mainly with two proteins (double band) from 
yeast lysates with a molecular weight of approximately 65-70 kDa (Figure 25). The 
interaction was most stable under nucleotide-free conditions (Apyrase, Apy), but was 
significantly weakened in the presence of either ATP or ADP. This behavior mirrors that 
observed with Bag-1M and Hsc70 (see above). The protein band around 45 kDa 
coprecipitated from the Apyrase-treated lysate is likely to be the ATPase domain of yeast 
Hsp70, proteolytically cleaved during the incubation periods of the pull down. Similar to 
the 70 kDa bands, the 45 kDa band also dissociated from the Snl1p domain in the 
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presence of nucleotides. Control NiNTA beads lacking the Bag domain did not bind to 
proteins in yeast lystates, as seen in the Coomassie-stained gel. 
 
 
Figure 24. Modeling of the C-terminal domain of Snl1p on the structure of the Bag 
domain of Bag-1M. (A) Structural alignment of Bag-1M and Snl1p. Helices of Bag-1M 
are indicated. Residues highlighted in red indicate the modeled part of Snl1p in (B). (B) 
Structural model of a subdomain of Snl1p aligning with Bag-1M. The Snl1p model was 
generated using the SwissModel internet interface (http//www.expasy.ch). Presentation 
was generated with the program Bobscript (Esnouf, 1999). Black labels correspond to the 
sequence of Bag-1M, red labels correspond to the sequence of Snl1p. (C) Stuctural model 
of the ATPase domain of Hsc70 in complex with the subdomain of Snl1p modelled in 
(B). Presentation was generated with the program WebLab viewer Pro (MSI). 
 
 
 The identities of the Snl1p-interacting proteins were revealed by Western blotting. 
A specific antibody raised against Ssa proteins, the major cytosolic isoforms of Hsp70 in 
yeast, clearly recognized one band of the doublet around 70 kDa. As had already been 
seen in the Coomassie-stained gel, the signal was strongly diminished in the presence of 
ATP and ADP to the level detected on the control beads. Similar results were obtained 
when a Ssb-specific antibody was used for detection. Ssb proteins are mainly bound to 
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the ribosome but there is also a free pool in the cytosol (Pfund et al., 1998) and for steric 
reasons, this is likely the population which interacts with Snl1p. Again, binding was 
strongest under nucleotide-free conditions, and substantially reduced in the presence of 
ATP and ADP. Nevertheless, there might be a preference for ADP over ATP since there 
is still more Ssb bound in the presence of ADP compared to ATP. As seen in Table 10, 
residues involved in Bag binding are conserved in Ssa as well as Ssb proteins; the latter 
sequence shows three minor changes mainly in hydrophobic contacts between Bag and 
the ATPase domain. 
 
 
Figure 25. NiNTA-pull down of Ssa and Ssb proteins from yeast lysates with the His6-
tagged Bag domain of Snl1p as bait. Proteins (60 mg) were bound to NiNTA resin  in 
buffer B for 20 min at room temperature. Beads were washed twice. Control beads 
without bound proteins were processed identically. Reactions were supplemented with 
yeast lysates. Binding (20 min at room temperature) was performed either in the presence 
of Apyrase (4 Units/ml), 5 mM ATP/Mg2+, or 5 mM ADP/Mg2+. Beads were washed 3-
times with the respective binding buffer. Bound proteins were eluted from the resin with 
2x SDS-PAGE sample buffer and analyzed by SDS-PAGE and Western blotting using 
Ssa- and Ssb-specific antibodies. 
 
 
 In summary, the Snl1p could be clearly identified as a Bag protein in S. cerevisiae. 
It has the same effect on the ATPase rate of Hsp70 and the regulation of substrate binding 
by the chaperone as observed with Bag-1M and its Bag domain. Furthermore, it strongly 
interacts with Ssa and Ssb proteins, the major isoforms of Hsp70 in the yeast cytosol. 
This interaction is sensitive to both ATP and ADP, ruling out a substrate-like interaction 
of Hsp70 with Snl1p. 
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C.4 Discussion 
 In the present study, the crystal structure of the Hsc70 ATPase domain in complex 
with the Bag domain of Bag-1M was solved to a resolution of 1.9 Å. The Bag domain 
forms an anti-parallel three-helix bundle inducing a conformational switch in the ATPase 
that is incompatible with nucleotide binding. Biochemical analysis of the functional effect 
of Bag-1 on Hsp70 confirms the functional relevance of the structural model. The 
structure provides a detailed view of the action of Bag-1 on Hsp70 clarifying the 
controversy whether Bag-1 is a nucleotide exchange factor of Hsp70. Furthermore, yet 
unidentified Bag proteins were predicted to exist in all eukaryotic orgasims including A. 
thaliana and S. cerevisiae. The Bag protein of S. cerevisiae, Snl1p, was further 
characterized in vitro, and was confirmed to function as a Bag protein. 
 While this thesis was written, a study was published identifying patches of surface 
residues in Hsc70 involved in Bag-1/Hsc70-interaction by using peptide libraries 
(Petersen et al., 2001). Also, the Bag domain structure solved by nuclear magnetic 
resonance (NMR) techniques was published (Briknarová et al., 2001). NMR chemical 
shift experiments marking the ATPase-interacting surface of the Bag domain are in 
agreement with the crystal structure presented here. 
 
 
C.4.1 Structural comparison of Bag-1 and GrpE 
 A comparison of the present structure with the one of the ATPase domain of the E. 
coli Hsp70 homolog DnaK with its well established nucleotide exchange factor GrpE is 
shown in Figure 26. Although the Bag domain and GrpE of E. coli are structurally 
unrelated (Figure 26A and B), they interact with the same subdomains, IB and IIB, of 
their respective Hsp70 ATPase domains. However, in contrast to the Bag domain, GrpE 
forms a dimer that mainly employs a b-strand subdomain, in addition to contacts from its 
a-helical region, to bind to the ATPase domain of DnaK (Figure 26B and Figure 27B) 
(Harrison et al., 1997). 
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Figure 26. Structural comparison of Bag domain/Hsc70 (A) and DnaK/GrpE complexes 
(B). The ATPase domains of Hsc70 and DnaK are colored green, the Bag domain red and 
GrpE yellow. 
 
 
Hydrophobic contacts from the b-strand region of GrpE reach deep into the 
nucleotide-binding cleft and contribute significantly to the tight interaction of the two 
proteins. In Figure 27, a LIGPLOT analysis is shown of both complex structures, again 
highlighting the different modes of binding of Bag-1 and GrpE to their respective ATPase 
domains of Hsp70. Bag mainly binds to the ATPase via hydrogen bonds, whereas the 
GrpE binding to Dnak is dominated by hydrophobic interactions. Different residues are 
contacted in the Hsp70 ATPase domains of the two complexes. GrpE additionally 
interacts with a loop in DnaK that is not conserved in eukaryotic cytosolic forms of 
Hsp70 (Figure 28B). In addition, it has been suggested that the long, extended helices of 
GrpE also contact the peptide binding domain of DnaK, influencing peptide binding in a 
direct manner. However, there is no indication that Bag-1M has a similar effect since the 
affinities of the full length protein and the isolated C-terminal Bag domain to Hsc70 are 
not substantially different. 
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Figure 27. Comparison of the mode of interaction in the complexes of Hsc70/Bag-1 and 
DnaK/GrpE. The diagrams were produced by LIGPLOT (Wallace et al., 1995). (A) Red: 
residues of Bag-1M; green: residues of Hsc70. (B) Yellow: residues of GrpE; green: 
residues of DnaK. 
 
 
C.4.2 Molecular mechansim of Bag-1 function on Hsp70 
The consequence of Bag-1 binding to the Hsp70 ATPase domain, a 14-degree 
rotation of subdomain IIB about a hinge in the region of Leu228 and Leu309 relative to 
the structure of ATP-bound Hsc70, is shown in Figure 28A. For comparison, the 
superposition of the DnaK/GrpE complex with the Hsc70/Bag structure is presented in 
Figure 28B. The color gradient from blue to red indicates the degree of deviation between 
the structures (blue: low rmsd, red: high rmsd). Despite striking structural differences 
between the Bag domain and GrpE, the conformation of the Hsc70 ATPase in complex 
with Bag is remarkably similar to the conformation of the ATPase domain of DnaK in 
complex with GrpE (Harrison et al., 1997). In both cases, this conformation is 
incompatible with high affinity nucleotide binding. Thus, the eukaryotic Bag domain has 
evolved convergently to induce a nucleotide release mechanism that has been conserved 
in Hsp70 proteins. It remains to be established, whether this conserved switch is exploited 
by as yet unidentified additional exchange factors. 
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Figure 28. Nucleotide exchange mechanism of Bag and GrpE proteins. Superposition of 
Hsc70(5-381) in complex with the Bag domain with the nucleotide-bound domain of 
Hsc70 (PDB code 3Hsc) (A) and with the ATPase domain of DnaK in complex with its 
nucleotide exchange factor GrpE (PDB code 1DKG) (B). Colour code represents the root 
mean square deviations (rmsd) of the superpositions calculated and visualized by 
SwissPDB Viewer (blue, low degree of deviation; red, high degree of deviation). A loop 
region in domain IIB of DnaK not present in Hsc70 is seen in red (maximal rmsd). 
 
 
A similar mechanism has been described for the protein Sos, the nucleotide 
exchange factor of the GTPase Ras (Boriack-Sjodin et al., 1998). In both cases, efficient 
release and rebinding of nucleotides is achieved by a conformational change that is 
induced in the enzyme by insertion of two a-helices from the exchange factor into the 
nucleotide binding cleft. 
 
 
C.4.3 Bag-1 function in protein folding in vitro and in vivo 
 From the structural studies, it is now evident how Bag-1 and most likely all other 
Bag proteins act on Hsp70 proteins, and that they function as nucleotide exchange factors. 
Nevertheless, the cellular function of Bag proteins especially with respect to protein 
folding still remains to be clarified. Present studies available in the literature, carried out 
in vitro and in vivo, fail to produce a clear picture of the influence of Bag action on 
Hsp70-mediated protein folding. In the cytosol, the high level of ATP (approximately 2 
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mM ATP) and a substoichiometric concentration of ADP (approximately 0.2 mM) will 
induce a release of Bag proteins from Hsp70 resulting in an ATP-bound form of Hsp70; 
Hsp40-dependent and/or peptide-stimulated nucleotide hydrolysis will convert Hsc70 to 
its ADP-bound form. 
Under the conditions applied so far, stoichiometric amounts of Bag-1 to Hsp70 
and superstoichiometric concentrations of ATP have been used which will effectively 
shift the equilibrium to ATP-bound Hsp70 as Bag proteins are very potent nucleotide 
exchange factors (see Figure 12). In the Hsp70 reaction cycle, this state is characterized 
by a high on- and off-rate for substrate, a circumstance which might be counterproductive 
for protein folding assuming that a substrate will need a certain time to be bound to the 
chaperone in order to be productively folded. This is also reflected in the results of the 
substrate release assays in this and other studies (Lüders et al., 2000; Zeiner et al., 1997) 
where Bag-1 and the Bag domains dissociate chaperone/substrate complexes in an ATP-
dependent manner. An opposite effect observed in another study, namely prevention of 
ATP-dependent substrate release from Hsp70 by Bag-1, might be explained by the 
different experimental setup (nucleotide-free native gel electrophoresis) and source of 
purified proteins used (Bimston et al., 1998). 
In vitro experiments carried out at different stoichiometries of Hsp70 and Hsp40 
to Bag-1 suggest a differential, concentration-dependent effect of nucleotide exchange on 
protein folding with positive regulation at lower, physiological concentration of Bag-1 
(Kanelakis et al., 1999; Terada and Mori, 2000). In cultured cells, overexpression of 
Bag-1 under a strong constitutive promotor interferes with the refolding of heat-
inactivated luciferase (Nollen et al., 2000). This is consistent with the concentration-
dependent effect of Bag-1 observed in vitro, in that high levels of Bag-1 relative to Hsp70 
are counterproductive for protein folding. It is possible that with lower levels of 
overexpression, Bag-1 may in fact enhance Hsp70-dependent protein folding. However, it 
is more likely that the normal cellular concentrations of Bag-1 and other cochaperones are 
optimal for protein folding, and that any artificial change of the level of these would be 
deleterious. 
Bag binding is incompatible with p48/Hip binding to Hsp70. p48/Hip is reported 
to stabilize the nucleotide bound form of the chaperone, therefore working as a 
counterbalance of Bag proteins (Nollen et al., 2001; Kanelakis et al., 2000). Bag binding 
to a complex of Hsp70 and p48/Hip releases the latter from Hsp70 effectively even in the 
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absence of nucleotide, whereas substrate release from Hsp70 by Bag-1 is highly 
dependent on the presence of ATP (Figure 13). One can imagine a mechanism by which 
p48/Hip binds to the ATPase of Hsp70 in a manner that mechanically ‘clamps’ 
subdomain IIB thereby preventing an opening of the nucleotide binding pocket. This 
might slow down the spontaneous release or exchange of nucleotide. Modelling studies 
and competition experiments suggested a binding site for p48/Hip at subdomain IIB close 
to or overlapping with the Bag binding site on this domain (Velten et al., 2000; Gebauer 
et al., 1997). 
In a cellular context, Bag proteins probably act in specific processes such as 
protein degradation, apoptosis or cellular signalling rather than being general nucleotide 
exchange factors for Hsp70 in de novo protein folding. Their involvement in specific 
cellular processes is achieved by different N-terminal domains of the various Bag 
proteins, such as the ubiquitin-like domain in Bag-1 and the WW domain in Bag-3 which 
might target Bag proteins to specific locations or functional complexes within the cell. In 
addition to the different binding modes of Bag and GrpE to Hsp70/DnaK, this is another 
striking difference between Bag proteins and the bacterial nucleotide exchange factor, 
GrpE, the latter being essential for proper folding of substrates by the DnaK/DnaJ system 
(Ang and Georgopoulos, 1989). 
 
 
C.4.4 S. cerevisiae as a model system for analyzing Bag-1 function in vivo 
 Yeast might be a suitable experimental system to address the cellular function of 
Bag proteins. In particular, the benefits of S. cerevisiae are the ease of genetic 
manipulation and the availability of a fully sequenced genome. Because Snl1p is the only 
Bag protein in S. cerevisiae, defects in the protein will not be immediately complemented 
by pre-existing Bag isoforms, as would be the case in mammalian cells. Snl1p may be 
involved in a limited number of cellular processes, as it is not essential and is localized at 
the nuclear and endoplasmic reticulum membrane. It has been proposed that Snl1p 
contributes to nuclear pore biogenesis, based on its ability to alleviate defects caused by 
expression of mutant nuclear pore proteins (Ho et al., 1998). However, the biochemical 
data presented in this thesis suggests that Snl1p may fulfil its cellular function by 
regulating Ssa (cytosolic Hsp70 in S. cerevisiae), and therefore that Ssa may be involved 
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in nuclear pore assembly. Thus, substitution of wild-type Snl1p with a mutant unable to 
regulate Ssa should lead to specific phenotypes related to nuclear pore biogenesis. The 
mechanism by which Snl1p relieves the nuclear pore phenotypes could also be addressed 
by determining whether the mutant pore proteins are stabilized by the refolding activity of 
Ssa together with Snl1p, or are more effectively cleared by degradation. 
 Most of the Bag proteins in all organisms harbor a protein-protein interaction 
domain in addition to the Hsp70-binding Bag domain, for example a ubiqutin-like domain 
in Bag-1, a WW domain in mammalian Bag-3, or the transmembrane domain of Snl1p in 
S. cerevisiae. It is likely that these domains target the Hsp70-regulatory function of the 
Bag domain to specific complexes or intracellular locations. In case of Snl1p, the 
importance of its endoplasmatic reticulum and nuclear membrane localization is not 
known. This may be experimentally tested in vivo by analyzing nuclear pore biogenesis in 
yeast overexpressing Snl1p lacking the transmembrane domain. 
It has been suggested that the Bag domain itself is capable of binding client 
proteins (Song et al., 2001) in addition to binding directly to the ATPase domain of 
Hsp70. From the structure presented in this thesis, it is probable that a client protein 
binding surface would involve the non-conserved helix 1 of Bag proteins. The lack of 
conservation within this region suggests that the various Bag proteins may have different 
substrate specificities. This possibility could be addressed in yeast by analyzing the 
nuclear pore phenotypes after overexpression of the Snl1p transmembrane domain fused 
to the Bag domain of the mammalian homologs, which will still interact with Ssa via the 
highly conserved binding surface. If these chimeric Bag proteins can rescue the nuclear 
pore defects as well as Snl1p, client protein binding by the Bag domains is likely to be 
promiscuous and not specific for a limited subset of client proteins. 
The distinct phenotypes of nuclear pore defects which can be rescued by Snl1p 
overexpression and the ease of genetic manipulation in S. cerevisiae may allow a detailed 
analysis of these and other aspects of Bag function in vivo. 
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D Characterization of a monocyte/macrophage-specific 
receptor for Hsp70 
 
 
D.1 Introduction 
 The immune system of all vertebrates and some invertebrates is designed to 
recognize and respond to foreign antigens. In such a reaction, antigens are presented by 
almost all cell types on cell surface molecules, major histocompatibility complex (MHC) 
class I and II, to specialized effector cells of the immune system. Subsequently, these 
cells react with a cascade of defense mechanisms against invading microbes or virally 
infected cells which bear the foreign antigens. Activated effector cells also trigger 
mechanisms to heal injured tissues. 
 
 
D.1.1 Mononuclear phagocytes and dendritic cells 
Mediaters of the mammalian immune response reside in the blood. All blood cells 
originate from a single stem cell type in the bone marrow. Differential maturation 
pathways lead to lymphoid progenitor cells, from which natural killer cells, B- and T-
cells arise, and to myeloid progenitor cells, precursors of all other blood cells. Among the 
latter, professional antigen presenting cells (APCs) from the monoblastic lineage, such as 
monocytes and macrophages, are particularily important in antigen presentation since 
they phagocytose and react to foreign particles very efficiently. This is achieved by a 
wide selection of various receptors mediating uptake and sensing of foreign antigens. One 
of them, CD14, is a common marker for monocytes, the first cell type which enters the 
peripheral blood from the bone marrow, and for macrophages, which are matured 
monocytes residing within the tissues. CD14 is a receptor for lipopolysaccharides (LPS), 
a cell wall component of microbes. Upon ligand binding, it triggers release of tumor 
necrosis factor a (TNFa) and other cytokines activating macrophages for an innate 
immune response. 
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Dendritic cells, first visualized as Langerhans cells in the skin, capture and process 
antigens in the periphery, migrate to lymphoid tissues and control lymphocyte function 
(Banchereau and Steinmann, 1998). In that, they are very potent antigen presenting cells 
and initiators of immune responses. Upon uptake of foreign antigens they differentiate 
into their mature form expressing costimulatory factors for a strong immune response. 
Immature dendritic cells can be generated in vitro from peripheral blood monocytes but 
are distinct from them in several aspects. Maturation in vitro is achieved by treatment of 
immature dendritic cells with TNFa and/or LPS. 
 
 
D.1.2 Antigen presentation 
MHC class I and II provide a continously updated display of the intracellular and 
environmental protein composition, respectively. The MHC class I presentation of 
antigens operates in almost all cells providing a mechanism for monitoring viral 
infections and tumors (Pamer and Cresswell, 1998). In the classical pathway, cytosolic 
proteins are hydrolyzed to short peptide fragments mainly by the proteasome, the 
cytosolic degradation machinery of the cell. Subsequently, the resulting peptides, usually 
8 to 10 residues in length, are translocated by the transporter in antigen processing (TAP) 
into the endoplasmic reticulum and become bound by newly synthesized MHC class I 
proteins comprising a polymorphic a chain harboring a transmembrane domain, non-
covalently bound b2 microglobulin and a peptide. The MHC class I/peptide complexes 
then reach the cell surface via the secretory pathway (Rock and Goldberg, 1999; 
Cresswell et al., 1999; Lehner and Cresswell, 1996). Usually peptides are derived from 
autologous proteins and therefore are tolerated by the immune system. Only if foreign 
peptides are displayed, either derived from viral polypeptides or mutated gene products 
such as those appearing in cancer, CD8-expressing cytotoxic T-lymphocytes (CTLs) will 
recognize the peptide/MHC complex and kill the peptide-presenting cell. Presented self-
antigens are not recognized except under abnormal conditions (i.e. in autoimmune 
diseases) due to the lack of the complementary T cell receptor on the CTLs or as a result 
of silencing of autoreactive CTLs. 
In contrast, the MHC class II pathway presents exogenous antigens to the effector 
cells. MHC class II molecules consist of polymorphic a and b  chains, and are present on 
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mononuclear phagocytes, dendritic cells, B lymphocytes, endothelial cells and the thymic 
epithelium. CD4-expressing cells, mostly helper T cells, are responsive to peptide 
presented on MHC class II complexes. Mechanistically, extracellular antigens are taken 
up by antigen presenting cells via receptor-mediated endocytosis, phagocytosis, and 
macropinocytosis. The antigens are proteolytically processed in the lysosomes and loaded 
onto MHC class II molecules which then will reach the plasma membrane by exocytosis 
(Watts, 1997; Germain, 1994). The peptides derived from extracellular proteins usually 
do not leave the vesicular structures and therefore do not appear in the cytosol. 
Recently, there is increasing evidence for a pathway termed cross-priming or 
cross-presentation, in which peptides derived from extracellular proteins appear on MHC 
class I molecules and are recognized by CTLs (Rock, 1996; Carbone et al., 1998; 
Yewdell et al., 1999). Cross-presentation is mainly achieved by professional APCs such 
as macrophages and dendritic cells. After uptake from the extracellular space, antigens 
reach the cytosol by an as yet unknown pathway. The mechanism is size-dependent (£ 30 
kDa) as measured by cytosolic staining of unspecifically internalized labeled dextran 
beads of different relative molecular masses and the appearance of a 30 kDa degradation 
fragment of internalized BSA (Rodriguez et al., 1999). Furthermore, transport is selective 
for proteins not normally resident in the lysosomal/endosomal compartment. Further 
processing of antigens appears to follow the typical MHC class I pathway, that is 
proteolysis by proteasomes in the cytosol, translocation into the ER by TAP transporters, 
and normal MHC class I assembly. Cross-priming is the result of another property of 
molecular chaperones and heat shock proteins (Hsps), namely their role and use as tumor 
rejection antigens (Reed and Nicchitta, 2000; Yewdell et al., 1999). 
 
 
D.1.3 Heat shock proteins in cellular immunity 
The role of molecular chaperones and heat shock proteins (Hsps) in mediating the 
folding of newly-synthesized proteins and the refolding of stress-denatured proteins is 
well established (see general introduction). Hsp70 has further been reported to generally 
enhance MHC class II presentation upon overexpression in macropahges (Panjwani et al., 
1999) by an as yet unknown mechanism. It is also selectively accumulated in exosomes 
of dendritic cells (Théry et al., 1999). 
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In addition, molecular chaperones and Hsps have a role in eliciting specific MHC 
class I immune responses against various tumor-derived and viral antigens that is not yet 
well understood (Srivastava et al., 1986; Nieland et al., 1996). Hsp/peptide complexes 
isolated from tumors were shown to mediate immunoprotection against that tumor in 
mice and may thus prove useful as therapeutic agents in anti-tumor vaccination 
(Przepiorka and Srivastava, 1998). Similarly, MHC class I anti-viral responses have been 
generated with Hsp/peptide complexes. Thus far, three cellular chaperones have been 
identified as potent peptide carriers in these vaccination approaches, namely Grp94 (the 
ER paralog of Hsp90), calreticulin (an ER-specific chaperone), and cytosolic Hsp70 
(Udono and Srivastava, 1994; Basu and Srivastava, 1999; Nair et al., 1999). Historically, 
Grp94 was the first of these discovered to act as a tumor rejection antigen in chemically 
induced sarcomas in mice (Srivastava et al., 1986). Other chaperones such as cytosolic 
Hsp90 or BiP (the ER paralog of Hsp70) are less active (Udono and Srivastava, 1994). In 
vitro, these proteins can induce specific CTL responses against bound peptides (Suto and 
Srivastava, 1995), with a few micrograms of Hsp/peptide complex being sufficient to 
elicit a potent response (Chandawarkar et al., 1999). In vivo, vaccinations with these 
proteins reduce the size and number of seeded tumors. Immune-active Hsp/peptide 
complexes can be isolated from tumor tissue, or reconstituted in vitro from purified 
components (Moroi et al., 2000; Blachere et al., 1997). The antigenic peptides introduced 
in chaperone complexes are ultimately presented on MHC class I molecules of APCs by 
an unknown mechanism that involves peptide uptake by endocytosis (Suto and 
Srivastava, 1995). Recently, receptor-mediated binding and uptake of Grp94 by APCs, 
e.g. dendritic cells and macrophages and B cells, followed by presentation of the bound 
peptides on MHC class I has been reported (Arnold-Schild et al., 1999; Wassenberg et al., 
1999; Singh-Jasuja et al., 2000). Binder and colleagues lately identified CD91 as a 
receptor for Grp94 on the surface of a mouse macrophage cell line (RAW264.7) and on 
primary monocytes (Binder et al., 2000). Such a receptor has not been described for 
Hsp70/Hsc70. To obtain evidences for the existence of such a receptor was the focus of 
the work presented here. 
Subsequent to internalization, alternative routes have been described for 
presentation of the chaperone-bound antigens depending on the structural context of the 
antigenic peptide. An engineered Hsp70 binding sequence fused to an antigenic peptide in 
different manners (C- or N-terminal fusions) determined whether Hsp70-mediated 
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loading of antigenic peptide onto MHC class I involved the classical pathway, involving 
proteasomal degradation and TAP-dependent ER-translocation, or via an as yet unknown 
mechanism in early endosomes (Castellino et al., 2000). An endosomal loading 
mechanism has also been suggested for Grp94-bound antigens after uptake, since a 
colocalization of Grp94 with MHC class I molecules in early endosomes has been 
observed (Arnold-Schild et al., 1999). On the other hand, depletion of cellular ATP and 
blockage of the secretory pathway with the specific inhibitor Brefeldin A abolish the 
effecive presentation of Hsp70-bound peptides on MHC class I molecules suggesting the 
classical loading pathway as the predominant mechanism, independent of processing in 
the acidic, lysosomal compartment (Suto and Srivastava, 1995). Upon uptake, Grp94 
further induces maturation of dendritic cells and downregulation of its receptor (Singh-
Jasuja et al., 2000). 
A different mode of uptake, probably unrelated to the one described before, has 
been described for pre-B cells, antibody-producing effector cells from the lymphoid 
lineage of blood cells. Hsp70 internalization by these cells occurs with very fast kinetics 
resulting in an intracellular staining suggesting a direct translocation across the plasma 
membrane. Furthermore, this process seems to be less restricted regarding the size of the 
protein, but specific for Hsp70 (Fujihara and Nadler, 1999). The uptake of Hsp70 by pre-
B cells is unrelated to the uptake observed with APCs and does not lead to MHC class I 
presentation. The exact mechanism of translocation remains to be established. 
As a more general immunostimulatory effect, Hsp70 and mitochondrial Hsp60 
can induce monocytes and macrophages to produce proinflammatory cytokines (Asea et 
al., 2000; Chen et al., 1999; Moroi et al., 2000). This cellular response is dependent on 
the expression of CD14 and toll-like receptors (Asea et al., 2000; Kol et al. 2000; Ohashi 
et al., 2000). In vivo, increased expression of Hsp70 during tumor cell killing leads to the 
infiltration of immature dendritic cells and macrophages into the tumor tissue and induces 
an innate immune response at the site of cell death. Immature dendritic cells treated with 
the lysates of Hsp70-overexpressing tumor cells are inhibited in their maturation and thus 
maintain the capability for efficient phagocytosis and antigen processing (Todryk et al., 
1999). Whether the chaperone-specific activation of APCs is distinct from the receptor-
mediated uptake of chaperone/peptide complexes remains to be analyzed. 
It is possible that Hsps released from cells act as part of the normal immune 
surveillance system, reaching the extracellular space upon necrosis of cells and probably 
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also apoptosis. Given a limited efficiency of the KDEL retention mechanism for ER 
lumenal proteins, it is also possible that small amounts of Grp94 and BiP may constantly 
be secreted from cells in complex with a variety of antigenic peptides that have been 
transported from the cytosol into the ER lumen for presentation on MHC class I. A 
specific binding of TAP-translocated peptides to Grp94 and calreticulin has been 
demonstrated suggesting a peptide loading mechanism for these chaperones (Lammert et 
al., 1997; Spee and Neefjes, 1997). Futhermore, the reported association of Grp94- and 
Hsp70-related antigens with the cell surface of certain tumor cells (Altmeyer et al., 1996; 
Multhoff et al. 1995) has been suggested to stimulate a natural killer cell response against 
the tumor (Multhoff et al., 1997), but may be unrelated to Hsp-mediated antigen 
presentation. 
 
 
D.1.4 Aim of the project 
 The goal of this project was to reach a better understanding of the molecular basis 
of chaperone-mediated tumor immunity. At the beginning of the work the existence of an 
Hsp70-specific receptor for endocytosis of chaperone/peptide complexes on antigen 
presenting cells had been proposed but not formally demonstrated. 
 The main aim was to establish an assay for the specific binding of Hsp70 to the 
cell surface of antigen presenting cells and the characterization of its binding properties, 
which would then serve as the basis for the identification of such a receptor. The assay 
was to be used to characterize the expression pattern and binding specificity of the 
receptor. Criteria for ligand specificity, in particular competition with homologs from the 
Hsp70 family and other chaperones, nucleotide effects, and peptide binding states were to 
be addressed. 
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D.2 Material and Methods 
Several materials and methods used have been already introduced in Chapter C 
but were also applied in this part of the present thesis. In order to avoid redundancy, only 
techniques will be described in the following which are unique to this part. 
 
 
D.2.1 Chemicals 
All chemicals were of quality pro analysi and were purchased from Merck 
(Darmstadt, Germany) or Sigma-Aldrich (Steinheim, Germany) if not stated otherwise. 
Plastic ware for cell culture was purchased from Greiner (Frickenhausen, Germany). 
 
Amersham (Buckinghamshire, England): Cy3 protein labeling kit. 
Biochrom KG Seromed (Berlin, Germany): DMEM, VLE-RPMI 1640 medium, fetal calf 
serum (low endotoxin), L-glutamine, penicillin/streptomycin. 
Biowhittaker (Walkersville, USA): Limulus Amebocyte Lysate (LAL) Complete Test Kit 
QCL-1000 (Endotoxin determination). 
Life Technologies/GibCo (Karlsruhe, Germany): human recombinant 
granulocyte/macrophage-colony stimulating factor (GM-CSF), human recombinant 
interleukin 4 (IL-4), human tumor necrosis factor a (TNFa). 
Molecular Probes (Leiden, Netherlands): Alexa488 protein labeling kit. 
Nycomed (Oslo, Norway): Lymphoprep, Nycoprep. 
Pharmingen (San Diego, USA): R-phycoerythrin (PE)-conjugated mouse anti-human 
monoclonal antibody aCD1a (clone HI149) and PE-IgG1 isotype control, fluorescein 
isothiocyanate (FITC)-conjugated mouse anti-human aCD83 (clone HB15e) and FITC-
IgG1 isotype control, 7-Amino-actinomycin D (7-AAD, Via-Probe). 
 
 
D.2.2 Instruments 
Becton Dickinson (San Jose CA, USA): FACSCalibur flow cytometer with CellQuest 
sofware. 
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D.2.3 Buffer 
· PBS: 137.0 mM NaCl, 2.7 mM KCl, 8.4 mM Na2HPO4· 2H2O, 1.5 mM KH2PO4, 
adjust with HCl to pH 7.4. 
· PBA: PBS, 1% (w/v) BSA, 0.02% (w/v) sodium azide. 
· PBMC wash buffer: 1% (w/v) BSA, 0.13%  (w/v) EDTA, 0.9% (w/v) NaCl 
 
 
D.2.4 Plasmids and bacterial strains 
 The following plasmids have been used for recombinant expression of native 
proteins (Table 11): 
 
Table 11. Plasmids used in this study. 
ORF Vector Purification tag 
Restriction 
sites Reference 
human hsp70 pProEx HTa His6 (N-term.) EcoRI/XhoI this study 
GST pGEX6P - - Pharmacia 
mouse BiP - His6 (C-term.) - Ingrid Haas 
human hsp40 pQE9 His6 (N-term.) - Minami et al., 1996 
human p60TPR1S pProEx HTa His6 (N-term.) EheI/HindIII Scheufler et al., 2000 
 
 
D.2.5 Mammalian cell culture and cell lines 
All cells were cultured in ‘Very low endotoxin’ (VLE)-RPMI 1640, supplemented 
with 10% FCS, 2 mM L-glutamine and antibiotics (100 U/500 ml penicillin and 100 
mg/500 ml streptomycin) (Seromed/Biochrom, Germany) at constant temperature, 
humidity and athmosphere (37°C, 5% CO2 and 95% air). 
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D.2.5.1 Cell lines 
The following cell lines were used in this study (Table 12): 
 
Table 12. Cell lines used in this study. 
Name Species Type Reference 
ANA-1 mouse macrophage Cox et al., 1989 
Raw264.7 mouse macrophage Ralph and Nakoinz, 1977 
Jurkat human T lymphocyte Schneider et al., 1977 
DC10 human dendritic cell Shen et al., 1997 
THP-1 human monocyte Tsuchiya et al., 1980 
U937 human monocyte Sundstrom et al., 1976 
70Z/3 mouse pre-B lymphoblast Bach et al., 1979 
293 human kidney epithelial Graham et al., 1977 
 
 
D.2.5.2 Isolation of fresh peripheral blood cells 
Human peripheral blood lymphocytes (PBLs) and monocytes (PBMCs) were 
isolated from a healthy donor. Fresh blood was diluted into PBS (1:1) and overlaid on top 
of a Lymphoprep cushion (Nycomed). After centrifugation at 500xg for 30 min, the 
interfaces containing the PBL- and PBMC-population were separated and mixed with 
FCS. After additional washing with PBS the cells were transferred into binding buffer 
PBA (PBS, 1% (w/v) BSA, 0.02% (w/v) sodium azide). 
Alternatively, monocytes were isolated using a Nycoprep gradient (Nycomed) 
resulting in a highly enriched PBMC population consisting of more than 95% CD14+ 
cells. The PBLs were removed during the isolation procedure. Specifically, fresh blood 
was supplemented with 0.1 volumes of 6% dextran and incubated for 40 min at room 
temperature. The plasma depleted of erythrocytes was centrifuged through a Nycoprep 
cushion (Nycomed) for 15 min at 800xg. The interface containing the monocytes was 
washed four times with wash buffer (1% (w/v) BSA, 0.13% (w/v) EDTA, 0.9% (w/v) 
NaCl) by centrifugation at 400xg for 10 min and subsequent resuspension in wash buffer. 
Finally, cells were resuspended in binding buffer PBA and directly used in the binding 
assay. For other experiments, PBMCs were resuspended in freshly prepared VLE-RPMI 
1640 medium and used for generation of primary dendritic cells. 
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D.2.5.3 Generation of primary dendritic cells 
Freshly purified human peripheral blood monocytes (Nycoprep gradient) were 
resuspended in VLE-RPMI medium additionally supplemented with 400 U/mlGM-CSF 
and 400 U/ml IL-4 and seeded into 24-well plates with 1 ml culture colume per well. 
Medium was carefully changed at day 2 and 4. For maturation of primary dendritic cells, 
cells were treated with 1000 U/ml LPS and/or 0.3 ng/ml TNFa for two additional days. 
Differentiation from PBMCs to dendritic cells were monitored by detection of CD1a cell 
surface expression, and maturation was controlled by expression of CD83 on the cell 
surface surface using FITC- and PE-conjugated monoclonal antibodies, respectively. 
Unrelated antibodies were used as isotype control. 
 
 
D.2.6 Protein expression and purification 
The cDNA of human Hsp70 (Mojave Therapeutics, New York, USA) was 
amplified by PCR and cloned into the prokaryotic expression vector pProExHTa (Life 
Technologies/GibCo) encoding a N-terminally His6-tagged protein. All recombinant 
proteins were expressed in E. coli BL21(DE3)pLysS cells grown in terrific broth 
supplemented with 100 mg/l carbenicillin (Sigma) at 18°C for 12 hours after induction 
with 0.5 mM IPTG at OD600=1.5. Cell lysates were prepared by repeated freeze-thawing 
and subsequent addition of lysozyme (Sigma) and Benzonase (Merck) followed by 
sonication and centrifugation at 100,000xg for 30 min at 4°C. Recombinant Hsp70 was 
purified by NiNTA chromatography followed by anion exchange chromatography on 
MonoQ (Phamarcia) and gel filtration on Sephacryl S-200 (Pharmacia), equilibrated 
with PBS. 
Human Hsp40 was expressed and purified using the plasmid pQE-9/Hsp40 as 
described (Minami et al., 1996). GST was expressed from pGEX6P vector (Pharmacia) 
and purified by glutathione-Sepharose chromatography. Hsc70 from bovine brain and 
liver and DnaK from E. coli were purified as described (Minami et al., 1996). 
The Hsp70 proteins used were functionally active as determined by their ability to 
bind the unfolded polypeptide reduced carboxymethylated a-lactalbumin (RCMLA) 
(Palleros et al., 1991) and to hydrolyze ATP in a manner sensitive to stimulation by the 
cochaperone Hsp40 (Liberek et al., 1991; Minami et al., 1996). Analytical gel filtration 
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was performed to exclude the appearance of aggregated Hsp70 protein before and after 
fluorescent labeling (data not shown). 
Protein concentrations were determined by Bradford assay (Pierce). Endotoxin 
contamination of all proteins was measured by quantitative chromogenic Limulus 
Amebocyte lysate assay (BioWhittaker) following the manufactorers’ instruction. 
Proteins were labeled using the protein labeling kit Alexa488 (Molecular Probes) 
or Cy3-labeling (Amersham) following the manufacturers’ instructions. FITC-labeled 
transferrin was comercially available (Molecular Probes). 
 
 
D.2.7 Hsp binding and uptake 
After two days of continuous culture, cells grown to sub-confluency (1.5x106 cells 
/ml) were gently washed off the culture flask. Cells were centrifuged at 500xg, 4°C for 5 
min and resuspended in PBA for binding assays (4°C) or in complete medium containing 
FCS for uptake experiments (37°C). 5x105 cells were incubated for 45 min at 4°C or 
37°C with 1 mM Alexa488-labeled ligand in the presence or absence of 20-fold excess of 
unlabeled competitor in a final volume of 500 ml. Cells were washed twice with 1 ml of 
ice-cold PBA, and finally resuspended in ice-cold PBS containing 1 g/ml propidium 
iodide, then directly subjected to flow cytometry analysis using a FACSCalibur (Becton 
Dickinson). In some experiments, cells were treated with 1.5 mg/ml Pronase dissolved in 
PBS for 30 min on ice before or after the binding assay. Proteolysis was stopped by 
washing cells twice with ice-cold PBA. Propidium iodide staining was used to restrict the 
analysis to viable cells. 
Cell surface binding of Alexa488-labeled proteins was quantified using the 
geometric mean fluorescence value that represents an average fluorescence weighted to 
the number of cells emitting at each fluorescence intensity in the range of 100-104. Values 
were normalized to 100% binding of Hsp70 with 2 to 5% of gated cells in the control 
(autofluorescence). 
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D.2.8 Confocal microscopy 
Microscopic studies have been carried out in colaboration with Felix Wieland and 
Thalia Becker (BZH Heidelberg, Germany). 
Cells were resuspended in medium containing 10% FCS. After incubation for 
binding with 100 nM Hsp70 or GST and 20 nM transferrin for 45 min on ice, cells were 
washed 4 times with 1 ml PBS and finally resuspended in 0.2 ml complete medium. Cells 
were either directly seeded onto sterile glass cover slips coated with poly-L-lysine for 10 
min or after additional incubation for 30 min at 37°C, followed by fixation with 3% 
paraformaldehyde for 20 min and mounting onto slides. 
Microscopy was carried out with a confocal microscope, Leica TCSSP, at 63-fold 
magnification. 
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D.3.1 Cell-specific binding and uptake of Hsp70 
A flow cytometry-based assay system was established to investigate the binding 
and uptake of human cytosolic Hsp70 by ANA-1 cells, a macrophage cell line, and by 
Jurkat cells, a T lymphocytic cell line. Recombinant Hsp70 was labeled fluorescently 
with the dye Alexa488 under physiological conditions in PBS with two molecules of 
Alexa488 being coupled per molecule of Hsp70 (data not shown). Essentially identical 
cell binding results were obtained with a variety of Hsp70 and Hsc70 preparations, either 
expressed as recombinant proteins or purified from bovine tissue sources. Cells were 
incubated in the presence of labeled Hsp70 with or without unlabeled competitor proteins 
at low temperature (4°C) to inhibit nonspecific endocytosis. Binding analysis was carried 
out by measuring the fluorescence intensity on the cell surface after washing out unbound 
material. Propidium iodide staining was used to restrict the analysis to viable cells 
(usually more than 95% of total). 
ANA-1 macrophage cells bound Hsp70 specifically (Figure 29). The addition of a 
20-fold excess of unlabeled Hsp70 competed the binding of fluorescent-labeled Hsp70 
significantly, indicated by highly reduced fluorescence intensities of the cell surfaces 
(Figure 29A). The same molar excess of the protein glutathione S-transferase (GST) 
(Figure 29B) and several His6-tagged proteins unrelated to Hsp70 (data not shown) were 
without effect. Competition of labeled with unlabeled Hsp70 was incomplete with about 
25% of bound Hsp70 not being competable. This issue will be addressed below in detail. 
Futhermore, Hsp70 binding was cell-type specific; it was observed with ANA-1 cells but 
not with Jurkat cells (Figure 29C and D). Other cells tested with this assay included 
various monocytic/macrophage cell lines (RAW264.7, THP-1, U937), a dendritic cell line 
(DC-10), a pre-B cell line (70Z/3), and kidney cells (293), and none of them showed any 
specific Hsp70-mediated cell surface staining (data not shown). There was no detectable 
ATP- or ADP-dependence of Hsp70 binding to ANA-1 cells (see Figure 33A). Moreover, 
Hsp70 binding was undiminished in the presence of a molar excess of peptide C 
(KLIGVLSSLFRPK) which binds with high affinity to the C-terminal polypeptide-
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binding domain of Hsp70 (Figure 33A) (Flynn et al., 1989). Because Hsp70 binding to 
ANA-1 cells is cell-type specific, nucleotide independent and not competable with 
peptide, it cannot be explained by a chaperone-like interaction of Hsp70 with unfolded 
cell-surface proteins in general. Instead, a more specific mode of binding is suggested. 
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Figure 29. Specific binding of Hsp70 to murine ANA-1 macrophages, but not to Jurkat 
cells. 5x105 ANA-1 cells (A, B) or Jurkat cells (C, D) were incubated at 4°C for 45 min in 
PBA with 1 mM Alexa488-labeled Hsp70 (*Hsp70) in the presence or absence of 20 mM 
unlabeled Hsp70 (A, C) or GST (B, D) as a competitor. Intensity of surface fluorescence 
(x-axis) is plotted against cell counts. Representative results of at least three independent 
experiments are shown. 
 
 
To determine whether the observed binding of Hsp70 to the surface of ANA-1 
cells (Figure 29A and B; Figure 30A) was due to a non-specific association of 
fluorescently labeled proteins with these cells, binding assays were carried out with 
Alexa488-labeled GST and Alexa488-labeled transferrin as control proteins. Transferrin 
was used as a positive control because this protein binds to the ubiquitously expressed 
transferrin receptor. Binding of labeled GST to the cell surface was not observed (Figure 
30B). However, transferrin showed similar properties of binding to ANA-1 cells as 
Hsp70. Unlabeled transferrin inhibited the binding of the labeled protein, whereas GST 
did not compete (Figure 30C). Transferrin did not compete for the binding of labeled 
Hsp70 (data not shown). 
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Binding reactions with ANA-1 cells were also carried out at physiological 
temperature where bulk endocytosis occurs (Figure 30D-F). Specific competition of 
binding and uptake of Hsp70 and transferrin by the unlabeled proteins was again 
observed. However, non-specific endocytosis predominated under these conditions 
(Figure 30D-F), as indicated by the uptake of GST which did not bind specifically to the 
cell surface. 
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Figure 30. Specific binding and uptake of Hsp70 by murine ANA-1 macrophages. ANA-
1 cells were incubated with labeled Hsp70 (*Hsp70) (A and D), labeled GST (*GST) (B 
and E), or labeled transferrin (*TF) (C and F) either at 4°C (A, B, and C) or at 37°C (D, 
E, and F) in the presence or absence of the respective unlabeled ligand as specific 
competitor, or GST as an unspecific competitor. Cells were analyzed as described in 
Figure 29. 
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D.3.2 Saturable Hsp70 cell surface binding by a proteinaceous receptor 
To determine whether surface binding of Hsp70 is mediated by a proteinaceous 
receptor, ANA-1 cells were incubated with the protease Pronase prior to Hsp70 binding. 
This treatment reduced the binding of labeled Hsp70 to the same extent as did the 
addition of excess unlabeled Hsp70 in reactions with control cells (Figure 31A), 
indicating that specific binding of Hsp70 is mediated by proteinaceous sites. The same 
reduction in the amount of bound Hsp70 was obtained when Pronase treatment was 
performed after the binding reaction (Figure 31B), indicating that under the conditions 
used (binding at 4°C), specifically bound Hsp70 remained at the cell surface. In contrast, 
the noncompetable binding of fluorescent labeled Hsp70 is probably not mediated by 
specific protein-protein interactions and may be due to a direct interaction of the 
fluorescence dye with the membrane. 
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Figure 31. Protease-sensitivity of Hsp70 binding to the cell surface of ANA-1 
macrophages. (A) 5x105 cells were treated with 1.5 mg/ml Pronase for 30 min on ice, 
washed twice with PBA, and then incubated with Alexa488-labeled Hsp70 (*Hsp70) (see 
Figure 29). Fluorescence intensities were measured by flow cytometry. (B) Protease 
treatment as in (A) was performed after binding of *Hsp70. 5x105 cells were treated with 
1.5 mg/ml Pronase for 30 min on ice after binding of *Hsp70. Mock treatment without 
protease was carried out as control. Cells were washed twice with PBA and then analyzed 
as in (A). Comparable results were obtained in three independent experiments. 
 
 
The above results strongly suggested that Hsp70 was recognized by a 
proteinaceous receptor expressed by the ANA-1 cells. Such receptor-mediated binding 
was expected to be saturable and to have a reasonably high affinity. To test these 
predictions, we investigated the concentration-dependence of Hsp70 binding to determine 
the binding mode and approximate affinity of the receptor-ligand interaction. ANA-1 
cells were incubated with 0-2 mM of fluorescence-labeled Hsp70, added either alone or in 
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combination with a 20-fold molar excess of unlabeled Hsp70 to determine the level of 
non-specific binding. As expected, competition for binding was optimal at the lowest 
concentration of labeled Hsp70 used where the ratio of specific to non-specific binding 
was maximal (Figure 32A). The difference curve obtained by subtracting non-specific 
binding indicates that specific Hsp70 binding is saturable and occurs with an apparent 
KD<100 nM (Figure 32B). The shape of the binding curve suggests that Hsp70 either 
binds to a single type of receptor or, less likely, to different receptors with binding 
properties that are indistinguishable by this assay. The exact number of Hsp70 receptor 
sites remains to be determined but their density is approximately 10-fold lower than that 
of the transferrin receptor (Huebers and Finch, 1987) and thus should be in the range of 
10,000 per cell. 
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Figure 32. Concentration-dependent binding of Hsp70 to ANA-1 cells. (A) 5x105 ANA-1 
cells were incubated at 4°C for 45 min in PBA with increasing concentrations of 
Alexa488-labeled Hsp70 (0-2 mM) in the absence (filled squares) or presence (open 
squares) of unlabeled Hsp70 (20-fold molar excess). Fluorescence intensities were 
analyzed by flow cytometry and plotted against the concentration of Alexa488-Hsp70 in 
the binding assay. (B) Difference binding curve obtained by substracting non-specific 
binding (open squares) from total binding (filled squares) in (A). Representative results of 
three independent experiments are shown. 
 
 
D.3.3 Specific binding of mammalian but not bacterial Hsp70 to ANA-1 cells 
The specificity of the Hsp70 receptor on ANA-1 cells for Hsp70 proteins from 
various sources was analyzed. Cells were incubated with fluorescently labeled human 
Hsp70 at 4°C in the presence of different Hsp70s as competitors and subsequently 
analyzed by flow cytometry. For comparison, the control reactions as described above are 
repeated here (Figure 33). Bovine Hsc70, either from brain or liver, was as efficient as 
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competitor as unlabeled human Hsp70 (Figure 33A and B). In contrast, the E. coli 
homologue of Hsp70, DnaK, did not compete the binding of labeled human Hsp70 
(Figure 33B), despite the high homology in primary sequence between both species (63% 
similarity, 49% identity). Mammalian Hsp70s and E. Coli DnaK recognize as chaperones 
a similar range of hydrophobic peptides (Blond-Elguindi et al., 1993; Flynn et al., 1983; 
Rüdiger et al., 1997). Thus, the absence of a specific association  of DnaK with the cell 
surface supports the conclusion that Hsp70 binding is not mediated by a chaperone-like 
interaction. The ER paralogue BiP competed only poorly for the binding of labeled Hsp70 
(Figure 33B), and fluorescent-labeled BiP showed only weak binding (data not shown). 
Grp94 from bovine liver did not compete the binding of Hsp70, indicating that the sites 
mediating Grp94 binding (Arnold et al., 1999; Wassenberg et al., 1999) differ from those 
for Hsp70 (data not shown). 
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Figure 33. Properties of Hsp70 binding to the cell surface of ANA-1 macrophages and 
ligand specificity. 5x105 cells were incubated for 45 min at 4°C in PBA with Alexa488-
labeled Hsp70 (1 µM; *Hsp70) in the presence or absence of competitor proteins (20 
mM), nucleotides (2 mM), peptide C (100 mM), or lipopolysaccharide (LPS) (100 mM). 
Fluorescence intensities were analyzed by flow cytometry and quantified by gating with 2 
to 5% of gated cells in the autofluorescence control. Values were normalized to 100% 
binding of labeled Hsp70 without subtraction of the autofluorescence value. Similar 
results were obtained in at least three independent experiments. (A) Unlabeled human 
Hsp70, GST, nucleotides, or peptide C (KLIGVLSSLFRPK) were present in the binding 
reaction. (B) Binding reactions contained, in addition to labeled Hsp70, Hsc70, purified 
from bovine liver or brain, BiP, E. coli DnaK, or LPS. Binding of labeled Hsp70 
remaining after Pronase treatment of cells is shown to indicate the level of non-specific, 
i.e. non-competable, Hsp70 binding. Representative results of three indenpendent 
experiments are shown. The deviation between the experiments was less than 5%. 
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Specific binding of Hsp70 was not mediated by a contamination of the protein 
with lipopolysaccharide (LPS), a ligand of the toll-like receptors and CD14 on monocytes 
and macrophages, because a 100-fold molar excess of LPS did not reduce the binding of 
Hsp70 (Figure 33B). Furthermore, all proteins used in this study were found to contain 
similar amounts of endotoxin in the range of 103 EU/mg protein (data not shown) as 
based on quantitative Limulus Amebocyte lysate assay. 
In summary, these results indicate the existence of proteinaceous receptor sites for 
mammalian but not bacterial Hsp70 on the surface of ANA-1 macrophages. Such receptor 
sites are not found on Jurkat T-lymphocytes and other cell lines tested (see Materials and 
Methods and D.3.1). 
 
 
D.3.4 Localization of bound and internalized Hsp70 by confocal microscopy 
In colaboration with Felix Wieland and Thalia Becker (BZH, Heidelberg), 
confocal microscopy was used to confirm the specific binding of Hsp70 to the cell surface 
of ANA-1 cells and the subsequent internalization of the bound protein. ANA-1 cells 
were incubated at 4°C with either Cy3-labeled Hsp70 or GST. FITC-labeled transferrin 
served as a positive control. At low concentrations of labeled Hsp70 (100 nM) or 
transferrin (20 nM) predominantly specific binding was observed. All cells showed clear 
surface binding of transferrin but no binding of GST (Figure 34A). Upon merging both 
fluorescence channels, only the FITC-transferrin staining was detected. Incubation with 
Hsp70 also resulted in a clear cell surface labeling which showed significant 
colocalization with the transferrin signal (Figure 34B). In both cases, punctate staining 
suggested a clustering of receptors. 
In a second series of experiments cells were shifted to 37°C after protein binding 
and removal of unbound material at 4°C. Whereas no binding and uptake was seen with 
Cy3-GST (Figure 34C), both Hsp70 and transferrin were internalized by the cells upon 
incubation for 30 min at 37°C, resulting in an intracellular, vesicular staining with partial 
co-localization of the two proteins (Figure 34D). 
These experiments corroborate the specificity of the flow cytometry-based 
binding assay and demonstrate that Hsp70 bound at 4°C is competent to undergo 
receptor-mediated endocytosis at 37°C. 
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Figure 34. Surface binding and uptake of Hsp70 by ANA-1 macrophages. (A, B) 
Localization of Hsp70 at the cell surface upon binding at 4°C. ANA-1 cells were 
incubated in the presence of 20 nM FITC-labeled Transferrin and either 100 nM Cy3-
labeled GST (A) or Hsp70 (B) for 45 min at 4°C in medium containing 10% FCS, washed 
as described in Material and Methods, and then analyzed by confocal microscopy. (C, D) 
Uptake of Hsp70 at 37°C after specific binding at 4°C. Following binding as in (A, B), 
cells were incubated for an additional 20 min at 37°C, and analyzed as above. 
Microscopic studies were perfomed by Thalia Becker in the group of Felix Wieland 
(BZH, Heidelberg). 
 
 
D.3.5 Receptor-mediated binding of Hsp70 to PBMCs but not PBLs 
The experiments described thus far analyzed the binding of Hsp70 to transformed 
and immortalized cell lines. Only one cell line, the macrophage cell line ANA-1, was 
observed to bind Hsp70 specifically. Therefore, an analysis of the overall expression 
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pattern of such a receptor on primary human blood cells was performed, which in 
addition would avoid any complications arising from the transformation process. To this 
end a mixture of peripheral blood lymphocytes (PBLs) and peripheral blood monocytes 
(PBMCs) was isolated from fresh blood by Ficoll gradient separation. Binding of 
fluorescence-labeled human Hsp70 was analyzed by flow cytometry as above. Co-
staining of CD14 was used as a specific marker for PBMCs. 
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Figure 35. Specific binding of Hsp70 to peripheral blood monocytes (PBMCs) but not 
lymphocytes (PBLs) in human blood. Cells freshly isolated from peripheral blood were 
incubated at 4°C for 45 min with 1 mM Alexa488-labeled Hsp70 (*Hsp70) in the 
presence or absence of 20 mM unlabeled Hsp70 or GST. Cells were analyzed by flow 
cytometry. (A) Forward-site-scatter plot of isolated peripheral blood cells showing the 
regions used for separate analysis of fluorescence intensities. (B) Fluorescence intensities 
of the whole cell population after incubation with *Hsp70 in the presence of unlabeled 
Hsp70 as specific competitor or GST as unspecific competitor. (C) Hsp70 binding 
analysis of CD14-negative cells in region R2. (D) Hsp70 binding analysis of CD14-
positive cells in region R2. Representative results of at least three independent 
experiments are shown. 
 
 
Upon binding of Hsp70 to the unfractionated mixture of PBLs and PBMCs 
(Figure 35A and B), a biphasic distribution of fluorescence intensity was observed.  
However, specific binding, as judged by competition with unlabeled Hsp70, was only 
detected in the cell population which was labeled more intensely (Figure 35B). Based on 
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co-staining for CD14, these cells were identified as monocytic (Figure 35D). In contrast, 
the CD14-negative cells showed little or no specific Hsp70 binding (Figure 35C). The 
CD14 positive monocytic cells showed the same properties of Hsp70 binding established 
for ANA-1 cells regarding specificity and saturation of binding (data not shown). 
To confirm these findings, a cell fraction enriched in PBMCs and depleted in 
PBLs and erythrocytes was prepared by the Nycoprep gradient technique. Figure 36A 
shows the CD14 positive surface staining of the final preparation of cells and the gating 
used to restrict the flow cytometry analysis to the CD14-positive cells. The forward/side 
scatter density plot in Figure 36B demonstrates the physical homogeneity of the 
preparation. These parameters were used to further restrict the binding analysis to a 
homogenous population of PBMCs. Efficient specific binding of Hsp70 was observed 
with these cells as based on the criteria established above (Figure 36C). 
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Figure 36. Specific binding of Hsp70 to PBMCs isolated by a combined ficoll/osmotic 
gradient. (A) Analysis of freshly isolated PBMCs was restricted to viable cells (ViaProbe; 
fluorescence 3) which were CD14-positive as judged by binding of a CD14-specific, PE-
labeled antibody (fluorescence 2) (R1). (B) Restriction to a cell population with 
homogeneous physical properties (forwad/side scatter; R2). (C) PBMCs were incubated 
at 4°C for 45 min with 1 mM Alexa488-labeled Hsp70 (*Hsp70) in the presence or 
absence of 20 mM unlabeled Hsp70 or GST. Cells were analyzed by flow cytometry. (D) 
An aCD14 antibody (clone MY4; Beckman-Coulter) or an isotype control (IgG2b) was 
used as competitor (20 mM). Representative results of at least three independent 
experiments are shown. 
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Following recent reports that the monocyte-specific receptor CD14 is involved in 
the activation of these cells by Hsp70 and Hsp60 (Asea et al., 2000; Kol et al., 2000), we 
examined whether CD14 directly mediates Hsp70 binding. To address this question, 
binding assays were performed in the presence of a 10-fold molar excess of a CD14-
specific monoclonal antibody, clone My4, which is known to block the CD14-mediated 
activation of monocytes by LPS and to inhibit the activation of human PBMCs by Hsp70 
and Hsp60 (Asea et al., 2000; Kol et al., 2000). However, no competition of Hsp70 
binding by this antibody was observed (Figure 36D). Additionally, pre-incubation of 
PBMCs with anti-CD14 antibodies also failed to reduce the specific binding of Hsp70 
(data not shown). Taken together with the finding that an excess of LPS did not compete 
the binding of Hsp70 (Figure 33B), it appears unlikely that CD14 represents the binding 
site for Hsp70 on the surface of PBMCs. 
 
 
D.3.6 Loss of Hsp70 binding properties upon differentiation to dendritic cells 
 To test whether Hsp70 binding was only restricted to monocytes or also to other 
specialized antigen presenting cells, primary dendritic cells were generated by treatment 
of PBMCs with GM-CSF and IL-4. Differentiation was monitored by expression of CD1a 
on the cell surface. Mature dendritic cells, monitored by expression of CD83, were 
obtained by treatment with LPS and/or TNFa. 
 Although a homogeneous population of differentiated cells was obtained, no cell 
surface binding of Hsp70 was detected either to immature or to mature dendritic cells 
(Figure 37A-D). This is due to a loss of the receptor since PBMCs used for generation of 
dendritic cells showed expression of a Hsp70-specific cell surface receptor, as seen in 
Figure 35 and 36. 
 Thus, specific Hsp70 cell surface binding was only detected on macrophages and 
primary monocytes, but was not observed on lymphocytes or primary dendritic cells. In 
the latter case, down-regulated expression of the Hsp70-specific receptor is the cause for 
the lack of binding. Hsp70-binding is apparently not directly mediated by CD14, the LPS-
receptor on monocytes/macrophages known to be involved in the Hsp70-mediated 
activation of these cells. 
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Figure 37. Loss of Hsp70 binding upon differentiation from PBMCs to dendritic cells. 
Analysis of primary dendritic cells was restricted to viable cells  which were CD1a-
positive as judged by binding of a CD1a-specific, PE-labeled antibody (data not shown) 
(A) An PE-conjugated aCD83 antibody or an isotype control (IgG1) was used to detect 
cell surface expression of CD83. (B) CD1a-positive, but CD83-negative cells were 
incubated at 4°C for 45 min with 1 mM Alexa488-labeled Hsp70 (*Hsp70) in the 
presence or absence of 20 mM unlabeled Hsp70 or GST. Cells were analyzed by flow 
cytometry. (C) An PE-conjugated aCD83 antibody or an isotype control (IgG1) was used 
to detect cell surface expression of CD83. (D) CD1a-positive, CD83-positive cells were 
incubated at 4°C for 45 min with 1 mM Alexa488-labeled Hsp70 (*Hsp70) in the 
presence or absence of 20 mM unlabeled Hsp70 or GST. Cells were analyzed by flow 
cytometry. Representative results of three independent experiments are shown. 
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Several reports appeared recently describing various functions of Hsp70 and other 
molecular chaperones in immunity. Their potential for tumor rejection therapy is 
particularly attractive since such an activity is not due to an adjuvant effect (MHC class 
II-mediated B-cell responses). The MHC class I response mediated by chaperones is 
specific for a certain subset of molecules leading to antigen-selective killing of cells, and 
the chaperone itself does not serve as an antigen. Therefore, the clinical application of a 
therapy based on vaccination with complexes of Hsps and tumor-associated antigenic 
peptides may provide advantages over conventional, less specific treatments like 
chemotherapy or radiation-based therapies once the main tumor mass has been surgically 
removed. Identification of the receptor and the dissection of the pathway of Hsp70-
mediated immunity may lead to new strategies for the development of Hsp-based 
vaccines. 
The basic role of an Hsp70-specific receptor would be to capture Hsp70 with 
bound antigenic peptide for eventual cross-presentation of the latter by MHC class I. The 
three proteins most active in eliciting this activity, Hsp70, Grp94, and calreticulin, would 
be expected to use similar mechanisms. Indeed, a receptor for Grp94 has recently been 
detected on the surface of APCs and has been shown to mediate the uptake of Grp94 into 
clathrin-coated pits and the co-localization with MHC class I components in vesicular 
structures (Arnold-Schild et al., 1999). Because Grp94 is structurally unrelated to Hsp70, 
it seems likely that both proteins bind to different receptors, or at least at different sites of 
a single receptor. This is consistent with our finding that Grp94 is unable to compete the 
binding of Hsp70. However, uptake of Hsp70-peptide complexes followed by peptide 
presentation on MHC class I has also been observed recently, suggesting a similar 
mechanism of receptor-mediated endocytosis (Castellino et al., 2000). 
The expression of a Hsp70-specific receptor on the surface of monocytes and 
macrophages, which are professional APCs, is in agreement with such a function in 
antigen delivery. On the other hand, the observed down-regulation of receptor expression 
on mature and immature dendritic cells, the most potent cells in antigen presentation by 
cross-priming, may suggest a different function or mode of action of the receptor 
described here. 
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Recently, it has been shown that Hsp70 released during tumor cell killing recruits 
T cells, macrophages and dendritic cells into the tumor, resulting in the expression of 
proinflammatory cytokines (Todryk et al., 1999). It is possible that one function of the 
Hsp70-receptor is to mediate this activation response. Interestingly, this stimulatory effect 
was shown to depend on the expression of CD14 on monocytes and Toll-like receptor 4 
on mouse macrophages (Asea et al., 2000; Kol et al. 2000; Ohashi et al., 2000). Whereas 
the activation of APCs by Hsp70 was inhibited by antibodies against CD14, neither the 
same antibody nor a natural ligand of CD14, LPS, was able to inhibit cell surface binding 
of Hsp70 to monocytes and macrophages analyzed in this study. Thus, the CD14-
dependent activation of APCs by Hsp70 may occur downstream of specific receptor 
binding and/or uptake of Hsp70. Although CD14 seems not to be the Hsp70-specific 
receptor, it is noteworthy that the expression of the actual receptor coincides with the 
expression of CD14 on the surface of various cell lines as well as the primary cells 
analyzed. Additionally, preliminary results obtained in this study confirmed the potency 
of Hsp70 in activation of the CD14-positive PBMCs and ANA-1 cells, but not the CD14-
negative cell lines tested (data not shown). The immunostimulatory activation of 
macrophages and monocytes by Hsp70, as measured by cytokine release, is not 
incompatible with uptake and processing of Hsp70/peptide complexes for the purpose of 
antigen presentation. Indeed, activation of cells by Hsp70/peptide complexes may be part 
of their tumor rejection activity. The Hsp70-receptor may thus have a dual role in the 
immune response, serving as a receptor for endocytosis as well as for signal transduction 
resulting in activation of antigen presenting cells. 
In addition to their therapeutic potential, Hsp/peptide complexes may play a role 
as endogenous anti-tumor and anti-viral vaccines. In principle, two routes may be 
envisioned by which Hsps can reach the extracellular space. In the first, Hsps may be 
released into the extracellular space by apoptotic or necrotic cells. In the second route, 
small amounts of antigenic peptide-binding Hsps of the ER lumen, such as BiP and 
Grp94, may constantly be secreted from cells, acting as part of the normal immune 
surveillance system. Based on our finding that BiP binds only weakly to APCs, Grp94 
may be the predominant agent in such a process. 
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F Appendix 
 
 
F.1 Amino acid sequences of Hsc70 and Bag-1M 
 
 
F.1.1 Amino acid sequence of rat Hsc70 
  1 mskgpavgid lgttyscvgv fqhgkveiia ndqgnrttps yvaftdterl igdaaknqva 
 61 mnptntvfda krligrrfdd avvqsdmkhw pfmvvndagr pkvqveykge tksfypeevs 
121 smvltkmkei aeaylgktvt navvtvpayf ndsqrqatkd agtiaglnvl riineptaaa 
181 iaygldkkvg aernvlifdl gggtfdvsil tiedgifevk stagdthlgg edfdnrmvnh 
241 fiaefkrkhk kdisenkrav rrlrtacera krtlssstqa sieidslyeg idfytsitra 
301 rfeelnadlf rgtldpveka lrdakldksq ihdivlvggs tripkiqkll qdffngkeln 
361 ksinpdeava ygaavqaail sgdksenvqd lllldvtpls lgietaggvm tvlikrntti 
421 ptkqtqtftt ysdnqpgvli qvyegeramt kdnnllgkfe ltgippaprg vpqievtfdi 
481 dangilnvsa vdkstgkenk ititndkgrl skediermvq eaekykaede kqrdkvsskn 
541 slesyafnmk atvedeklqg kindedkqki ldkcneiisw ldknqtaeke efehqqkele 
601 kvcnpiitkl yqsaggmpgg mpggfpggga ppsggassgp tieevd 
 
Figure 38. Amino acid sequence of Hsc70 from rattus norvegicus (Accession number: 
S07197). The fragment used for crystallization (residues 5-381) is indicated in bold. 
 
 
F.1.2 Amino acid sequence of human Bag-1M 
  1 mkkktrrrst rseeltrsee ltlseeatws eeatqseeat qgeemnrsqe vtrdeestrs 
 61 eevtreemaa agltvtvths nekhdlhvts qqgssepvvq dlaqvveevi gvpqsfqkli 
121 fkgkslkeme tplsalgiqd gcrvmligkk nspqeevelk klkhleksve kiadqleeln 
181 keltgiqqgf lpkdlqaeal ckldrrvkat ieqfmkilee idtlilpenf kdsrlkrkgl 
241 vkkvqaflae cdtveqnicq eterlqstnf alae 
 
Figure 39. Amino acid sequence of Bag-1M from rattus norvegicus (Accession number: 
XP_005538). The fragment used for crystallization (residues 151-263) is indicated in 
bold. 
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F.2 Abreviations 
 
m   micro (10-6) 
(v/v)   volume/volume 
(w/v)   weight/volume 
Å   Angström (=0.1 nm) 
A. thaliana  Arabidopsis thaliana 
AA/BisAA  acrylamide/Bis-acrylamide 
Ac   acetate 
ADP   adenosine 5’-diphosphate 
APC   antigen presenting cell 
ATP   adenosine 5’-triphosphate 
Bag   Bcl2-associated athanogene 
BiP   binding protein 
C. elegans  Caenorhabditis elegans 
CCT   chaperonin-containing TCP-1 
cdc   cell devision cycle 
CHIP   carboxyl-terminus Hsc70-interacting protein 
CTL   cytotoxic T lymphocyte 
D. melanogaster Drosophila melanogaster 
Da   dalton 
ddH2O   double-destilled water 
DDT   Dithiothreitole 
DNA   deoxyribonucleic acid 
dNTP   didesoxy-nucleoside triphosphate 
E. coli   Escherichia coli 
EDTA   ethylenediaminetetraacetic acid 
ER   endoplasmic reticulum 
FACS   fluorescence-activated cell sorting 
FCS   fetal calf serum 
FITC   fluorescein-isothiocyanate 
FPLC   fast performance liquid chromatography 
F Appendix 136
g   gram 
GM-CSF  granulocyte/macrophage-colony stimulating factor 
Grp78   glucose-regulated protein 78 kDa 
Grp94   glucose-regulated protein 94 kDa 
GST   glutathione-S-transferase 
GTP   guanosine 5’-triphosphate 
HEPES  N-(2-hydroxyethyl)piperazine-N’-(2-ethanesulfonic acid) 
HGF   hepatocyte growth factor 
Hip   Hsc70 interacting protein 
Hop   heat shock organizing protein 
Hsc   heat shock cognate protein 
Hsp   heat shock protein 
HspBP1  heat shock protein binding protein 1 
Ibp   inclusion body binding protein 
IL-4   interleukine 4 
IPTG   isopropyl-b-D-thiogalactopyranoside 
ITC   isothermal titration calorimetry 
k   kilo (=103) 
KD   thermodynamical binding constant 
l   liter 
LB   Luria-Bertani 
LBD   ligand-binding domain 
LPS   lipopolysaccharide 
M   molar 
m   milli (10-3) 
MAD   multiple anomalous dispersion 
MHC   major histocompatibility complex 
min   minutes 
MIR   multiple isomorphous replacement 
MR   molecular replacement 
n   nano (=10-9) 
OD   optical density 
Pi   inorganic phosphate 
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PAGE   polyacrylamide gelelctrophoresis 
PBL   peripheral blood lymphocytes 
PBMC   peripheral blood monocytes 
PBS   phosphate-buffered saline 
PCR   polymerase chain reaction 
PDB   Protein Data Base 
PDGF   platelet-derived growth factor 
PE   R-phycoerythrin 
PEG   polyethylene glycol 
rmsd   route mean square deviation 
S. cerevisiae  Saccharomyces cerevisiae 
S. pombe  Schizosaccharomyces pombe 
SDS   sodium dodecylsulfate 
sec   seconds 
SeMet   selenomethionine 
t1/2   half time 
TAP   transporter in antigen processing 
TB   terrific broth 
TCP-1   T-complex contained protein 1 
TEMED  N,N,N’,N’-tetramethylethylendiamine 
TEV   tobacco etch virus 
TLC   thin layer chromatography 
TNFa   tumor necrosis factor a 
TPR   tetratrico peptide repeat 
TriC   TCP-1 ring complax 
Tris   Tris(hydroxymethyl)aminomethane 
U   Unit 
WB   Western blot 
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F.3 Publications 
 
· Sondermann, H., C. Scheufler, C. Schneider, J. Höhfeld, F. U. Hartl, and Ismail 
Moarefi. (2001). Structure of a Bag/Hsc70 complex: convergent functional evolution 
of Hsp70 nucleotide exchange factors. Science 291: 1553-1557. 
· Sondermann, H., T. Becker, M. Mayhew, F. Wieland, and F. U. Hartl. 2000. 
Characterization of a Receptor for Heat Shock Protein 70 on Macrophages and 
Monocytes. Biol Chem 381: 1165-1174. 
· Obermann W. M. J., H. Sondermann, A. A. Russo, N. P. Paveletich, and F. U. Hartl. 
(1998). In vivo function of Hsp90 is dependent on ATP binding and ATP hydrolysis. 
J Cell Biol 143(4): 901-910. 
 
 
F.4 Published Meeting Abstracts 
 
· Sondermann, H., T. Becker, M. Mayhew, F. Wieland, and F. U. Hartl. (2000). 
Characterization of a monocyte/macrophage-specific receptor for heat shock protein 
70. FALL MEETING OF THE GESELLSCHAFT FÜR BIOCHEMIE UND 
MOLEKULARBIOLOGIE. Munich, October 10-13, 2000. Biol Chem 
381(Supplement Issue): S219. 
 
 
F.5 Unpublished Meeting Abstracts 
 
· Sondermann H., C. Scheufler, C. Schneider, J. Höhfeld, F. U. Hartl, and I. Moarefi. 
(2001). Structure of a Bag domain/Hsc70 ATPase domain Complex: Convergent 
Functional Evolution of Hsp70 Nucleotide Exchange Factors. EuroConference 
/EMBO workshop "Mechanisms and Cellular Functions of Molecular Chaperones": 
May 26 - 31, 2001. 
· Sondermann H., T. Becker, F. Wieland, and F. U. Hartl. (2000). Receptor-mediated 
Binding and Uptake of Heat Shock Protein 70 by Antigen Presenting Cells. COLD 
SPRING HARBOR MEETING “Molecular Chaperones & Heat Shock Response”: 
May 3-7, 2000. 
· Sondermann H., W. M. J. Obermann, A. A. Russo, N. P. Paveletich, and F. U. Hartl. 
(1999). In vivo function of Hsp90 is dependent on ATP binding and ATP hydrolysis. 
KEYSTONE SYMPOSIUM “Protein Folding, Degradation and Molecular 
Chaperones”: April 10-16, 1999. 
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